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Mesenchymal	stromal	cells	
MSCs	features	
Mesenchymal	 stem	 cells	 (MSCs)	 are	 multipotent	 stromal	 cells	 capable	 of	 self-renewal	 and	
multilineage	 mesenchymal	 differentiation	 (Jackson,	 Nesti,	 &	 Tuan,	 2012)	 (Figure	 1).	 MSCs	 represent	
approximately	0.01%	of	mononuclear	 cells	 in	 the	bone	marrow,	and	provide	 functional	and	 structural	
support	 to	hematopoietic	 stem	cells	 (HSCs)	 (Johnson	&	Dorshkind,	1986;	Pittenger	et	al.,	1999).	MSCs	
were	originally	 identified	ex	vivo	 in	 small	numbers	by	plastic	adherence	 from	rat	whole	bone	marrow	
cultures	 (BMMSC)	 (Friedenstein,	Petrakova,	Kurolesova,	&	Frolova,	1968).	However,	plastic	adherence	
does	not	seem	to	represent	an	essential	MSCs	feature.	Indeed,	recent	studies	have	shown	the	existence	
of	a	non-adherent	MSC	subpopulation	with	multipotency	characteristics,	capable	to	migrate	to	the	site	
of	injury,	and	of	tissue	regeneration	(Leonardi	et	al.,	2009;	Z.	L.	Zhang	et	al.,	2009).		
	
Figure	 1.	 MSCs	 multipotency.	 MSCs	 can	 differentiate	 into	 osteoblasts,	 chondrocytes,	 adipocytes,	
astrocytes,	 myocytes,	 skeletal	 cells.	 (James	 A.	 W.	 Review	 of	 Signaling	 Pathways	 Governing	 MSC	
Osteogenic	and	Adipogenic	Differentiation.	Scientifica	(Cairo),	v.	2013,	p.	684736,		2013)	
	
MSCs	 can	 be	 virtually	 found	 in	 all	 postnatal	 organs	 and	 tissues,	 although	 they	 are	 most	 commonly	
isolated	from	bone	marrow	(BMMSC),	adipose	tissue	(ADMSC),	Wharton’s	jelly	umbilical	cord	and	dental	
pulp	(DPSC)	(Campagnoli	et	al.,	2001;	Caplan,	1991;	In	't	Anker	et	al.,	2003;	Nakahara	et	al.,	1991;	Zuk	et	
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al.,	 2002).	MSCs	 have	 been	 isolated	 and	 cultured	 from	 several	 species	 other	 than	 humans,	 including	
mice,	rats,	cats,	dogs,	rabbits,	pigs,	and	baboons	(Javazon,	Beggs,	&	Flake,	2004).	Phenotypically,	MSCs	
express	a	number	of	markers,	none	of	which,	unfortunately,	 is	 specific	 to	MSCs.	 It	 is	generally	agreed	
that	adult	human	MSCs	do	not	express	 the	hematopoietic	markers	CD45,	CD34,	CD14,	or	CD11.	They	
also	do	not	express	the	costimulatory	molecules	CD80,	CD86,	or	CD40	or	the	adhesion	molecules	CD31	
(platelet/endothelial	cell	adhesion	molecule-1),	CD18	(leukocyte	function-associated	antigen-1),	or	CD56	
(neuronal	cell	adhesion	molecule-1),	but	they	can	express	CD105	(SH2),	CD73	(SH3/4),	CD44,	CD90	(Thy-
1),	 CD71,	 and	 Stro-1	 as	 well	 as	 the	 adhesion	 molecules	 CD106	 (vascular	 cell	 adhesion	 molecule-1),	
CD166	(activated	leukocyte	cell	adhesion	molecule),	intercellular	adhesion	molecule	(ICAM)-1,	and	CD29	
(Conget	&	Minguell,	1999;	Galmiche,	Koteliansky,	Brière,	Hervé,	&	Charbord,	1993;	Haynesworth,	Baber,	
&	Caplan,	1992;	Le	Blanc,	Tammik,	Rosendahl,	Zetterberg,	&	Ringdén,	2003;	Pittenger	et	al.,	1999;	Sordi	
et	 al.,	 2005).	 It	 is	 generally	 accepted	 that	 all	MSCs	 lack	 the	 pan-hematopoietic	marker	 CD45	 and	 the	
endothelial	cell	marker	CD31,	although	MSCs	from	other	species	do	not	express	all	the	same	molecules	
as	 those	 on	 human	 cells	 (Peister	 et	 al.,	 2004).	 It	 is	 important	 to	 note	 that	 differences	 in	 cell	 surface	
expression	 of	 several	 markers	may	 be	 influenced	 by	 factors	 secreted	 by	 accessory	 cells	 in	 the	 initial	
passages,	 and	 the	 in	 vitro	 expression	 of	 some	markers	 by	MSCs	 does	 not	 always	 correlate	with	 their	
expression	patterns	 in	vivo	 (Gronthos,	Simmons,	Graves,	&	Robey,	2001).	The	mentioned	variability	 in	
MSCs	marker	expression	is	also	linked	to	variations	in	tissue	source,	method	of	isolation	and	culture,	and	
species	differences	(Baddoo	et	al.,	2003;	Javazon	et	al.,	2004).		
Adult	MSCs	 are	widely	 studied	 in	 the	prospective	of	 clinical	 applications	 for	 their	 immunomodulatory	
properties	 and	 their	 ability	 to	 migrate	 to	 the	 injured	 site	 (homing),	 thus	 stimulating	 bone	 tissue	
regenerative	process	(Ciapetti,	Granchi,	&	Baldini,	2012).	
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Bone	tissue	
Bone	 is	 a	 highly	 specialized	 form	 of	 connective	 tissue	with	 a	mineralized	 extracellular	matrix	
made	of	calcium	and	phosphate	in	the	form	of	hydroxyapatite,	conferring	marked	rigidity	and	strength	
to	the	skeleton	while	maintaining	some	degree	of	elasticity.	In	addition	to	its	supportive	and	protective	
functions,	bone	is	a	major	source	of	inorganic	ions,	actively	participating	in	calcium	homeostasis	in	the	
body.	Morphologically,	bone	tissue	can	be	distinguished	 in	cortical	 (compact)	and	cancellous	(spongy).	
Cortical	 bone	 provides	mechanical	 and	 protective	 functions,	while	 cancellous	 bone	 is	 associated	with	
metabolic	 functions	 (Horwitz	 et	 al.,	 2002).	 Bone	 is	 composed	 of	 different	 cell	 types,	 including	
osteoblasts,	osteocytes,	osteoclasts,	and	bone	lining	cells	(Figure	2).	
	
	
Figure	 2.	Bone	 tissue	with	 bone	 cells.	 (Marks	 S.	 C.,	 Popoff	 S.	 N.	 Bone	 cell	 biology:	 the	 regulation	 of	
development,	structure,	and	function	in	the	skeleton.	Am	J	Anat,	v.	183,	n.	1,	p.	1-44,	Sep	1988)	
	
Osteoblasts,	 osteocytes,	 and	 bone	 lining	 cells	 originate	 from	 local	 osteoprogenitor	 cells,	 whereas	
osteoclasts	arise	from	the	fusion	of	mononuclear	precursors,	which	originate	in	the	various	hemopoietic	
tissues.	Osteoblasts,	which	mature	into	osteocytes,	are	responsible	for	the	deposition	of	the	mineralized	
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matrix	and	the	secretion	of	the	growth	factors	necessary	for	osteogenesis.	Osteoclasts,	derived	from	the	
monocyte-macrophage	 line,	 play	 a	 crucial	 role	 in	 the	 bone	 remodeling	 process	 by	 actively	 resorbing	
bone.	 Bone	 lining	 cells	 are	 flat,	 elongated,	 inactive	 cells	 covering	 bone	 surfaces	 that	 do	 not	 undergo	
either	 bone	 formation	 or	 resorption,	 but	 seem	 to	 act	 as	 precursors	 for	 osteoblasts	 (Chow,	 Wilson,	
Chambers,	&	Fox,	1998;	Matic	et	al.,	2016).	The	bone	extracellular	matrix	is	composed	for	approximately	
95%	 by	 Type	 I	 collagen,	 and	 for	 the	 remaining	 5%	 by	 proteoglycans	 and	 numerous	 noncollagenous	
proteins,	 such	 as	 osteocalcin,	 osteopontin,	 and	 bone	 sialoprotein	 (Kwan,	 Slater,	 Wan,	 &	 Longaker,	
2008).	
There	 are	 two	 processes	 resulting	 in	 the	 formation	 of	 normal	 bone	 tissue,	 or	 osteogenesis,	 both	
involving	 the	 transformation	 of	 a	 preexisting	mesenchymal	 tissue	 into	 bone	 tissue.	 Intramembranous	
ossification	is	the	direct	conversion	of	mesenchymal	tissue	into	bone.	This	process	occurs	mainly	in	the	
bones	of	the	skull.	Endochondral	ossification	is	the	process	by	which	the	mesenchymal	cells	differentiate	
into	cartilage,	and	this	cartilage	is	then	replaced	by	bone.	
The	process	of	intramembranous	ossification	starts	when	a	small	group	of	MSCs	begin	to	proliferate	and	
form	a	 small,	 dense	 cluster	of	 cells,	 called	nodule.	 Then,	MSCs	 inside	 the	nodule	 stop	 replicating	 and	
acquire	morphological	changes:	the	cell	body	becomes	larger	and	rounder,	the	long	thin	cell	processes	
disappear	and	the	amount	of	Golgi	apparatus	and	rough	endoplasmic	reticulum	increase.	Eventually,	all	
of	 the	 cells	 within	 the	 nodule	 develop	 into,	 and	 show	 the	 morphologic	 characteristics	 of,	 an	
osteoprogenitor	cell	(Brighton	&	Hunt,	1991).	Then,	at	this	stage	of	development,	osteoprogenitor	cells	
may	undergo	further	morphological	changes	that	lead	them	to	finally	become	osteoblast.	In	the	process	
of	bone	formation,	osteoblasts	function	in	groups	of	connected	cells.		As	mentioned	above,	osteoblasts	
secrete	 a	 collagen-proteoglycan	 matrix	 that	 is	 able	 to	 bind	 calcium	 salts.	 Through	 this	 binding,	 the	
prebone	 (osteoid)	 matrix	 becomes	 calcified,	 osteoblasts	 become	 osteocytes,	 and	 the	 osteoid	
mineralizes,	giving	rise	to	a	nodule	that	contains	osteocytes.	The	nodule	has	now	become	a	rudimentary	
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bone	 tissue.	 Furthermore,	 the	 entire	 region	 of	 calcified	 spicules	 becomes	 surrounded	 by	 compact	
mesenchymal	 cells	 that	 form	 the	periosteum,	a	membrane	 that	 surrounds	 the	bone.	 The	 cells	on	 the	
inner	surface	of	the	periosteum	become	osteoblasts	and	deposit	osteoid	matrix	parallel	 to	that	of	 the	
existing	spicules.	In	this	manner,	many	layers	of	bone	are	formed.		
Endochondral	ossification	is	the	process	responsible	for	long	bones	development.	In	this	process,	blood	
vessels	invade	cartilage	matrix	at	the	center	of	the	template,	bringing	this	way	osteoblasts	for	producing	
bone.	After	 skeletal	maturity,	bone	 replaces	most	of	 the	 cartilage	 template,	while,	 at	 the	ends	of	 the	
bone,	 it	persists	as	 the	 joint	 surfaces.	The	growth	plate,	 that	 is	a	 cartilaginous	area	 localized	near	 the	
ends	of	the	bone	between	the	cartilaginous	epiphysis	and	the	newly	generated	bone	in	the	metaphysis,	
is	 responsible	 for	 longitudinal	 bone	 development	 during	 skeletal	 growth.	 The	 growth	 plate	 contains	
inside	cells	called	chondrocytes	and	it	is	surrounded	by	the	perichondrium,	a	layer	of	dense	connective	
tissue.	 Through	 the	 resting,	 proliferating,	 prehypertrophic	 and	 hypertrophic	 stages,	 the	 chondrocytes	
experience	 a	 coordinated	 process	 of	 differentiation	 and	 eventually	 programmed	 cell	 death,	 arranging	
the	 scaffold	on	which	new	bone	 is	 formed.	At	 the	 same	 time,	blood	vessels	 continue	 to	bring	 in	new	
osteoblasts	to	elongate	the	bone	(Kronenberg,	2003).		
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MSCs	immunomodulatory	properties	
MSCs	have	been	reported	to	regulate	the	immune	response	in	many	diseases	(Denburg,	Inman,	
Sehmi,	Uno,	&	O'Byrne,	1998;	Puissant	et	al.,	2005;	Siegel,	Schäfer,	&	Dazzi,	2009;	Uccelli,	Moretta,	&	
Pistoia,	 2006).	 Numerous	 reports	 have	 shown	 that	 adult	 MSCs	 can	 affect	 the	 immune	 T-	 and	 B-cell	
response:	they	suppress	T-cell	proliferation,	cytokine	secretion	and	cytotoxicity	and	regulate	the	balance	
of	Th1/Th2	(Glennie,	Soeiro,	Dyson,	Lam,	&	Dazzi,	2005;	Puissant	et	al.,	2005;	Yañez	et	al.,	2006).	Adult	
MSCs	regulate	the	functions	of	regulatory	T	cells	 (Tregs)	 (Selmani	et	al.,	2008),	 increase	B-cell	viability	
but	may	also	inhibit	their	proliferation	and	arrest	the	cell	cycle;	in	addition,	MSCs	affect	the	secretion	of	
antibodies	and	production	of	co-stimulatory	molecules	of	B	cells	(Corcione	et	al.,	2006).	MSCs	inhibit	the	
maturation,	 activation	 and	 antigen	 presentation	 of	 dendritic	 cells	 (Burchell,	 Strickland,	 &	 Stumbles,	
2010;	 Ramasamy	 et	 al.,	 2007),	 and	 interleukin-2	 (IL-2)-induced	 natural	 killer	 (NK)	 cell	 activation	
(Spaggiari,	Capobianco,	Becchetti,	Mingari,	&	Moretta,	2006).	
Interestingly,	 current	 evidence	 suggests	 that	 MSCs	 exert	 variable	 immunomodulatory	 effects	 on	 the	
same	 types	of	 immune	cell	 depending	on	 the	 local	microenvironment	or	disease	 status.	 For	example,	
MSCs	decrease	the	Th1	response	in	patients	with	acute	graft	versus	host	disease	(GvHD)	(Le	Blanc	et	al.,	
2004)and	 autoimmune	 diseases	 such	 as	 systemic	 lupus	 erythematosus	 (SLE)	 (Rafei	 et	 al.,	 2009).	
However,	BMMSC	 lead	 to	a	 shift	 from	Th2	 to	Th1	 responses	 in	airway	allergic	 inflammatory	diseases,	
including	allergic	rhinitis	(K.	S.	Cho	&	Roh,	2010)	and	asthma	(Bonfield,	Nolan	Koloze,	Lennon,	&	Caplan,	
2010).	 Inflammatory	conditions	also	have	been	proven	to	change	 immunomodulatory	gene	expression	
in	MSCs	or	promote	the	cell–cell	contact	effect,	resulting	in	an	enhanced	immunosuppressive	response	
(Ren	et	al.,	2010).	These	observations	suggest	that	MSCs	are	capable	of	switching	their	effects	to	protect	
the	body	from	disease	in	different	situations.		
Although	 the	underlying	mechanisms	of	MSC	 immunomodulation	have	 yet	 to	 be	 elucidated,	 they	 are	
likely	mediated	by	soluble	factors	and	cell	contact-dependent	mechanisms	in	response	to	immune	cells.	
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It	has	been	shown	that	MSCs	regulate	the	adaptive	and	innate	immune	systems	by	suppression	of	T	cells	
and	maturation	of	dendritic	cells,	reducing	B-cell	activation	and	proliferation	and	inhibiting	proliferation	
and	cytotoxicity	of	NK	cells,	and	promote	the	generation	of	regulatory	T	cells	via	soluble	factors	or	cell–
cell	contact	mechanisms	(Fu	et	al.,	2012;	Yagi	et	al.,	2010).	
The	 effect	 of	 soluble	 factors	 on	 the	 activity	 of	MSCs	may	 vary	 depending	 on	 the	 origin	 of	 the	MSCs,	
target	cells	and	the	microenvironment.		
	
MSCs	homing	
Homing	 is	 the	 process	 by	which	 cells	migrate	 to,	 and	 engraft	 in,	 the	 tissue	 in	which	 they	 can	
exert	 local,	 functional	 effects.	 The	 high	 concentration	 of	 inflammatory	 chemokines	 released	 in	 the	
tissues	after	the	injury	can	modulate	the	MSCs	migratory	activity,	due	to	their	expression	of	chemokine	
receptors,	such	as	CCR2,	CCR3,	CCR4	and	CCL5	(Tondreau	et	al.,	2009).	 It	has	been	demonstrated	that	
bone	marrow	derived	MSCs	express	many	integrins	on	their	surface	(De	Ugarte	et	al.,	2003),	 including	
high	 levels	 of	 integrin	 β1	 and	α4	 (Ip	 et	 al.,	 2007),	which	mediate	 cell-cell	 and	 cell-matrix	 interactions	
through	the	binding	to	the	vascular	adhesion	molecule	(VCAM-1)	and	the	fibronectin	V	region.	Ruster	et	
al.	 (2006)	 have	 shown	 that	 MSCs	 interact	 in	 a	 coordinated	 fashion	 with	 endothelial	 cells,	 involving	
activation	 of	 both	 selectin-dependent	 and	 integrin-dependent	 binding.	 The	 C-X-C	 motif	 chemokine	
12	(CXCL12)	or	stromal	cell-derived	factor	1	(SDF1)	has	been	shown	to	play	a	central	role	in	MSC	homing	
phenomena,	 through	 its	 specific	 receptor	 CXCR4.	 However,	 cell	 surface	 receptor	 levels	 of	 CXCR4	 on	
MSCs	has	been	found	to	be	low,	with	large	amounts	intracellularly	instead,	suggesting	a	storage	function	
of	 this	 chemokine.	 The	 CXCR4	 receptor	 is	 likely	 to	 be	 translocated	 to	 the	 surface	 upon	 chemokine	
stimulation,	and	thus	contributing	to	MSCs	migration	(Wynn	et	al.,	2004).	
The	 exact	 mechanisms	 regulating	 MSCs	 migration	 are	 still	 unclear,	 and	 need	 further	 investigation,	
mainly	because	of	their	great	interest	for	clinical	applications.	
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Differentiation	potential	of	MSCs	
In	 addition	 to	 the	 identification	 of	 MSCs	 based	 on	 their	 morphologic	 or	 phenotypic	
characteristics,	a	further	way	to	identify	supposed	MSC	populations	is	by	their	capacity	to	be	induced	to	
differentiate	into	bone,	fat,	or	cartilage	in	vitro.		
	
Osteogenic	differentiation	
The	 classic	 method	 for	 differentiation	 of	 MSCs	 to	 osteoblasts	 in	 vitro	 involves	 incubating	 a	
confluent	 monolayer	 of	 MSCs	 with	 ascorbic	 acid,	 β-glycerophosphate,	 and	 dexamethasone	 for	 2–3	
weeks.	 The	MSCs	 form	 aggregates	 or	 nodules	 and	 increase	 their	 expression	 of	 alkaline	 phosphatase;	
calcium	 accumulation	 can	 be	 detected	 over	 time	 (Pittenger	 et	 al.,	 1999).	 These	 bone	 nodules	 stain	
positively	by	alizarin	 red	and	von	Kossa	 techniques.	These	conditions,	however,	 are	unlikely	 to	 reflect	
the	 physiological	 signals	 MSCs	 receive	 that	 induce	 osteogenesis	 in	 vivo.	 At	 a	 molecular	 level,	 the	
osteogenic	 differentiation	 process	 is	 managed	 by	 specific	 transcription	 factors.	 Runt-related	
transcription	 factor	2	(Runx2),	 also	known	as	core-binding	 factor	 subunit	alpha-1	(Cbfa1),	has	a	 crucial	
role	in	osteoblast	differentiation	and	bone	formation	(Komori	et	al.,	1997;	Otto	et	al.,	1997).	Mice	with	a	
homozygous	 mutation	 in	 Runx2	 die	 just	 after	 birth	 and	 show	 complete	 absence	 of	 bone	 formation	
(Komori	 et	 al.,	 1997;	 Otto	 et	 al.,	 1997).	 Runx2	 has	 also	 been	 shown	 to	 participate	 in	 early	
chondrogenesis,	 and	 to	 inhibit	 adipogenesis	 by	 interfering	 with	 peroxisome	 proliferation-activated	
receptor	2	(PPAR-γ)	action	(Sanchez-Gurmaches	&	Guertin,	2014).	On	the	other	hand,	the	transcription	
factor	Osterix	 suppresses	 chondrogenesis,	 and	 triggers	 osteogenesis,	 in	 the	 late	 steps	 of	 the	 process.	
Low	levels	of	Osterix	are	enough	to	inhibit	chondrogenesis,	while	high	levels	are	necessary	to	promote	
osteogenic	 differentiation	 (Oreffo,	 Kusec,	 Romberg,	&	 Triffitt,	 1999).	Osteoblasts	 in	 adult	 animals	 are	
thought	 to	 originate	 from	 multipotent	 MSCs	 resident	 in	 the	 bone	 marrow.	 Recently,	 a	 number	 of	
markers	have	been	postulated	to	identify	this	cell	population.	The	best-characterized	marker	in	human	
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bone	marrow	 is	 CD146,	which	 labels	 a	 perisinusoidal	 cell	 population	 (Sacchetti	 et	 al.,	 2007),	while	 in	
mice,	markers	used	 to	 identify	MSCs	 include	CD51,	CD105,	CD90,	 stem	cell	 antigen-1	 (Sca1),	 platelet-
derived	growth	factor	α	 (PDGFRα),	α-smooth	muscle	actin	 (αSMA),	Nestin,	Leptin	receptor	 (Lepr),	and	
relative	combinations	(Chan	et	al.,	2015;	Z.	Kalajzic	et	al.,	2008;	Méndez-Ferrer	et	al.,	2010;	Pinho	et	al.,	
2013;	Qian	et	al.,	2013).	
	
Adipogenic	differentiation	
To	 promote	 adipogenic	 differentiation,	 MSCs	 are	 typically	 treated	 in	 culture	 with	
dexamethasone,	insulin,	isobutyl-methylxanthine,	and	indomethacin.	More	recently,	some	groups	have	
replaced	 indomethacin	 by	 adding	 rosiglitazone,	 hydrocortisone	 and	 triiodothyronine	 to	 the	 basic	
adipogenic	 ingredients	 isobutyl-methylxanthine	 and	 dexamethasone	 (M.	 J.	 Lee,	 Wu,	 &	 Fried,	 2012;	
Lequeux,	Auxenfans,	Mojallal,	 Sergent,	&	Damour,	2009;	Skurk,	Ecklebe,	&	Hauner,	2007).	There	 is	an	
accumulation	 of	 lipid-rich	 vacuoles	 within	 cells,	 and	 they	 express	 PPAR-γ,	 lipoprotein	 lipase,	 and	 the	
fatty	acid-binding	protein	aP2	(Pittenger	et	al.,	1999).	Eventually,	the	lipid	vacuoles	combine	and	fill	the	
cells.	Accumulation	of	lipid	in	these	vacuoles	can	be	detected	histologically	by	oil	red	O	staining.	PPAR-γ	
plays	 a	 crucial	 role	 in	 the	 adipogenic	 differentiation	 process,	 by	 regulating	 specific	 adipocytes	 gene	
expression	(Tang	&	Lane,	2012).	PPAR-γ	 interacts	with	CCAAT/enhancer	binding	protein	(C/EBP)	family	
members	in	the	latest	stage	of	the	adipogenic	process(Tang	&	Lane,	2012).		
	
Chondrogenic	differentiation	
To	promote	 chondrogenic	differentiation,	MSCs	are	 centrifuged	 to	 form	a	pelleted	micromass	
and	 cultured	 in	 the	 presence	 of	 transforming	 growth	 factor-β	 (Mackay	 et	 al.,	 1998).	 The	 cell	 pellets	
develop	 a	 multilayered,	 matrix-rich	 morphology,	 and	 histological	 analysis	 shows	 strong	 staining	 with	
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toluidine	or	Alcian	blue,	 indicating	an	abundance	of	glycosaminoglycans	within	the	extracellular	matrix	
(Kopen,	Prockop,	&	Phinney,	1999).	The	cells	also	produce	type	II	collagen,	which	is	typical	of	articular	
cartilage	 (Pittenger	et	al.,	1999).	During	 the	chondrogenesis,	 the	gene	SRY-box9	 (Sox	9)	 interacts	with	
the	proteins	Sox5	and	Sox6	in	order	to	induce	chondrocyte	proliferation,	and	the	consequent	cartilage	
matrix	 deposition	 and	maturation	 (Gruber,	 Norton,	 Ingram,	&	Hanley,	 2005).	 Sox9	 is	 expressed	 in	 all	
chondroprogenitors	 and	 differentiated	 chondrocytes,	 and	 is	 essential	 for	 differentiating	 chondrogenic	
mesenchymal	 condensations	 into	 chondrocytes,	 as	 well	 as	 for	 regulating	 every	 stage	 of	 chondrocyte	
differentiation	 (Akiyama,	 Chaboissier,	 Martin,	 Schedl,	 &	 de	 Crombrugghe,	 2002;	 Bi,	 Deng,	 Zhang,	
Behringer,	&	de	Crombrugghe,	1999).	The	transforming	growth	factor	β	(TGFβ),	as	well,	plays	a	relevant	
role	in	chondrogenesis,	and	has	been	found	to	increase	its	expression	when	administered	together	with	
the	bone	morphogenic	protein	2	(BMP2)	(Shen,	Wei,	Tao,	Diwan,	&	Ma,	2009).		
	
Differentiation	to	other	lineages	
It	has	also	been	demonstrated	that,	when	treated	with	5-azacytidine	and	amphotericin	B,	MSCs	
differentiate	 into	myoblasts	 that	 fuse	 into	 rhythmically	 beating	myotubes	 (Wakitani,	 Saito,	 &	 Caplan,	
1995),	leading	to	a	better	cardiac	function	in	animal	models	of	infarcted	myocardium	(Choi	et	al.,	2010).	
In	addition,	differentiation	into	neuron-like	cells	expressing	markers	typical	for	mature	neurons	has	been	
reported	(Kohyama	et	al.,	2001;	Kopen	et	al.,	1999).	However,	Hofstetter	and	colleagues	has	reported	
that	 these	 neuron-like	 cells	 lack	 voltage-gated	 ion	 channels	 necessary	 for	 generation	 of	 action	
potentials;	therefore,	these	cells	cannot	be	classified	as	true	neurons	(Hofstetter	et	al.,	2002).		
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MSCs	in	vivo	identification	
The	definition	of	MSCs	relies	solely	on	the	analysis	of	in	vitro	culture-expanded	cell	populations.	
Despite	years	of	intense	investigation,	there	is	a	lack	of	data	about	the	 in	vivo	properties	of	the	native	
MSCs	within	their	tissues	and	niches,	mainly	because	of	the	absence	of	specific	markers	allowing	their	
clear	 identification	 (Bianco,	 Robey,	 &	 Simmons,	 2008;	 Morikawa	 et	 al.,	 2009).	 Moreover,	 MSCs	
phenotype	and	abilities	vary	between	in	vivo	and	in	vitro	settings	due	to	the	removal	from	their	natural	
environment	 and	 the	 use	 of	 chemical	 and	 physical	 growth	 conditions	 that	 might	 alter	 their	
characteristics.	MSCs	are	known	to	undergo	phenotypic	 rearrangements	during	ex	vivo	manipulations,	
losing	expression	of	 some	markers	while	also	acquiring	new	ones	 (Jones	et	al.,	2002).	 Inserting	 the	 in	
vitro	results	 in	the	context	of	the	organism	is	difficult	also	because	the	exact	 location	and	functions	of	
MSCs	in	vivo	remain	elusive	(da	Silva	Meirelles,	Caplan,	&	Nardi,	2008).		
A	valid	method	to	study	MSCs	 in	vivo	properties	resides	 in	the	use	of	murine	models.	However,	 in	the	
murine	system,	some	of	the	MSCs	antigens	are	not	universal	for	all	the	mouse	strains,	thus	complicating	
the	establishment	of	a	panel	of	common	surface	antigens,	and	the	consequent	prospective	isolation	of	
these	cells	from	mice	of	different	strains	(Anjos-Afonso	&	Bonnet,	2011).	There	 is	a	general	consensus	
that,	like	in	human	cells,	murine	MSCs	do	not	express	most	common	surface	antigens	that	are	found	on	
haematopoietic	and	endothelial	cells,	 such	as	Ter119,	CD45,	and	CD31	(Anjos-Afonso	&	Bonnet,	2008;	
Peister	et	al.,	 2004;	Phinney,	Kopen,	 Isaacson,	&	Prockop,	1999).	 Therefore,	 the	 common	view	 is	 that	
murine	 mesenchymal	 progenitor	 cells	 are	 confined	 in	 the	 CD45-Ter119-CD31-	 fraction.	 Most	 studies	
looking	at	identifying	skeletal	stem	or	progenitor	cell	populations	focus	on	cells	isolated	from	the	bone	
marrow,	or	 total	bone	 (Chan	et	al.,	 2013;	Chan	et	al.,	 2015;	Morikawa	et	al.,	 2009).	A	number	of	 cell	
surface	marker	combinations	have	been	used,	although	there	are	differences	between	different	groups.	
There	is	some	solid	evidence	supporting	the	idea	that	Sca1	could	be	a	potential	positive	marker	for	the	
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identification	of	murine	mesenchymal	 progenitor	 cells.	 For	 instance,	 Sca1-/-	mice	present	 age-related	
osteoporosis	 characterized	 by	 weakening	 in	 bone	 tissue	 (Bonyadi	 et	 al.,	 2003).	 Decreased	
osteoprogenitors,	osteoblasts	and	bone	formation	are	observed	in	these	mutant	mice,	as	the	result	of	
reduced	 numbers	 of	 MSCs.	 Also,	 Sca1-/-	 mice	 display	 reduced	 adipogenesis	 in	 vitro	 (Bonyadi	 et	 al.,	
2003).	 In	 addition	 to	 these	 findings,	 some	 reports	 have	 shown	 that	 the	 tri-lineage	 potential	 of	 cells	
isolated	based	on	Sca1+	expression	alone	(Lundberg	et	al.,	2007;	Morikawa	et	al.,	2009;	Nakamura	et	al.,	
2010;	 Steenhuis,	 Pettway,	 &	 Ignelzi,	 2008)	 or	 in	 combination	 with	 other	 antigens	 is	 confined	 to	 the	
Sca1+	fraction	whereas	the	Sca1-	fraction	displays	mainly	osteo-	and	chrondrogenic	potential	(Lundberg	
et	al.,	2007;	Morikawa	et	al.,	2009;	Nakamura	et	al.,	2010;	Steenhuis	et	al.,	2008).	Sca1	has	been	used	in	
combination	with	other	markers	such	as	CD166	(Alcam),	CD51/Alpha	V	(integrin	alpha	V)	and	PDGFRα	to	
further	enrich	murine	mesenchymal	progenitor	 cells	 in	vivo	 (Arai,	Ohneda,	Miyamoto,	Zhang,	&	Suda,	
2002;	 Kitaori	 et	 al.,	 2009;	 Lundberg	 et	 al.,	 2007;	 Morikawa	 et	 al.,	 2009;	 Nakamura	 et	 al.,	 2010).	
Morikawa	 et	 al.	 (2009)	 have	 demonstrated	 that	 the	 CD45-Ter119-Sca1+PDGFRα+	 bone	 marrow	
subpopulation,	 derived	 from	 C57BL/6	 mice,	 is	 enriched	 with	 mesenchymal	 progenitor	 cells	 with	 tri-
lineage	capacity,	whereas	other	cellular	fractions	have	a	more	restricted	differentiation	potential,	mainly	
lacking	adipogenic	differentiation	capacity	(Morikawa	et	al.,	2009).	Specifically,	flow	cytometry	analysis	
of	clones	from	single	cells	revealed	that	subpopulation	with	multilineage	differentiation	potential	were	
positive	 for	 the	 human	 MSCs	 markers	 CD105	 and	 CD90,	 unlike	 those	 with	 limited	 differentiation	
potential.	This	observation	suggests	that	also	CD105	and	CD90	may	be	useful	indicators	for	multipotency	
of	cultured	murine	MSCs.	The	authors	used	digested	adult	murine	bone	marrow/bone	associated	cells	
isolated	 from	 tibias	 and	 femurs,	 which	 were	 stained	 with	 antibodies	 to	 PDGFRα,	 Sca1,	 CD45,	 and	
TER119,	and	analyzed	by	flow	cytometry.	Sorted	cells	for	the	different	subpopulation	were	then	cultured	
for	a	traditional	colony-forming	unit-fibroblast	(CFU-F)	assay,	which	showed	that	the	number	of	colonies	
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per	1000	cells	was	highest	in	the	double	positive	population	CD45-Ter119-Sca1+PDGFRα+;	however,	the	
cells	in	the	other	subpopulations	still	produced	a	significant	number	of	colonies	(Morikawa	et	al.,	2009).	
Although	this	study	provides	interesting	developments	in	the	identification	of	mesenchymal	progenitor	
cells	 in	mice,	 it	 is	necessary	 to	notice	 that	most	of	 the	 study	was	performed	using	 cells	 isolated	 from	
bone	fragments	after	collagenase	digestion,	so	the	isolated	cells	are	mainly	bone-derived	and	not	bone	
marrow-derived.	Chan	et	al.	 (2015)	 investigated	the	lineage	origin	of	the	mouse	skeletal	stem	cells,	by	
flow	 cytometry	 analysis.	 The	 markers	 analyzed	 were	 CD45,	 Ter119,	 Tie2,	 and	 AlphaV	 integrin	 (also	
known	 as	 CD51),	 corresponding	 to	 markers	 present	 on	 hematopoietic	 (CD45,	 Ter119),	 vascular	 and	
hematopoietic	(Tie2),	and	osteoblastic	(AlphaV	integrin)	cells.	They	further	analyzed	subpopulations	of	
AlphaV+	 cells	 expressing	 different	 combination	 of	markers	 such	 as	 CD105,	 Thy,	 6C3,	 and	 CD200.	 The	
authors	defined	a	lineage	tree	of	skeletal	stem/progenitor	cells	(Chan	et	al.,	2015).	In	this	scheme,	the	
mouse	 skeletal	 stem	 cells	 are	multipotent	 and	 capable	 of	 self-renewal	 and	 differentiation	 into	more	
lineage-restricted	progenitor	cells,	such	as	pre-BCSP	(pre-bone,	cartilage,	and	stromal	progenitors)	and	
BCSP	(bone,	cartilage,	and	stromal	progenitors)	(Chan	et	al.,	2013).	The	mouse	skeletal	stem	cells,	pre-
BCSPs,	and	BCSPs	have	been	found	capable	of	giving	rise	to	bone	(CD45-Ter119-Tie2-AlphaV+Thy+6C3-
CD105+),	cartilage	(CD45-Ter119-Tie2-AlphaV+Thy+6C3-CD105+CD200+),	and	hematopoietic	supportive	
stroma	 (CD45-Ter119-Tie2-AlphaV+Thy+6C3+CD105+).	 According	 to	 these	 data,	 bone,	 cartilage,	 and	
stromal	tissue	are	clonally	derived	in	vivo	from	lineage-restricted	stem	and	progenitor	cells	that	do	not	
also	give	rise	to	muscle	and	fat,	at	least	at	the	time	points	examined	(Chan	et	al.,	2015).	
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MSCs	microenvironment		
MSCs	microenvironment	 is	 represented	by	 their	niche	 (Figure	3).	The	 stem	cell	niche	 is	 the	 in	
vivo	 microenvironment	 where	 stem	 cells	 both	 reside	 and	 receive	 stimuli	 that	 determine	 their	 fate.	
Therefore,	the	niche	should	not	be	considered	simply	as	a	physical	location	for	stem	cells,	but	rather	as	
the	place	where	 extrinsic	 signals	 interact	 and	 integrate	 to	 influence	 stem	 cell	 behavior.	 These	 stimuli	
include	 cell-to-cell	 and	 cell-matrix	 interactions	 and	 signals	 (molecules)	 that	 activate	 and/or	 repress	
genes	and	transcription	pathways	(Ferraro,	Celso,	&	Scadden,	2010).	Schofield	has	 first	postulated	the	
hypothesis	 of	 a	 specialized	 stem	 cell	 microenvironment	 in	 1978	 (Schofield,	 1978).	 He	 proposed	 that	
niches	have	a	defined	anatomical	location	and	also	that	removal	of	stem	cells	from	their	niche	results	in	
differentiation.		
	
	
Figure	3.	HSCs	niche	in	the	bone	marrow.	The	stem	cell	niche	is	composed	of	both	cells,	such	as	stromal	
cells	and	progenitor	cells,	and	matrix.	(Moore	K.	A.,	Lemischka	I.	R.	Stem	cells	and	their	niches.	Science,	v.	
311,	n.	5769,	p.	1880-5,	2006)	
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Oxygen	tension	
Low	 oxygen	 tension	 is	 an	 important	 component	 of	 the	 stem	 and	 progenitor	 cell	
microenvironment	since	it	provides	signals	that	are	conducive	to	the	maintenance	of	stem-cell	functions	
(Buravkova,	 Grinakovskaia,	 Andreeva,	 Zhambalova,	 &	 Kozionova,	 2009).	 Hypoxia	 modulates	 the	
behavior	 of	 different	 stem	 cell	 types,	 such	 as	 embryonic	 stem	 cells	 (M.	 C.	 Simon	&	 Keith,	 2008),	 iPs	
(Yoshida,	 Takahashi,	 Okita,	 Ichisaka,	 &	 Yamanaka,	 2009),	 and	 adult	 stem	 cells	 (Fotia,	Massa,	 Boriani,	
Baldini,	 &	 Granchi,	 2015).	 However,	 in	 many	 studies,	 cells	 are	 usually	 cultured	 under	 normoxic	
conditions	 equivalent	 to	 atmospheric	 oxygen,	 paying	 scarce	 attention	 to	 the	 niche	 metabolic	
environment	 in	 which	 stem	 cells	 grow	 or	 reside	 physiologically.	 Oxygen	 tension	 in	 adult	 tissues	 is	
considerably	different	 from	 that	 in	 the	 inhaled	atmosphere,	which	 corresponds	 to	21%	 (160	mm	Hg).	
The	partial	oxygen	pressure	(pO2)	of	the	inhaled	air	decreases	progressively	after	entering	into	the	lungs	
and	the	bloodstream.	When	it	reaches	organs	and	tissues,	pO2	level	drops	down	to	2-9%	(14-65	mm	Hg)	
(Brahimi-Horn	&	Pouysségur,	2007;	Silván	et	al.,	2009).	This	pressure	is	dramatically	different	from	the	
oxygen	 tension	 typically	 considered	 "normoxic"	 according	 to	 conventional	 cell	 culture	 standards.	 The	
key	adaptive	response	to	hypoxic	conditions	is	the	stabilization	of	hypoxia	inducible	factor	(HIF)-1	(G.	L.	
Wang	 &	 Semenza,	 1993)	 (Figure	 4).	 HIF-1	 is	 the	 main	 regulator	 controlling	 the	 metabolic	 fate	 and	
multipotency	of	MSCs.	HIF-1	is	a	heterodimer	that	consists	of	a	constitutively	expressed	HIF-	1β	subunit	
and	a	HIF-1α	subunit;	the	expression	of	the	latter	is	highly	regulated	and	is	determined	by	the	relative	
rates	 of	 its	 synthesis	 and	 degradation.	 Synthesis	 of	 HIF-1α	 is	 regulated	 via	 oxygen-independent	
mechanisms,	whereas	 its	 degradation	 is	 oxygen-dependent	 (Semenza,	 2003).	 In	 the	 presence	 of	 high	
levels	 of	 oxygen	 (>	 9%),	 HIF-1α	 is	 subjected	 to	 proteasome-dependent	 degradation.	 In	 hypoxic	
conditions,	HIF-1α	stabilizes,	dimers	with	HIF-1β,	and	induces	the	expression	of	various	genes	involved	
in	hypoxia-like	processes	such	as	glycolysis,	erythropoiesis	and	angiogenesis	(Semenza,	2003).		
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Figure	4.	HIF-1α	regulation	by	proline	hydroxylation.	In	normoxic	conditions,	HIF-1α	is	hydroxylated	by	
prolyl	 ydroxylases,	 and	 then	 degraded.	 In	 hypoxic	 conditions,	 HIF-1α	 translocates	 to	 the	 nucleus	 and	
activates	 its	 target	 genes	 implicated	 in	 several	 cellular	 processes.	
(http://journals.cambridge.org/fulltext_content/ERM/ERM7_06/S14623994050	09117sup010.g)	
	
The	effects	of	a	 low	oxygen	environment	on	MSCs	behavior	have	been	 intensively	 investigated	 in	 the	
last	 20	 years,	 showing	 several	 conflicting	 results.	 Numerous	 studies	 have	 demonstrated	 that	 MSCs	
constantly	 propagated	 at	 low	 oxygen	 (1–5%)	 generally	 display	 enhanced	 proliferative	 potential	
(Basciano	et	al.,	2011;	D'Ippolito,	Diabira,	Howard,	Roos,	&	Schiller,	2006;	Dos	Santos	et	al.,	2010;	Fehrer	
et	al.,	2007;	Grinakovskaya,	Andreeva,	Buravkova,	Rylova,	&	Kosovsky,	2009;	Iida	et	al.,	2010;	López	et	
al.,	2013;	Malladi,	Xu,	Chiou,	Giaccia,	&	Longaker,	2006;	Valorani	et	al.,	2012;	Zhambalova,	Darevskaya,	
Kabaeva,	 Romanov,	 &	 Buravkova,	 2009)	 and	 greater	 colony-forming	 activity	 as	 compared	 to	 cells	
cultured	under	normoxic	conditions	(21%	O2)	(Diaz-Flores,	Gutierrez,	Lopez-Alonso,	Gonzalez,	&	Varela,	
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1992;	Dos	Santos	et	al.,	2010;	Fehrer	et	al.,	2007;	Iida	et	al.,	2010;	López	et	al.,	2013).	However,	these	
effects	can	be	driven	by	specific	circumstances,	such	as	the	culture	passage	(Basciano	et	al.,	2011;	Khan,	
Adesida,	&	Hardingham,	2007).	The	capacity	for	multilineage	differentiation	is	one	hallmark	of	MSCs.	It	
is	well	 established	 that	under	 specific	 conditions,	MSCs	 can	differentiate	 into	osteoblasts,	 adipocytes,	
and	 chondroblasts.	 However,	 some	 studies	 show	 that	 MSCs	 isolated	 from	 bone	 marrow	 in	 hypoxic	
conditions	have	a	decreased	ability	 to	differentiate	 in	adipocytes	and	osteoblasts,	 thus	supporting	the	
theory	 that	 low	 oxygen	 tension	 promotes	 an	 undifferentiated	 state	 of	MSCs	 (D'Ippolito	 et	 al.,	 2006;	
Fehrer	et	al.,	2007;	Pasarica	et	al.,	2010).	Other	studies	report	that	MSCs	cultured	in	hypoxic	conditions	
have	 an	 improved	 differentiation	 capacity	 into	 the	 chondrogenic	 lineage	 (Adesida,	 Mulet-Sierra,	 &	
Jomha,	2012;	Holzwarth	et	al.,	2010).	Summarizing,	although	the	experimental	results	are	highly	variable	
for	the	different	experimental	conditions	and	the	samples	used	(MSCs	isolated	from	different	sources),	
considerable	data	 clearly	demonstrate	 that	hypoxia	 significantly	modulates	MSC	properties,	especially	
MSCs	differentiation	capacity.	
	
Extracellular	acidity		
A	less	studied	peculiar	feature	of	the	stem-cell	niche	microenvironment	 is	 its	characteristic	pH	
value,	 which	 is	 able	 to	 influence	 MSCs	 proliferation,	 differentiation	 and	 paracrine	 activity	
(Disthabanchong,	 Radinahamed,	 Stitchantrakul,	 Hongeng,	 &	 Rajatanavin,	 2007).	 In	 physiological	
conditions,	peripheral	blood	pH	is	approximately	7.4–7.35,	while	pH	of	the	fluids	flowing	among	cells	in	
tissues	is	lower,	and	subject	to	alterations	due	to	cell	metabolism.	Extracellular	acidosis	is	caused	by	an	
increase	in	glycolytic	and	oxidative	metabolism	of	the	cells	that	leads	to	the	production	of	high	amount	
of	carbonic	and	 lactic	acids,	which	are	extruded	 to	maintain	an	 intracellular	pH	near	 the	physiological	
value.	As	a	consequence,	an	inverted	membrane	pH	gradient	is	established:	the	extracellular	pH	(pHe)	is	
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lower	than	the	intracellular	pH	(pHi)	(Gerweck	&	Seetharaman,	1996).		
This	altered	acidic	microenvironment	 is	 commonly	associated	with	 renal	and	 respiratory	diseases,	but	
also	with	anaerobic	exercise,	gastroenteritis,	excessive	consumption	of	acidifying	substances,	diabetes,	
anemias,	 obesity,	 osteoporosis,	 and	arthritis	 (Domínguez-Bendala,	 Lanzoni,	 Inverardi,	&	Ricordi,	 2012;	
Garibotto	 et	 al.,	 1996;	 Lardner,	 2001;	 X.	 Liu	 et	 al.,	 2014).	 Acidosis	 can	 also	 locally	 arise	 as	 a	 result	 of	
growth	 factor	 or	 cytokine	 stimulation	 of	 cell	 metabolism,	 vascular	 disease,	 ischemia,	 inflammation,	
infection,	tumors,	wounds,	and	fractures	(T.	R.	Arnett,	2008).		
Acidosis	is	reported	to	inhibit	osteoblast	function	by	decreasing	expression	of	extracellular	matrix	genes,	
including	collagen,	as	well	as	by	 reducing	mineralization	 (Frick	&	Bushinsky,	1998;	Sprague,	Krieger,	&	
Bushinsky,	1994).	Brandao-Burch	et	al.	(2005)	has	studied	the	effects	of	pH	on	osteoblasts	function	using	
primary	 rat	 osteoblast	 cultures.	 They	 found	 that	 acidification	 progressively	 reduces	mineralization	 of	
bone	 nodules,	 reaching	 a	 complete	 abolition	 at	 pH	 6.9	 (Brandao-Burch	 et	 al.,	 2005).	 Alkaline	
phosphatase	 activity,	 which	 is	 required	 for	 bone	 mineralization,	 peaks	 strongly	 near	 pH	 7.4	 but	 is	
reduced	by	more	than	90%	at	pH	6.9,	whereas	matrix	Gla	protein,	an	inhibitor	of	mineralization,	is	up-
regulated.	 The	 pH	 reduction	 is	 associated	 with	 an	 increase	 in	 solubility	 for	 hydroxyapatite,	 thus	
indicating	 that	 acidosis	 exerts	 a	 selective,	 inhibitory	 action	 on	matrix	mineralization	 that	 is	 reciprocal	
with	the	osteoclast	activation	response	(Brandao-Burch	et	al.,	2005).		
Cell	culture	experiments	on	rat	osteoclasts	have	shown	that	protons	exert	a	direct	stimulatory	effect	on	
bone	resorption	(T.	R.	Arnett	&	Dempster,	1986).	These	experiments	show	that	osteoclasts	are	almost	
inactive	at	a	physiological	pH	value	of	7.4,	and	that	bone	resorption	increases	as	pH	is	reduced,	reaching	
a	plateau	at	about	pH	6.8.	Subsequent	studies	showed	that	avian	(T.	R.	Arnett	&	Dempster,	1987)	and	
human	(T.	R.	Arnett,	2008)	osteoclasts	also	exhibit	acid-activation	responses.	Osteoclasts	sensitivity	 to	
extracellular	H+	is	such	that	pH	reductions	of	<0.1	unit	can	cause	a	doubling	of	resorptive	activity	(T.	R.	
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Arnett	 &	 Spowage,	 1996).	 This	 effect	 is	 not	 subject	 to	 desensitization	 in	 longer-term	 cultures:	 acid-
activated	osteoclasts	continue	with	their	resorption	activity	over	periods	of	7	days	or	more,	amplifying	
the	 effects	 of	 modest	 pH	 differences	 (T.	 Arnett,	 2003).	 Acidosis	 is	 required	 for	 the	 initiation	 of	
resorption;	once	activated,	osteoclasts	can	be	 further	stimulated	by	 factors	such	as	 receptor	activator	
for	nuclear	factor	kB	ligand	(RANKL)	(Barzel,	1995),	1,25-dihydroxycholecalciferol	(1,25D3),	parathyroid	
hormone	(T.	R.	Arnett	&	Dempster,	1986),	and	ATP/ADP	(Hoebertz,	Meghji,	Burnstock,	&	Arnett,	2001).	
Thus,	osteoclasts	stimulation	 is	a	two-step	process,	with	acid-activation	as	the	key	 initial	 requirement,	
and	 extracellular	 protons	 may	 be	 considered	 as	 osteoclasts	 activation	 factors.	 Acidification	 rapidly	
increases	 osteoclasts	 expression	 of	 carbonic	 anydrase	 II	 and	 the	 vacuolar-type	 H+-ATPase,	 which	 is	
required	for	the	generation	and	pumping	of	the	protons	that	solubilize	bone	mineral	(Biskobing	&	Fan,	
2000;	 Nordström	 et	 al.,	 1997),	 and	 strongly	 up-regulates	 cathepsin	 K,	 involved	 in	 organic	 matrix	
degradation	(Muzylak,	Arnett,	Price,	&	Horton,	2007).	Other	resorption-associated	factors	upregulated	
or	 stabilized	by	acidosis	 include	 tartrate-resistant	 acid	phosphatase,	 TNF	 receptor-associated	 factor	6,	
and	the	transcription	factor	NFATc1	(Komarova,	Pereverzev,	Shum,	Sims,	&	Dixon,	2005).	
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Figure	5.	Effects	of	extracellular	pH	on	bone	formation	and	resorption.	Matrix	mineralization	is	strongly	
inhibited	 by	 acidosis,	 and	 osteoclasts	 resorption	 activity	 is	 activated.	 (Arnett	 T.	 R.	 Extracellular	 pH	
regulates	bone	cell	function.	J	Nutr,	138(2),	415S-418S,	2008)	
	
Acidic	microenvironment	and	autophagy	
According	 to	 recent	 works,	 an	 acidic	 microenvironment	 is	 able	 to	 modulate	 stemness	 and	
regenerative	potential	of	MSCs	(Mohyeldin,	Garzón-Muvdi,	&	Quiñones-Hinojosa,	2010).	Similarly,	a	cell	
process	called	autophagy	has	been	associated	with	the	regulation	of	MSC	stem-like	features,	as	well	as	
with	senescence	and	cell	death/survival	(Eom	et	al.,	2014),	and	can	be	induced	by	acidic	conditions.		
Autophagy	is	a	catabolic	and	degradative	process	activated	by	cells	under	stressful	conditions,	consisting	
of	three	different	forms:	microautophagy,	which	implies	the	direct	uptake	of	soluble	cytosolic	substrates	
in	 the	 lysosomes	via	 invagination	of	 the	 lysosomal	membrane	 (W.	W.	Li,	 Li,	&	Bao,	2012);	 chaperone-
mediated	 autophagy,	 which	 degrades	 specific	 proteins	 carrying	 the	 peptide	 motif	 KFERQ	 and	
translocated	 to	 lysosomes	 via	 chaperone	 protein	 Hsc70	 (heat	 shock	 cognate	 70)	 (Kaushik	 &	 Cuervo,	
2012);	 and	macroautophagy	 (referred	 to	as	 autophagy),	 involving	 the	 formation	of	double-membrane	
vesicles	(autophagosomes)	containing	an	autophagic	cargo	and	their	fusion	with	lysosomes	(Mehrpour,	
Esclatine,	 Beau,	 &	 Codogno,	 2010).	 Independently	 of	 the	 type	 of	 autophagy,	 the	 autophagic	 cargo	 is	
degraded	by	lysosomal	acidic	hydrolases	and	cathepsins	and	the	molecules	produced	are	released	into	
the	 cytoplasm	 and	 re-used	 as	 building	 blocks	 in	 different	 anabolic	 pathways	 (Mizushima	&	 Komatsu,	
2011).	Basal	 autophagy	allows	 the	 removal	of	 redundant	or	damaged	and	potentially	 toxic	organelles	
and	 protein	 aggregates,	 thus	 representing	 an	 important	 system	 for	 quality	 control	 in	 cellular	
homeostasis.	 Autophagy	 can	 be	 upregulated	 by	 conditions	 of	 stress	 represented	 by	 hypoxia,	 nutrient	
deprivation,	metabolic,	 oxidative	 and	proteotoxic	 stress	 (Kroemer,	Mariño,	&	 Levine,	 2010).	 Although	
starvation-induced	 autophagy	 is	 a	 non-selective	 process	 degrading	 bulk	 cytosolic	 material	 to	 provide	
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nutrients	and	 support	 cellular	metabolism	and	survival	 in	 stress	 conditions,	 there	are	 several	 types	of	
selective-autophagy,	where	specific	organelles	and	substrates	 like	mitochondria,	 lipid	droplets,	protein	
aggregates	and	ferritin	are	targeted	to	the	autophagosome	and	delivered	to	lysosomes	for	degradation	
(Stolz,	 Ernst,	 &	 Dikic,	 2014).	 Many	 types	 of	 selective-autophagy	 rely	 on	 the	 recognition	 of	 poly-
ubiquitylated	 targets	 by	 specific	 autophagy	 receptors,	 including	 sequestosome	 1	 (SQSTM1	 or	 p62),	
neighbor	of	BRCA1	(NBR1)	and	Optineurin	(Lippai	&	Lőw,	2014).	The	autophagic	process	(Figure	6)	starts	
with	 the	 elongation	 of	 membrane	 precursors	 and	 the	 formation	 of	 a	 double	 membrane	 vesicle	
(autophagosome),	 which	 engulfs	 bulk	 cytosolic	 material	 and	 targeted	 cellular	 organelles.	 Autophagy-	
related	proteins	(ATG)	are	responsible	for	the	elongation	and	formation	of	the	autophagosome	(Lamb,	
Yoshimori,	&	Tooze,	2013).	Moving	along	the	microtubules	network	(Aplin,	Jasionowski,	Tuttle,	Lenk,	&	
Dunn,	 1992),	 the	 autophagosome	 fuses	 with	 a	 lysosome	 whose	 acidic	 lumen	 activates	 hydrolytic	
enzymes	 that	 degrade	 the	 content	 of	 the	 autolysosome,	 giving	 rise	 to	 amino	 acids,	 fatty	 acids,	
nucleosides	and	other	metabolites	released	into	the	cytosol	and	recycled	in	anabolic	cellular	metabolism	
(Rabinowitz	&	White,	2010).		
	
	
Figure	6.	Representative	scheme	of	 the	steps	of	autophagy.	Autophagy	begins	with	 the	 formation	of	
the	 phagophore	 (vesicle	 nucleation),	 which	 then	 expands	 becoming	 an	 autophagosome	 (vesicle	
elongation).	 The	 autophagosome	 engulfs	 bulk	 cytoplasm	 cargo.	 When	 the	 outer	 membrane	 of	 the	
autophagosome	 fuses	 with	 a	 lysosome	 (docking	 and	 fusion	 steps),	 it	 forms	 an	 autophagolysosome.	
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Eventually,	the	sequestered	material	is	degraded	inside	the	autophagolyosome	(vesicle	breakdown	and	
degradation)	and	recycled.	(Meléndez	A.,	Levine	B.	Autophagy	in	C.	elegans	WormBook,	p.	1-26,	2009)	
	
At	 the	 molecular	 level,	 autophagy	 is	 negatively	 regulated	 by	 the	 mammalian	 target	 of	 rapamycin	
complex-1	 (mTORC1),	which	 in	 the	presence	of	sufficient	nutrients	and	growth	factors	phosphorylates	
and	inactivates	the	serine/threonine	kinase	ULK1/2	(J.	Kim,	Kundu,	Viollet,	&	Guan,	2011).	The	complex	
containing	ULK1/2	regulates	the	initiation	of	the	autophagic	process	and	is	activated	by	AMPK-mediated	
phosphorylation	and	in	presence	of	inactive	MTORC1	due	to	nutrients	starvation	and/or	growth	factors	
deprivation	(J.	Kim	et	al.,	2011).	The	ULK1	complex	activates	the	class	III	PI3K	complex,	containing	Beclin-
1	 and	 the	 class	 III	 phophatidylinositol	 3-kinase	 (PtdIns3K)	 protein	 VSP34	 (Funderburk,	 Wang,	 &	 Yue,	
2010).	 VPS34	 is	 a	 lipid	 kinase	 producing	 phosphatidylinositol-3-	 phosphate	 (PI3P),	 essential	 for	
autophagosomal	membrane	elongation	and	for	the	recruitment	of	proteins	with	PI3P	binding	domains	
(e.g.	WIPI1/2)	 involved	 in	vesicle	elongation,	 followed	by	 the	activity	of	 two	ubiquitin-like	conjugation	
systems.	The	first	is	the	complex	ATG12–	ATG5-ATG16L,	an	E3-like	ligase	that	mediates	the	lipidation	of	
the	light	chain	3	(LC3)	family	members	LC3,	GATE16	and	GABARAP,	which	will	be	then	associated	to	the	
autophagosomal	 membrane.	 The	 ATG12–ATG5-ATG16L	 complex	 will	 dissociate	 from	 the	 membrane	
before	closure	while	lipidated	LC3	members	(e.g.	LC3-II	or	LC3-	PE)	will	regulate	final	maturation	of	the	
autophagosome,	being	retained	on	the	inner	membrane.	In	the	case	of	selective	autophagy,	autophagy	
receptors	like	SQSTM1	contain	an	LC3-interacting	region	(LIR)	and	a	ubiquitin-associated	domain	(UBA),	
which	allow	the	selective	recruitment	of	ubiquitinated	organelles	or	structures	 to	the	autophagosome	
(Figure	7).	
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Figure	7.	Schematic	representation	of	the	mTOR	signaling	pathway.	Autophagy	is	negatively	regulated	
by	 mTOR,	 a	 serine/threonine	 kinase,	 via	 the	 formation	 of	 the	 mTORC1	 complex.	 This	 complex	 is	
inhibited	by	specific	inhibitors,	which	therefore	induce	autophagy.	(Fleming,	A.,	Noda,	T.,	Yoshimori,	T.,	
&	Rubinsztein,	D.	C.	Chemical	modulators	of	autophagy	as	biological	probes	and	potential	therapeutics.	
Nat	Chem	Biol,	v.	7,	n.	1,	p.	9-17,	2011)	
	
Summarizing,	autophagy	is	a	crucial	process	that	modulates	the	adaptive	response	to	cellular	stress	and	
contributes	 to	 maintain	 cellular	 homeostasis	 in	 physiological	 conditions.	 Because	 of	 these	 important	
functions,	 alterations	 in	 autophagy	 are	 associated	 with	 several	 human	 conditions,	 including	
neurodegenerative,	cardiovascular	and	infectious	diseases,	as	well	as	cancer	(Sridhar,	Botbol,	Macian,	&	
Cuervo,	2012).	Recently	it	has	been	shown	that	autophagy	plays	a	basic	role	also	in	the	commitment	of	
MSCs	 to	 different	 lineages,	 especially	 in	 the	 osteoblastic	 lineage.	 Nuschke	 et	 al.	 (2014)	 have	
demonstrated	 that	 undifferentiated	MSCs	 have	 an	 accumulation	 of	 undegraded	 autophagic	 vacuoles	
and	a	little	autophagic	turnover,	while	the	stimulation	of	osteogenic	differentiation	leads	to	a	consistent	
increase	in	turnover	(Nuschke	et	al.,	2014).	According	to	these	observations,	autophagy	seems	to	be	of	
fundamental	 importance	 in	 the	 control	 of	 osteogenic	 differentiation.	 Also,	 SATB2,	 an	 AT-rich	 binding	
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protein,	 has	 the	 capacity	 of	 promoting	 osteogenic	 differentiation	 and	 bone	 defect	 regeneration	 of	
BMMSC,	 by	 upregulating	 pluripotency	 genes	 and	 autophagy-related	 genes	 which	 activate	 the	 mTOR	
signaling	 pathway	 (W.	 Dong	 et	 al.,	 2015).	 While	 mTOR	 signaling	 may	 function	 to	 affect	 osteoblastic	
differentiation,	 conflicting	 results	 have	 been	 reported	 on	 whether	 rapamycin	 decreases	 or	 increases	
osteogenesis,	according	to	the	cell	type.	 In	rats,	rapamycin	does	not	exhibit	a	spontaneous	osteogenic	
effect	on	MSC,	but	inhibits	the	effect	of	osteogenic	differentiation	induced	by	dexamethasone	(Isomoto	
et	al.,	 2007).	On	 the	other	hand,	 rapamycin	promotes	osteogenic	differentiation	 in	human	embryonic	
stem	cells	(ESC)	by	blocking	mTOR	and	stimulating	BMP/Smad	signaling	pathway	(K.	W.	Lee	et	al.,	2010),	
once	again	suggesting	that	no	general	statement	can	be	made	on	the	role	of	autophagy. 
	
Acidic	microenvironment	and	inflammation	
As	 previously	 mentioned,	 local	 acidosis	 can	 trigger	 the	 activation	 of	 inflammatory	 pathways	
(Lardner,	 2001).	 Systemic	 inflammation	 characterizes	 several	 chronic	 conditions,	 such	 as	 rheumatoid	
arthritis	 (RA),	diabetes	mellitus,	and	systemic	 lupus	erythematosus	 (SLE)	 (Hardy	&	Cooper,	2009),	 that	
are	closely	associated	with	bone	loss	and	secondary	osteoporosis,	and,	consequently,	increased	fracture	
risk	(Hardy	&	Cooper,	2009).	Although	fracture	treatment	has	improved	considerably	in	the	last	decades,	
a	 large	 proportion	 still	 exhibit	 a	 delayed	 healing	 and	 several	 complications,	 including	 non-union.	 The	
outcome	of	fracture	healing	depends	on	a	number	of	factors,	such	as	trauma	severity	(Fong	et	al.,	2013;	
Karladani,	 Granhed,	 Kärrholm,	 &	 Styf,	 2001),	 quality	 of	 fracture	 reduction	 (realignment),	 fracture	
fixation	technique	and	presence	of	comorbid	diseases	(Hayda,	Brighton,	&	Esterhai,	1998),	such	as	those	
mentioned	 above.	 In	 a	 retrospective	 study,	 fracture	 healing	 in	 patients	 with	 RA	was	 associated	 with	
higher	 complication	 rates,	 including	 non-unions,	 but	 the	 intrinsic	 molecular	 mechanisms	 are	 still	
unknown	 (Strömqvist,	 1984).	 Clinical	 studies	 have	 shown	 impaired	 fracture	 healing	 in	 patients	 with	
diabetes	mellitus	(Loder,	1988),	and	the	results	of	experiments	in	animal	models	suggest	that	disrupted	
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repair	is	at	least	partly	caused	by	inflammatory	mediators.	Specifically,	TNF	was	shown	to	be	associated	
with	increased	chondrocyte	apoptosis,	pre-mature	loss	of	cartilage	and	enhanced	osteoclasts	formation	
during	diabetic	fracture	healing	(Alblowi	et	al.,	2009;	Kayal	et	al.,	2010;	Kayal	et	al.,	2007).	Dominak	et	
al.	 (2005)	found	immunoglobulin	and	complement	deposition	at	the	site	of	a	non-healing	fracture	in	a	
patient	with	SLE;	the	authors	of	this	study	concluded	that	disease-related	autoantibodies	inhibited	bone	
cell	differentiation,	resulting	in	non-union	(Dominiak	et	al.,	2005).	
Inflammation	 is	 an	 important	 factor	 during	 bone	 healing,	 with	 molecular	 factors	 and	 immune	 cells	
appearing	locally	at	the	fracture	site	in	a	distinct	spatial	and	temporal	way.	Perturbations	of	this	finely	
tuned	 sequence	 of	 events	 leads	 to	 impaired	 fracture	 healing	 (Claes,	 Recknagel,	 &	 Ignatius,	 2012;	
Gerstenfeld,	 Cho,	 et	 al.,	 2003;	Wallace,	 Cooney,	 Englund,	&	 Lubahn,	 2011;	 Yang	 et	 al.,	 2007).	 Studies	
show	that	in	a	sheep	bone-healing	model,	in	which	healing	was	mechanically	impaired	through	flexible	
fixation,	 a	higher	number	of	 cytotoxic	 T	 cells	 and	other	 leukocytes	was	detected	 in	 the	early	 fracture	
hematoma	and	the	bone	marrow	close	to	the	fracture	gap,	compared	with	more	rigid	fracture	fixation	
(Schmidt-Bleek	 et	 al.,	 2012).	 A	 prolonged	 inflammatory	 phase	 was	 observed	 in	 the	 impaired	 healing	
group	 (Schmidt-Bleek	 et	 al.,	 2012).	 Likely,	 cytotoxic	 T	 cells	 release	 cytokines	 that	 can	 prolong	 the	
presence	of	proinflammatory	M1	macrophages,	possibly	by	delaying	their	differentiation	into	the	more	
anti-inflammatory	and	proangiogenic	M2	macrophages.	Grundnes	et	al.	 (Grundnes	&	Reikeraas,	2000)	
supported	 this	 theory	 with	 their	 study,	 in	 which	 they	 observed	 impaired	 fracture	 healing	 after	 local	
stimulation	of	macrophage	to	secrete	proinflammatory	cytokines	(Grundnes	&	Reikeraas,	2000).	
In	conclusion,	a	balance	between	the	different	inflammation	stimuli	at	the	fracture	site	seems	to	exist,	
and	 be	 dependent	 on	 the	 quantitative,	 qualitative	 and	 temporal	 composition	 of	 the	 fracture	 callus.	
However,	 further	 studies	 are	needed	 to	 clarify	 the	 consequences	of	 inflammation	on	 fracture	healing	
outcome,	 perhaps	 starting	 from	 a	 better	 characterization	 of	 this	 phase	 of	 fracture	 repair	 and	 its	
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relationship	to	the	healing	outcome.		
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Therapeutic	potential	of	MSCs	
MSCs	 specific	 features,	 such	 as	 multipotency,	 immunoregulatory	 properties,	 and	 ability	 to	
migrate	to	the	site	of	 injury,	are	critical	for	their	clinical	applications.	As	a	matter	of	fact,	MSCs	can	be	
easily	isolated	from	bone	marrow,	adipose	tissue,	and	dental	pulp	(R.	H.	Lee	et	al.,	2004),	and	eventually	
administered	to	the	patients	with	an	autologous	transplant,	avoiding	immune	reactions.		
	
Tissue	repair	
MSCs	have	 shown	a	 strong	propensity	 to	 ameliorate	 tissue	damage	 in	 response	 to	 injury	 and	
disease.	MSCs	actively	respond	to	stress	or	 injury	 in	a	manner	that	 is	very	similar	to	how	the	adaptive	
and	 innate	 immune	 system	 cells	 respond	 to	 pathogen	 exposure	 or	 apoptosis.	 When	 supplied	
exogenously,	 MSCs	 home	 to	 sites	 of	 injury	 primarily	 inflamed	 or	 with	 impaired	 blood	 supply.	 MSCs	
secrete	 soluble	 factors	 that	 alter	 the	 tissue	 microenvironment,	 promote	 angiogenesis,	 regeneration,	
remodeling,	 immune	 cell	 activation	 or	 suppression,	 and	 cellular	 recruitment,	 thus	 triggering	 the	
regenerative	 process	 (Ciapetti	 et	 al.,	 2012;	 Prockop,	 2007).	 The	 repair	 process	 consists	 in	 regulating	
extracellular	 matrix	 deposition,	 collagen	 synthesis,	 fibroblast	 proliferation,	 platelet	 activation,	
fibrinolysis,	 and	 angiogenesis.	 MSCs	 were	 originally	 evaluated	 for	 their	 capacity	 to	 repair	 skeletal	
defects,	 first	 in	 experimental	 animal	 models,	 and	 subsequently	 in	 human	 patients	 afflicted	 with	
osteogenesis	 imperfecta	 (OI),	 a	 genetic	 defect	 in	 bone	 and	 other	 tissues	 caused	 by	mutations	 in	 the	
genes	for	Type	I	collagen	(Horwitz	et	al.,	2002).	
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Fracture	healing	process	
Fracture	healing	 (Figure	8)	 is	 a	 postnatal	 process	 that	 reflects	many	of	 the	ontological	 events	
that	take	place	during	embryonic	development	of	the	skeleton	(Einhorn	&	Gerstenfeld,	2015).	
		
	
Figure	8.	Fracture	healing.	 Immediately	after	 injury,	a	hematoma	forms,	 followed	by	an	 inflammatory	
response	 at	 the	 fracture	 site.	Within	 days	 of	 fracture,	 the	 periosteum,	 if	 intact,	 thickens	 because	 of	
extensive	 cell	 proliferation,	 and	 a	 callus	 made	 of	 fibrous	 and	 osteocartilaginous	 tissue	 forms.	 After	
mineralization,	 a	 hard	 callus	 forms	 and	 is	 eventually	 remodeled	 to	 regain	 the	 original	 bone	 anatomy.	
(Einhorn	T.	A.,	Gerstenfeld	L.	C.	Fracture	healing:	mechanisms	and	interventions.	Nat	Rev	Rheumatol,	v.	
11,	n.	1,	p.	45-54,	2015)	
	
Even	though	there	 is	still	a	 lot	to	fully	define	the	pathways	of	bone	regeneration,	several	studies	have	
been	developed,	providing	a	general	understanding	of	how	fracture	healing	occurs.	The	use	of	animal	
models	 has	 made	 it	 possible	 to	 investigate	 fracture	 healing	 from	 all	 the	 different	 aspects	 such	 as	
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histology,	 biochemistry	 and	 biomechanics,	 thus	 becoming	 significant	 tool	 in	 understanding	 fracture	
biology	(Bonnarens	&	Einhorn,	1984).	
Indirect	 (secondary)	 fracture	 healing	 is	 the	most	 common	 form	of	 fracture	 healing,	which	 consists	 of	
both	endochondral	and	 intramembranous	bone	regeneration	processes	(Gerstenfeld	et	al.,	2006),	and	
typically	occurs	in	non-operative	fracture	treatment	(Green,	Lubahn,	&	Evans,	2005).	
	
Acute	inflammatory	response	
Immediately	 after	 the	 trauma,	 a	 hematoma	 consisting	 of	 cells	 from	 both	 peripheral	 and	
intramedullary	blood,	as	well	as	bone	marrow	cells,	forms.	An	inflammatory	response	is	initiated	at	the	
injury	 site,	 causing	 the	 hematoma	 to	 coagulate,	 thus	 generating	 a	 template	 for	 the	 callus	 formation	
(Gerstenfeld,	 Cullinane,	 Barnes,	 Graves,	 &	 Einhorn,	 2003).	 The	 acute	 inflammatory	 response	 peaks	
within	the	first	24	hr	and	 is	complete	after	7	days	(T.	 J.	Cho,	Gerstenfeld,	&	Einhorn,	2002).	The	 initial	
proinflammatory	response	involves	secretion	of	tumor	necrosis	factor-α	(TNF-α),	interleukin-1	(IL-1),	IL-
6,	 IL-11	 and	 IL-18	 (Gerstenfeld,	 Cullinane,	 et	 al.,	 2003).	 These	 factors	 recruit	 inflammatory	 cells	 and	
promote	angiogenesis	(Tohma	et	al.,	2017).	TNF-α	is	expressed	by	macrophages	and	other	inflammatory	
cells,	and	has	been	shown	to	act	as	a	chemotactic	agent	responsible	for	recruiting	the	cells	necessary	to	
the	injury	acute	response	(Kon	et	al.,	2001).	IL-1	and	IL-6	are	believed	to	be	most	important	interleukins	
involved	 in	 fracture	 healing.	 IL-1	 is	 produced	 by	macrophages	 in	 the	 acute	 phase	 of	 inflammation;	 it	
stimulates	the	generation	of	the	soft	cartilaginous	callus,	and	promotes	angiogenesis	at	the	injured	site.	
IL-1	is	also	responsible	for	the	induction	of	IL-6	secretion	from	osteoblasts	(Kon	et	al.,	2001;	S.	K.	Lee	&	
Lorenzo,	2006).	IL-6	is	only	produced	during	the	acute	phase	of	inflammation;	it	stimulates	angiogenesis,	
vascular	 endothelial	 growth	 factor	 (VEGF)	 production,	 and	 the	 differentiation	 of	 osteoblasts	 and	
osteoclasts	(Yang	et	al.,	2007).		
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Recruitment	of	MSCs	
In	order	for	bone	to	regenerate,	specific	MSCs	have	to	be	recruited,	proliferate	and	differentiate	
into	osteogenic	cells.	Exactly	where	these	cells	come	from	has	not	been	completely	defined	yet.	Most	
studies	 indicate	 that	MSCs	 involved	 in	 fracture	 healing	 derive	 from	 the	 surrounding	 soft	 tissues	 and	
bone	marrow.	Periosteum	 is	also	considered	a	major	source	of	MSCs	 for	bone	repair,	and	 it	has	been	
shown	that	the	healing	is	delayed	without	it	(Colnot,	Zhang,	&	Knothe	Tate,	2012;	Grcevic	et	al.,	2012).	
Furthermore,	studies	support	the	thesis	of	a	systemic	recruitment	of	circulating	MSCs	to	the	injured	site	
for	 an	 optimal	 healing	 response	 (Granero-Moltó	 et	 al.,	 2009;	 Kitaori	 et	 al.,	 2009).	 Molecular	 events	
mediating	this	recruitment	are	still	under	debate.		
Current	data	suggest	that	SDF-1	and	its	G-protein-coupled	receptor	CXCR-4	form	an	axis	(SDF-1/CXCR-4)	
that	 is	a	key	regulator	of	recruiting	and	homing	specific	MSCs	to	the	site	of	trauma	(Granero-Moltó	et	
al.,	2009;	Kitaori	et	al.,	2009;	Ma	et	al.,	2005).	These	reports	show	that	SDF-1	expression	is	increased	at	
the	 fracture	site,	especially	 in	 the	periosteum.	They	also	demonstrate	that	SDF-1	has	a	specific	 role	 in	
recruiting	CXCR-4	expressing	MSCs	 to	 the	 injured	site	during	endochondral	 fracture	healing	(Kitaori	et	
al.,	 2009).	 The	 importance	 of	 this	 axis	 has	 been	 further	 verified	 as	 treatment	 with	 an	 anti-SDF-1	
antagonist	or	genetic	manipulation	of	SDF-1	and	CXCR-4	impairs	fracture	healing.	It	has	also	been	shown	
that	transplanted	MSCs	only	home	to	the	fracture	site	if	they	express	CXCR-4,	whereas	CXCR-4	negative	
MSCs	do	not	have	this	ability	(Granero-Moltó	et	al.,	2009;	Kitaori	et	al.,	2009).	
	
Generation	of	a	soft	and	a	hard	callus	
Following	 the	previously	described	 formation	of	 the	primary	hematoma,	a	 soft	 callus	made	of	
fibrous	 tissue	 and	 cartilage	 forms	 (Rahn,	Gallinaro,	 Baltensperger,	&	 Perren,	 1971).	 At	 this	 stage,	 the	
cartilage	 constituting	 the	 soft	 callus	 is	 fibrocartilage,	 which	 expresses	 Type	 I	 and	 Type	 II	 collagen,	 in	
contrast	with	hyaline	cartilage	of	the	joints.	The	fibrocartilage	cells	eventually	become	osteoblasts	after	
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the	 hypertrophic	 stage	 (Stump,	 1925).	 In	 animal	 models	 (rat,	 rabbit,	 mouse)	 the	 peak	 of	 soft	 callus	
formation	 occurs	 7–9	 days	 post	 trauma,	 characterized	 by	 an	 increased	 presence	 of	 both	 Type	 II	
procollagen	 and	 proteoglycan	 core	 protein	 extracellular	 markers	 (Einhorn,	 1998).	 After	 cartilage	
mineralization,	a	hard	callus	forms	and	is	ultimately	remodeled	to	regain	the	original	bone	anatomy.	It	is	
the	 final	 bridging	 of	 this	 central	 hard	 callus	 that	 ultimately	 provides	 the	 fracture	 with	 a	 semi-rigid	
structure	which	allows	weight	bearing	(Gerstenfeld	et	al.,	2006).	
The	generation	of	 these	callus	 tissues	 is	dependent	on	the	recruitment	of	MSCs	 from	the	surrounding	
soft	 tissues,	 cortex,	 periosteum,	 and	bone	marrow	as	well	 the	 systemic	mobilization	of	HSCs	 into	 the	
peripheral	 blood	 from	 remote	 hematopoetic	 sites.	 Once	 recruited,	 a	 molecular	 cascade	 involves	
collagen-I	and	collagen-II	matrix	production	and	the	participation	of	several	peptide	signaling	molecules.	
In	this	process	the	TGF-β	superfamily	members	have	been	shown	to	be	of	great	importance.	TGF-	β2,	-
β3	 and	 GDF-5	 are	 involved	 in	 chondrogenesis	 and	 endochondral	 ossification,	 whereas	 BMP-5	 and	 -6	
have	been	suggested	to	induce	cell	proliferation	in	intramembranous	ossification	at	periosteal	sites	(T.	J.	
Cho	et	al.,	2002;	Marsell	&	Einhorn,	2009).	
	
Vascularization	and	neoangiogenesis	at	the	fracture	site	
An	 important	 requirement	 for	 fracture	 healing	 is	 blood	 supply,	 indeed	 revascularization	 is	
essential	for	successful	bone	repair	(Kanczler	&	Oreffo,	2008).	In	order	to	allow	blood	vessels	growth	at	
the	injured	site,	chondrocytes	undergo	apoptosis,	and	cartilage	is	degraded,	thus	removing	unnecessary	
cells	and	extracellular	matrix	(Ai-Aql,	Alagl,	Graves,	Gerstenfeld,	&	Einhorn,	2008).		
Once	 this	 structural	 pattern	 is	 achieved,	 the	 vascularization	 process	 is	 mainly	 regulated	 by	 two	
molecular	 pathways,	 an	 angiopoietin-dependent	 pathway,	 and	 a	 vascular	 endothelial	 growth	 factor	
(VEGF)-dependent	 pathway	 (Tsiridis,	 Upadhyay,	 &	 Giannoudis,	 2007).	 The	 angiopoietins,	 specifically	
angiopoetin-1	 and	 2,	 are	 vascular	 morphogenetic	 proteins,	 whose	 expression	 is	 induced	 early	 in	 the	
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healing	 cascade.	 The	 angiopoietins	 promote	 an	 initial	 vascular	 growth	 from	 existing	 vessels	 in	 the	
periosteum	 (Lehmann	et	 al.,	 2005),	while	 the	VEGF	pathway	 is	 considered	 to	 be	 the	 key	 regulator	 of	
vascular	regeneration	(Keramaris,	Calori,	Nikolaou,	Schemitsch,	&	Giannoudis,	2008).	It	has	been	shown	
that	 both	 osteoblasts	 and	hypertrophic	 chondrocytes	 express	 high	 levels	 of	 VEGF,	 thereby	promoting	
the	 invasion	 of	 blood	 vessels	 and	 transforming	 the	 avascular	 cartilaginous	matrix	 into	 a	 vascularized	
osseous	 tissue	 (Keramaris	 et	 al.,	 2008).	 VEGF	 promotes	 both	 vasculogenesis,	 identified	 in	 the	
aggregation	 and	 proliferation	 of	 endothelial	 mesenchymal	 stem	 cells	 into	 a	 vascular	 plexus,	 and	
angiogenesis,	 representing	 the	 growth	 of	 new	 vessels	 from	 existing	 ones	 (Kanczler	 &	 Oreffo,	 2008).	
VEGF	importance	in	these	processes	is	further	supported	by	the	observation	that	addition	of	excessive	
VEGF	promotes	fracture	healing,	whereas	blocking	of	VEGF-receptors	inhibit	vascular	growth	and	delays	
or	disrupts	the	regenerative	process	(Ai-Aql	et	al.,	2008;	Kanczler	&	Oreffo,	2008).		
	
Mineralization	of	the	soft	callus	
In	order	to	progress	in	bone	repair,	the	initial	soft	cartilaginous	callus	needs	to	be	replaced	by	a	
hard-bony	 callus.	During	 this	 final	 step	of	 fracture	healing,	 a	 combination	of	 cellular	proliferation	and	
differentiation	occurs,	with	an	 increase	 in	 cellular	 volume	and	matrix	deposition	 (Breur,	VanEnkevort,	
Farnum,	&	Wilsman,	1991).	Recent	studies	have	focused	their	attention	on	the	understanding	of	the	role	
of	the	Wnt-family	molecules,	shown	to	give	an	important	contribution	in	the	bone	healing	process.	The	
Wnt-family	 is	 thought	 to	regulate	the	differentiation	of	pluripotent	MSCs	 into	the	osteoblastic	 lineage	
and,	 at	 later	 stages	 of	 development,	 to	 positively	 regulate	 osteoblastic	 bone	 formation	 (Y.	 Chen	 &	
Alman,	2009).	Chondrocytes	in	the	callus	proliferate,	become	hypertrophic,	and	the	extracellular	matrix	
calcifies.	 The	mechanism	 of	 calcification	 involves	mitochondria,	 which	 accumulate	 calcium-containing	
granules	that,	after	being	elaborated	into	the	cytoplasm	of	fracture	callus	chondrocytes,	are	transported	
into	 the	extracellular	matrix	where	 they	precipitate	with	phosphate	and	 form	 initial	mineral	deposits.	
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These	deposits	of	 calcium	and	phosphate	will	 evolve	 into	apatite	 crystals	 (Ketenjian	&	Arsenis,	1975).	
The	peak	of	the	hard	callus	formation	is	usually	reached	by	day	14	in	animal	models,	as	confirmed	by	the	
detection	of	extracellular	matrix	markers,	such	as	Type	I	procollagen,	osteocalcin,	alkaline	phosphatase	
and	osteonectin	(Einhorn,	1998).		
	
Bone	remodeling	
In	order	to	achieve	the	completed	restoration	of	the	biomechanical	properties	of	normal	bone,	
the	fracture	healing	process	initiates	a	second	resorptive	phase,	this	time	to	remodel	the	hard	callus	into	
a	 lamellar	 bone	 structure	 with	 a	 central	 medullary	 cavity	 (Gerstenfeld,	 Cullinane,	 et	 al.,	 2003).	 This	
phase	is	biochemically	played	by	IL-1	and	TNF-α,	both	found	to	be	highly	expressed	during	this	stage,	as	
opposed	to	most	members	of	the	TGF-β	family	whose	expression	is	strongly	decreased	by	this	time	(Ai-
Aql	 et	 al.,	 2008;	Mountziaris	&	Mikos,	 2008).	 However,	 some	 TGF-	 β	 family	members	 such	 as	 BMP2,	
seem	 to	be	 involved	 in	 this	 phase	with	 reasonably	high	expression	 levels,	 as	well	 (Marsell	&	Einhorn,	
2009).	
The	remodeling	process	is	carried	out	by	a	balance	of	hard	callus	resorption	by	osteoclasts,	and	lamellar	
bone	 deposition	 by	 osteoblasts.	 This	 process	 is	 initiated	 after	 3–4	weeks	 from	 the	 day	 of	 fracture	 in	
animal	 and	 human	 models,	 and	 may	 last	 years	 before	 completely	 restoring	 a	 regenerated	 bone	
structure	(WENDEBERG,	1961).	As	just	mentioned,	bone	remodeling	is	the	result	of	a	combined	activity	
of	osteoclasts	 and	osteoblasts,	 and	has	been	 shown	 to	be	a	 result	of	production	of	 electrical	 polarity	
created	when	pressure	is	applied	in	a	crystalline	environment	(Marsell	&	Einhorn,	2011).	Axial	loading	of	
long	 bones	 occurs,	 creating	 one	 electropositive	 convex	 surface,	 and	 one	 electronegative	 concave	
surface,	activating	osteoclastic	and	osteoblastic	activity	respectively.	By	these	actions	the	external	callus	
is	gradually	replaced	by	a	lamellar	bone	structure,	whereas	the	internal	callus	remodeling	re-establishes	
a	medullar	cavity	characteristic	of	a	diaphyseal	bone	(Marsell	&	Einhorn,	2011).	
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The	 major	 bone	 compartment	 responsible	 for	 bridging	 the	 callus	 formation	 and	 participating	 to	
endochondral	and	intramembranous	ossifications	during	fracture	healing	is	the	periosteum.	As	a	matter	
of	 fact,	most	cells	 involved	 in	 the	regenerative	process	come	from	this	bone	compartment	 (Ferretti	&	
Mattioli-Belmonte,	2014).	
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Periosteum	
Periosteum	is	a	structure	comprised	of	two	layers	that	surround	the	cortical	bone	(Figure	9).	
	
Figure	9.	Schematic	representation	of	periosteum.	The	periosteum	is	the	membrane	composed	of	both	
cells	 and	 matrix	 that	 surrounds	 the	 diaphyseal	 bone.	 PDPCs:	 Periosteum-derived	 precursor	 cells.	
(Ferretti	 C.,	Mattioli-Belmonte	M.	 Periosteum	 derived	 stem	 cells	 for	 regenerative	medicine	 proposals:	
Boosting	current	knowledge.	World	J	Stem	Cells,	v.	6,	n.	3,	p.	266-77,	2014)	
	
	The	outer	 layer	provides	mechanical	 stability	 to	 the	periosteum,	and	 is	made	of	 fibroblasts,	 collagen,	
and	elastin	along	with	a	nerve	and	microvascular	network	(Allen,	Hock,	&	Burr,	2004).	The	inner	layer	is	
enriched	 in	 cells	 that	 regulate	 bone	 formation	 and	 bone	 repair,	 represented	 by	 adult	 mesenchymal	
skeletal	 progenitor	 cells,	 osteoblasts,	 fibroblasts,	 and	 sympathetic	 nerves	 (Allen	 et	 al.,	 2004).	 For	 the	
properties	 listed	above,	the	periosteum	can	be	considered	a	structure	with	regenerative	capacity.	Due	
to	 its	 high	 vascularity,	 there	 are	 also	 numerous	 pericytes	 within	 the	 periosteum	 (Diaz-Flores	 et	 al.,	
1992).	 Pericytes	 are	 cells	 distributed	 around	 capillary	 endothelial	 cells,	 which	 can	 differentiate	 into	
several	cell	 types,	 including	osteoblasts	 (Reilly,	Seldes,	Luchetti,	&	Brighton,	1998).	Thus,	 the	pericytes	
could	be	considered	a	supplemental	source	of	osteoprogenitor	cells	within	the	periosteum	(Diaz-Flores	
et	al.,	1992).	The	periosteum	is	known	to	make	major	contributions	to	the	bone-healing	process.	Within	
24	 to	48	hours	 following	 injury,	 an	acute	 inflammatory	 reaction	develops	 (Colnot,	 Thompson,	Miclau,	
Werb,	 &	 Helms,	 2003;	 Lu	 et	 al.,	 2005),	 periosteal	 cells	 start	 to	 proliferate,	 and	 a	 thickening	 of	
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periosteum	 is	 observed.	 This	 process	 is	 defined	 as	 periosteal	 activation.	 It	 has	 been	 shown	 that	
expansion	of	the	mesenchymal	progenitor	cell	population	from	the	periosteum	largely	accounts	for	the	
formation	 of	 cartilage	 and	 bone	within	 the	 callus	 (Colnot,	 2009;	 Grcevic	 et	 al.,	 2012;	 X.	 Zhang	 et	 al.,	
2005).	 Conversely,	 cells	 belonging	 to	 the	 bone	 marrow	 or	 endosteum	 compartments	 remain	 in	 the	
marrow	cavity	and	do	not	migrate	out	to	form	the	callus	(Colnot,	2009).	These	results	indicate	that	the	
contributions	of	periosteal	cells	are	critical	for	callus	formation.	In	fact,	activation	of	periosteum-derived	
progenitor	 cells	 (PDPCs)	 induces	 robust	 chondrogenesis	 and	 osteogenesis,	 together	 with	 marked	
induction	 of	 angiogenesis,	 which	 eventually	 leads	 to	 vascularization	 and	 remodeling	 of	 bone	 grafts	
(Colnot	 et	 al.,	 2012;	 X.	 Zhang	 et	 al.,	 2005).	 Different	 groups	 have	 demonstrated	 that	 the	 healing	 is	
impaired	when	the	periosteum	is	absent	(Colnot,	2009;	Ozaki,	Tsunoda,	Kinoshita,	&	Saura,	2000).	Ozaki	
et	 al.	 (2000)	 observed	only	 little	 chondrocyte	 generation	when	 the	 periosteum	had	been	 removed	 in	
induced-tibia	 fracture	 rats;	Colnot	 (2009)	 caused	periosteal	 injuries	 in	mice,	by	exposing	 the	anterior-
proximal	 tibia	 surface	 and	 stripping	 the	 periosteum	with	 a	 razor	 blade,	 and,	 in	 this	way,	 she	 showed	
that,	 in	 the	 absence	 of	 periosteum,	 bone	 bridging	 was	 reduced.	 It	 has	 been	 demonstrated	 that	
periosteal	 replacement	 can	 heal	 critical-sized	 bone	 defects	 in	 animal	 models	 (Chang	 &	 Knothe	 Tate,	
2012;	Knothe	Tate,	Ritzman,	Schneider,	&	Knothe,	2007).	
Other	sources	of	mesenchymal	progenitor	cells	have	also	been	proposed	to	participate	in	bone-fracture	
healing,	 including	 local	bone	marrow,	adjacent	muscle	 tissue,	 and	 circulating	mesenchymal	 stem	cells	
(Colnot	et	al.,	2012;	R.	Liu	et	al.,	2011;	D.	Park	et	al.,	2012).	However,	the	relative	contribution	to	healing	
by	each	cellular	phenotype	is	still	unclear.	Liu	et	al.	(2011)	showed	that	myogenic	progenitors	contribute	
to	 open	 fracture	 repair.	 Specifically,	 Liu	 et	 al.	 (2011)	 compared	 closed	 tibial	 fractures,	 presenting	 an	
intact	 periosteum,	 with	 an	 open,	 highly-traumatic	 fracture	 model,	 featuring	 periosteal	 stripping	 and	
local	 tissue	 trauma.	A	major	 contribution	by	 cells	expressing	 the	myogenic	 specific	marker	MyoD	was	
observed	 in	 the	open	 fracture	model,	 at	 all	 stages	of	 the	 repair	 process.	 In	 contrast	 to	 the	 traumatic	
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open	fracture	scenario,	MyoD-lineage	cells	made	an	insignificant	contribution	to	closed	fracture	repair.	
This	may	suggest	 that	 the	 intact	periosteum	contribution	to	bone	healing	 is	sufficient	 for	bone	repair,	
and	does	not	necessary	require	alternative	osteoprogenitor	sources.		
Fracture	healing	 is	a	 regenerative	process	 that	 involves	coordinated	responses	of	many	cell	 types,	but	
the	characterization	of	these	specific	cell	populations	in	this	process	has	been	limited.	However,	recent	
lineage-tracing	studies	during	fracture	healing	in	mice	have	shed	a	first	light	on	the	markers	that	could	
be	used	to	identify	skeletal	progenitor	cells	in	vivo.	Transgenic	Cre	reporter	mice	have	become	a	useful	
tool	 for	 studying	 specific	 cell	 populations	 in	 vivo.	 These	 reporter	 mice	 are	 genetically	 engineered	 to	
encode	 a	 fluorescent	 marker	 that	 is	 only	 expressed	 upon	 removal	 of	 a	 STOP	 codon	 cassette	 that	 is	
flanked	by	lox	P	sites	that	are	recognized	and	excised	by	Cre	recombinase.	Therefore,	the	use	of	reporter	
mice	that	express	Cre	recombinase	under	the	control	of	tissue-specific	gene	promoters	has	enabled	the	
identification	and	lineage	tracing	of	various	stem	cell	types	 in	vivo,	such	as	progenitor	cells	(Grcevic	et	
al.,	 2012;	 Z.	 Kalajzic	 et	 al.,	 2008;	 Kawanami,	Matsushita,	 Chan,	 &	Murakami,	 2009;	Matthews	 et	 al.,	
2014;	Murao,	Yamamoto,	Matsuda,	&	Akiyama,	2013;	D.	Park	et	al.,	2012;	Roguljic	et	al.,	2013;	Zhou,	
Yue,	Murphy,	 Peyer,	&	Morrison,	 2014).	 Park	 et	 al.	 (2012)	 showed	 that	Mx-1-Cre	 recombined	widely	
among	hematopoietic	cells,	PDGFRα+	stromal	cells,	and	CFU-Fs	in	the	bone	marrow,	and	these	cells	gave	
rise	 to	most	 of	 the	 osteoblasts	 formed	 in	 adult	 bone	marrow	 (D.	 Park	 et	 al.,	 2012).	 Kawanami	 et	 al.	
(2009),	 using	 a	 with	 Prx1–CreER–GFP	 transgenic	 mice,	 has	 shown	 that	 PRX1-expressing	 cells	 in	 the	
periosteum	 are	 osteochondroprogenitor	 cells	 that	 give	 rise	 to	 chondrocytes	 and	 osteoblasts	 in	 the	
fracture	callus	(Kawanami	et	al.,	2009).	A	recent	study	by	Murao	et	al.	(2013)	further	revealed	that	while	
no	SOX9-positive	cells	are	detected	 in	 resting	periosteum,	 these	cells	quickly	arise	after	bone	 fracture	
(Murao	 et	 al.,	 2013).	 Zhou	 et	 al.	 (2014)	 showed	 that	 LepR+	 cells	 are	 highly	 enriched	 for	 CFU-F	 and	
uniformly	express	Prx1-Cre,	PDGFRα,	and	CD51,	markers	expressed	by	bone	marrow	MSCs.	LepR+	cells	
were	 the	main	 source	of	new	osteoblasts	and	adipocytes	 in	adult	bone	marrow	and	could	 form	bony	
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ossicles	 that	support	hematopoiesis	 in	vivo	 (Zhou	et	al.,	2014).	 In	previous	studies,	Grcevic	et	al.	have	
used	alpha	smooth	muscle	actin(αSMA)–CreERT2	transgenic	mice	 to	demonstrate	 that	 the	majority	of	
the	callus	cells,	including	chondrocytes	and	osteoblasts,	are	derived	from	αSMA-expressing	cells	(Grcevic	
et	 al.,	 2012).	 αSMA	 is	 a	 marker	 of	 pericytes	 and	 myofibroblastic	 cells	 that	 identifies	 mesenchymal	
progenitor	 cells	with	 proliferative	 and	multi-lineage	 differentiation	 potential	 in	 bone	marrow	 stromal	
cell	 cultures	 in	 vitro	 (Z.	 Kalajzic	 et	 al.,	 2008),	 and	 osteoblast	 precursors	 in	 the	 bone	 marrow	 and	
periodontium	in	vivo	(Grcevic	et	al.,	2012;	Roguljic	et	al.,	2013).	Although	the	origin	of	αSMA+	cells	is	still	
unknown,	they	are	most	likely	cells	derived	from	the	local	vascular	system	adjacent	to	the	fracture	site	
(Grcevic	et	al.,	2012).	When	periosteal	αSMA+cells	were	isolated,	they	exhibited	skeletal	progenitor	cell	
characteristics,	including	the	expression	of	several	mesenchymal	progenitor	cell	markers	and	the	ability	
to	 differentiate	 along	 the	 osteogenic,	 chondrogenic	 and	 adipogenic	 lineage	 (Grcevic	 et	 al.,	 2012;	
Matthews	et	al.,	2014).		 	
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Molecular	signaling	during	periosteal	activation	
Until	 recently,	 little	 was	 known	 about	 the	 molecular	 signaling	 that	 controls	 the	 periosteal	
responses	during	callus	formation.	With	the	development	of	genetically	modified	mouse	models,	studies	
have	probed	several	 signaling	pathways	and	 their	effects	on	periosteal	 cells.	BMP,	Wnt,	Notch,	PDGF,	
FGF,	Hedgehog,	and	inflammatory	mediators	have	all	been	shown	to	contribute	to	the	healing	process,	
and	therapies	that	target	these	pathways	are	currently	under	development	for	bone	metabolic	diseases.	
	
Bone	morphogenetic	protein-2	(BMP2)	
BMP2	is	well-known	for	its	powerful	effect	on	bone	development	and	regeneration	(Lowery	et	
al.,	 2011).	 The	 scientific	 community	 had	 agreed	 for	 years	 that	 BMP2	 is	 an	 intrinsic	 initiator	 of	 bone	
healing.	 However,	 there	 was	 a	 limited	 number	 of	 studies	 to	 support	 this	 theory,	 since	 global	 BMP2-
deletion	results	in	embryonic	lethality	(Lowery	et	al.,	2011).	Tsuji	et	al.	(2006)	developed	a	mouse	model	
in	which	the	Bmp2	gene	 is	conditionally	 inactivated	 in	 the	mesoderm	by	means	of	a	Prx-1-Cre	deleter	
mouse.	 A	 delayed	 periosteal	 activation	 response	 and	 a	 complete	 absence	 of	 bridging	 callus	 upon	
fracture	were	found	 in	these	Bmp2	conditional	knockout	mice,	underlining	the	crucial	role	of	BMP2	in	
the	initiation	of	fracture	healing.	Similarly,	Wang	et	al.	(2011)	deleted	Bmp2	postnatally	at	the	initiation	
stage	 of	 fracture	 healing	 using	 a	 Tamoxifen-inducible	 CreER	 mouse	 model,	 and	 found	 that	 Bmp2	
inactivation	at	the	early	stages	of	healing	impaired	the	bone	and	cartilage	callus	formation	derived	from	
the	 periosteum.	 Further	 analysis	 of	 the	 periosteal	 callus	 showed	 that	 most	 of	 the	 Bmp2	 conditional	
knockout	 progenitors	 remained	 undifferentiated	 (Q.	 Wang	 et	 al.,	 2011).	 Recently,	 Mi	 et	 al.	 (2013)	
conditionally	knocked	out	the	Bmp2	gene	in	chondrocytes	and	in	osteoblasts	by	means	of	Col2-Cre	and	
Col1-Cre	deleter	mice.	They	showed	that	the	lack	of	Bmp2	expression	in	chondrocytes	led	to	prolonged	
cartilage	 callus	 formation	 and	 delayed	 osteogenesis	 initiation.	 However,	 when	 the	 Bmp2	 gene	 was	
inactivated	in	osteoblasts	by	the	Col1-Cre	deleter,	the	mice	showed	no	significant	difference	in	fracture	
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healing.	 These	 results	 indicate	 that,	 during	 fracture	 repair,	 expression	 of	 BMP2	 is	 required	 in	
undifferentiated	 preosteoblasts	 but	 not	 in	 mature	 osteoblasts.	 Interestingly,	 the	 skeletal-specific	
inactivation	 of	 Bmp4	 and	 Bmp7	 by	means	 of	 a	 Prx1-Cre	 deleter	 shows	 no	 effects	 on	 fracture	 repair	
(Bandyopadhyay	et	al.,	2006),	suggesting	that,	in	vivo,	under	physiological	conditions,	BMP2,	not	BMP4	
or	 BMP7,	 represents	 a	 primary	 modulator	 of	 periosteum-mediated	 fracture	 repair.	 These	 results	
indicate	that	the	use	of	recombinant	BMP2	in	bone	repair	procedures	may	require	the	presence	of	the	
periosteum	to	reach	a	maximal	therapeutic	efficiency.		
	
Wnt	family	members	
Many	members	of	the	Wnt	family	are	expressed	in	the	injured	periosteum	(Y.	Chen	et	al.,	2007;	
J.	B.	Kim	et	al.,	2007).	It	has	been	shown	that	the	inactivation	of	the	Wnt/β-catenin	signaling	pathway	in	
chondrocytes	leads	to	compromised	bone	repair	due	to	reduced	and	delayed	cartilage	formation	(Huang	
et	al.,	2012).	Kim	et	al.	(2007)	observed	that	the	inhibition	of	Wnt	signaling	in	bone	healing	by	using	the	
Wnt	inhibitor	Dkk1	reduces	bone	regeneration	by	84%,	and	the	addition	of	recombinant	DKK1	or	other	
Wnt	 inhibitor	Sclerostin	to	primary	periosteal	cells	reduces	proliferation	and	increases	apoptosis	(H.	K.	
Kim,	Oxendine,	&	Kamiya,	2013).	Therefore,	it	is	assessed	that	Wnt	signaling	contributes	significantly	to	
fracture	 healing.	 In	 confirmation	 of	 these	 observations,	 gain-of-function	 of	 Wnt	 signaling	 seems	 to	
promote	bone	 fracture	healing.	 In	 fact,	expression	of	an	activated	 form	of	beta-catenin	 in	osteoblasts	
dramatically	enhanced	bone	healing	in	mice	(Y.	Chen	et	al.,	2007).	Additionally,	gene	knockout	of	Axin2,	
a	 negative	 regulator	 of	 Wnt	 signaling,	 resulted	 in	 accelerated	 bone	 healing	 after	 injury,	 which	 was	
related	 to	 more	 robust	 proliferation	 and	 earlier	 differentiation	 of	 skeletal	 stem	 and	 progenitor	 cells	
(Minear	et	al.,	2010).	Also,	the	administration	of	DKK1	neutralizing	antibody	 in	bone	healing	 improved	
bone	 repair	 and	 regeneration	 in	mice	 (Agholme,	 Isaksson,	 Kuhstoss,	 &	 Aspenberg,	 2011;	 X.	 Li	 et	 al.,	
2011).	In	vivo	deletion	of	the	secreted	Frizzled	Related	Protein	1	(sFRP1),	one	of	several	frizzled	related	
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Wnt	antagonists,	improves	fracture	repair	by	promoting	early	bone	union	(Gaur	et	al.,	2009).	However,	
studies	have	shown	that	Wnt-responsive	cells	appear	to	be	located	mainly	on	the	endosteal	surface	of	
injured	bone,	in	contrast	to	the	BMP	target	cells	resident	in	the	periosteum	(Minear	et	al.,	2010),	leading	
to	 consider	 that,	 during	 fracture	 repair,	 BMP	 signaling	 and	 Wnt	 signaling	 act	 in	 different	 bone	
compartments.	 Thus,	 a	Wnt-based	 therapy	may	not	directly	 target	 the	periosteum	but	may	 indirectly	
enhance	 periosteal-mediated	 bone	 regeneration.	 It	 is	 therefore	 possible	 that	 therapies	 under	
development	 that	 target	 the	Wnt	 pathway,	 such	 as	 therapies	 based	 on	 DKK1	 and	 SOST	 neutralizing	
antibodies,	may	 be	 beneficial	 not	 only	 for	 bone	 endocrinology	 disorders	 but	 for	 periosteal-mediated	
bone-regenerative	therapy	as	well.		
	
Notch	signaling	
Notch	signaling	has	been	shown	to	regulate	skeletal	development	(Tao,	Chen,	&	Lee,	2010).	
In	 the	 skeleton,	disruption	of	Notch	 signaling	promotes	osteoblast	 formation,	 and	markedly	 increases	
osteoprogenitor	 differentiation	 (Tao	 et	 al.,	 2010),	 while	 ultimately	 depleting	 the	 mesenchymal	
progenitor	pool	(Y.	Dong	et	al.,	2010;	Hilton	et	al.,	2008).	There	has	been	limited	characterization	of	the	
role	 of	 Notch	 signaling	 in	 fracture	 repair,	 although	 regulation	 of	 Notch	 signaling	 is	 important	 during	
healing	in	a	number	of	other	tissues	(Chigurupati	et	al.,	2007;	Conboy,	Conboy,	Smythe,	&	Rando,	2003;	
Gude	et	al.,	2008).	Interestingly,	Dishowitz	and	colleagues	recently	showed	that	Notch	signaling	pathway	
components	expression	is	upregulated	during	fracture	healing	as	Jag1	and	Notch2	expression	is	localized	
in	 the	 undifferentiated	mesenchymal	 cells	 of	 the	 healing	 periosteum	 (Dishowitz,	 Terkhorn,	 Bostic,	 &	
Hankenson,	 2012).	 Another	 study	 showed	 that	 genetically	 inducible	 systemic	 inhibition	 of	 Notch	
signaling	prolonged	the	inflammatory	phase	of	fracture	healing	and	altered	cartilage	formation,	but	it	is	
unclear	which	cell	types	are	responsible	for	this	change	(Dishowitz	et	al.,	2013).	A	recent	study	showed	
that	 αSMA+	 cell	 population	 presents	 a	 downregulation	 of	 many	 components	 of	 the	 Notch	 signaling	
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pathway	in	the	early	phases	after	fracture,	 including	all	four	receptors	and	two	of	the	canonical	target	
genes.	 These	 changes	 have	 been	 observed	 specifically	 in	 the	 αSMA+	 population.	 It	 has	 been	 also	
demonstrated	that	forced	expression	of	Notch	in	αSMA+	cells	from	periosteum	and	bone	marrow	blocks	
differentiation	 into	 osteoblast,	 chondrocyte,	 and	 adipocyte	 lineages	 in	 vitro	 and	 reduced	 bone	
formation	in	an	in	vivo	implant	(Matthews	et	al.,	2014).	Downregulation	of	Notch	signaling	in	these	cells	
may	 be	 important	 for	 their	 contribution	 to	 fracture	 callus	 formation.	 However,	 further	 studies	 are	
required	to	clarify	the	role	of	Notch	signaling	in	different	lineage	populations	in	vivo	at	different	stages	
of	fracture	healing.		
	
Platelet-derived	growth	factors	(PDGFs)	
PDGFs	 are	 involved	 in	 the	 wound-healing	 processes	 of	 various	 tissues,	 including	 bone.	 PDGF	
ligands	and	receptors	have	been	shown	to	be	expressed	in	osteoblasts,	chondrocytes,	and	mesenchymal	
stem	cells	 (Kaigler	et	al.,	 2011).	Deletion	of	PDGF	 receptors	α	and	β	 in	mice	 showed	 that	 the	primary	
effects	 of	 PDGF	 signaling	 in	 bone	 healing	 are	 proliferation	 and	migration	 responses	 (Tokunaga	 et	 al.,	
2008).	 Recombinant	 PDGF-BB	 is	 currently	 utilized	 for	 periodontal	 regenerative	 therapy	 (Kaigler	 et	 al.,	
2011),	but	if	it	can	be	utilized	for	periosteal-mediated	bone	regeneration	has	not	been	proven	yet.	
	
Fibroblast	growth	factors	(FGFs)	
The	 role	 of	 fibroblast	 growth	 factors	 (FGFs)	 and	 their	 receptors	 in	 fracture	 healing	 has	 been	
extensively	 investigated	 over	 the	 years	 (Du,	 Xie,	 Xian,	 &	 Chen,	 2012).	 Fgf2,	 5,	 and	 6	 are	 strongly	
upregulated	during	early	callus	formation	and	maintain	high	levels	of	expression	throughout	the	healing	
process.	 Other	 FGFs,	 such	 as	 Fgf16	 and	 Fgf18,	 reached	 their	 peak	 expression	 at	 the	 chondrogenesis	
stage	of	callus	formation,	whereas	FGF	receptors	such	as	Fgfr1	and	Fgfr2	were	shown	to	be	expressed	in	
the	 proliferating	 periosteum	 stage	 (Du	 et	 al.,	 2012).	 Many	 studies	 have	 explored	 the	 use	 of	 FGFs,	
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especially	 FGF2,	 for	 promoting	 fracture	 healing.	 In	 the	mouse,	 rat,	 rabbit,	 and	 non-human	 primates,	
FGF2	 has	 been	 found	 to	 stimulate	 the	 proliferation	 of	 periosteal	 cells,	 osteoprogenitors,	 and	
chondrogenitors,	enhancing	callus	formation	(Du	et	al.,	2012).	However,	some	studies	have	shown	that	
FGF2	 treatment	did	not	 lead	 to	 increased	bone	mineral	density	and	 increased	mechanical	 strength	of	
the	 callus	 (Nakajima,	 Nakajima,	 Ogasawara,	 Moriya,	 &	 Yamazaki,	 2007).	 To	 explain	 this	 discrepancy,	
additional	studies	suggested	that	the	effect	of	FGF	on	bone	formation	is	biphasic,	with	inhibitory	effects	
at	high	doses	(Du	et	al.,	2012).	All	up	to	date	data	about	FGF	and	bone	healing	indicate	that	a	precise,	
time-controlled	modulation	of	FGF	signaling	may	be	useful	in	bone-regenerative	procedures	(van	Gastel	
et	al.,	2014).	
	
Indian	hedgehog	(Ihh)	
The	 Indian	 hedgehog	 (Ihh)	 pathway	 is	 known	 to	 be	 a	 master	 regulator	 in	 chondrocyte	
differentiation,	 proliferation,	 and	 maturation,	 especially	 during	 endochondral	 ossification	 (Lai	 &	
Mitchell,	 2005).	 Loss	 of	 hedgehog	 signaling	 in	 postnatal	 chondrocytes,	 either	 genetically	 or	
pharmacologically,	 leads	 to	 loss	 of	 epiphyseal	 growth	 plates,	 with	 premature	 fusion	 and	 shortened	
stature.	 However,	 Ihh	 also	 plays	 critical	 roles	 in	 periosteum-mediated	 fracture	 healing.	 Studies	 have	
shown	that	Ihh	is	highly	expressed	during	callus	formation	of	both	non-stabilized	and	stabilized	fractures	
(Le,	Miclau,	Hu,	&	Helms,	 2001),	 and	 appears	 to	 be	 expressed	within	 the	 newly	 formed	 cartilaginous	
tissues,	 close	 to	 the	 bone	 surface	 of	 the	 callus	 (Q.	Wang,	 Huang,	 Zeng,	 Xue,	 &	 Zhang,	 2010).	 All	 Hh	
signals	 are	 transduced	 by	 the	 transmembrane	 protein	 known	 as	 Smoothened	 (Smo).	 By	 using	 a	
tamoxifen-inducible	 cre-mediated	gene	 inactivation	mouse	model,	Wang	et	al.	 (Q.	Wang	et	al.,	 2010)	
showed	that	deletion	of	Smo	at	the	onset	of	bone	autograft	repair	resulted	in	a	nearly	50%	reduction	in	
periosteal	bone	callus	 formation	at	the	cortical	bone	 junction.	From	the	healing	periosteum,	they	also	
isolated	a	population	of	early	periosteum-callus-derived	mesenchymal	stem	cells;	gene	knockout	of	Smo	
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markedly	 reduced	 osteogenic	 differentiation	 of	 these	 progenitor	 cells	 (Q.	 Wang	 et	 al.,	 2010).	 Thus,	
targeting	the	hedgehog	pathway	may	represent	an	approach	to	bone	anabolism	as	well	as	an	approach	
to	periosteal-mediated	bone	regeneration.		
	
Inflammatory	mediators	
A	wide	variety	of	 inflammatory	 signals	are	 thought	 to	 regulate	 the	periosteal	 response	during	
fracture	 healing.	 Indeed,	 matrix	 metalloproteinase-9	 (Mmp9),	 strongly	 expressed	 by	 neutrophils	 and	
macrophages	in	the	early	fracture	callus,	is	involved	in	bone	healing.	Colnot	and	her	group	have	shown	
that	Mmp9-/-	mice	have	non-unions	and	delayed	unions	of	their	fractures	caused	by	persistent	cartilage	
at	the	injury	site	(Colnot	et	al.,	2003).	It	has	been	further	demonstrated	that	MMP9	mediates	its	effects	
on	 skeletal	 cell	 differentiation	 by	 regulating	 the	 inflammatory	 response	 and	 the	 distribution	 of	
inflammatory	cells,	leading	to	the	local	regulation	of	periosteal	cell	differentiation	(X.	Wang	et	al.,	2013).		
Cyclooxygenase	 2	 (COX-2)	 is	 the	 inducible	 isoform	 of	 cyclooxygenase,	 an	 enzyme	 involved	 in	 the	
prostaglandin	 biosynthesis	 pathway,	which	 is	 a	 critical	 regulator	 in	 inflammation.	Cox-2	was	 found	 in	
chondroprogenitors	 and	 mesenchymal	 cells	 along	 the	 periosteal	 surface,	 and	 its	 expression	 was	
correlated	with	the	early	induction	of	chondrogenesis	and	early	expansion	of	the	cartilaginous	callus	(Xie	
et	al.,	2009).	Administration	of	a	COX-2	inhibitor	in	the	early	phase	of	the	healing	process	compromised	
fracture	 repair	 (A.	M.	 Simon,	Manigrasso,	&	O'Connor,	 2002).	 Furthermore,	 genetic	 ablation	 of	Cox-2	
impaired	 periosteal	 progenitor	 cell	 proliferation	 and	 delayed	 subsequent	 endochondral	 and	
intramembranous	 repair,	 leading	 to	 reduction	 of	 bone	 formation,	 persistence	 of	 cartilaginous	 tissue,	
and	high	 incidence	of	non-unions.	Contrarily,	overexpressing	Cox-2	 locally	accelerated	fracture	healing	
and	bone	unions	(X.	Zhang	et	al.,	2002).	Although	further	studies	are	needed,	molecules	involved	in	the	
inflammatory	process	may	represent	a	valid	target	in	periosteal-mediated	bone-regenerative	therapy.		
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Aim	of	the	study	
The	extracellular	microenvironment	of	 the	stem	cell	niche	 is	known	to	be	determinant	 for	 the	
regulation	 of	 MSCs	 behavior.	 Low	 oxygen	 tension	 is	 an	 important	 component	 of	 the	 stem	 and	
progenitor	 cells	microenvironment	 since	 it	 provides	 signals	 that	 are	 conducive	 to	 the	maintenance	of	
stem	 cell	 functions	 (Buravkova	 et	 al.,	 2009),	 modulating	 the	 behavior	 of	 different	 stem	 cell	 types,	
including	adult	stem	cells	(Fotia	et	al.,	2015).	A	 less	studied	but	peculiar	feature	of	the	stem	cell	niche	
microenvironment	is	the	pH	levels	of	the	interstitial	space,	which	is	able	to	influence	MSCs	proliferation,	
differentiation	 and	 paracrine	 activity	 (Disthabanchong	 et	 al.,	 2007).	 Specifically,	 an	 acidic	
microenvironment	 is	 able	 to	modulate	 stemness	 and	 regeneration	 of	MSCs	 (Mohyeldin	 et	 al.,	 2010).	
Similarly,	autophagy,	that	can	be	induced	by	acidic	conditions,	has	been	associated	with	the	regulation	
of	 MSC	 stem-like	 features,	 as	 well	 as	 with	 senescence	 and	 cell	 death/survival	 (Eom	 et	 al.,	 2014).	
Furthermore,	 the	 activation	 of	 inflammatory	 pathways	 (Lardner,	 2001)	 can	 be	 triggered	 by	 acidosis	 a	
condition	typically	found	in	several	chronic	inflammatory	diseases	associated	with	bone	loss,	secondary	
osteoporosis,	 and,	 as	 a	 consequence,	 an	 increased	 fracture	 risk	with	 impaired	bone	healing	 (Hardy	&	
Cooper,	 2009).	 Inflammation	 is	 an	 important	 factor	 during	 bone	 healing,	 with	molecular	 factors	 and	
immune	cells	acting	locally	at	the	fracture	site	in	a	finely	tuned	sequence	of	events.	Changes	in	the	pH	
value	of	 the	extracellular	microenvironment	 affect	 bone	generation	 and	mineralization,	 since	 acidosis	
inhibits	the	deposition	of	mineral	matrix	by	osteoblasts	and	promotes	bone	resorption	by	osteoclasts	(T.	
R.	Arnett,	2010).		
Even	though	there	is	still	a	lot	to	fully	define	the	pathways	of	bone	regeneration,	several	studies	
have	been	developed,	providing	a	general	understanding	of	how	fracture	healing	occurs	(Bonnarens	&	
Einhorn,	1984).	Fracture	healing	is	a	regenerative	process	that	involves	coordinated	responses	of	many	
cell	 types,	but	 the	characterization	of	 these	specific	cell	populations	has	been	 limited.	Recent	 lineage-
tracing	studies	during	fracture	healing	in	mice	have	shed	a	first	light	on	the	markers	that	could	be	used	
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to	 identify	 skeletal	 progenitor	 cells	 in	 vivo,	 even	 though,	 in	 the	 murine	 system,	 some	 of	 the	 MSCs	
antigens	 are	 not	 universal	 for	 all	 the	mouse	 strains.	 The	 common	 view	 is	 that	murine	mesenchymal	
progenitor	cells	are	confined	in	the	CD45-Ter119-CD31-	fraction	(Anjos-Afonso	&	Bonnet,	2008;	Peister	
et	 al.,	 2004;	 Phinney	 et	 al.,	 1999).	 Several	 studies	 support	 the	 idea	 that	 Sca1	 could	 be	 a	 potential	
positive	marker	for	the	identification	of	murine	mesenchymal	progenitor	cells,	alone	or	in	combination	
with	other	markers	(Lundberg	et	al.,	2007;	Morikawa	et	al.,	2009;	Nakamura	et	al.,	2010;	Steenhuis	et	
al.,	 2008).	Other	 potential	markers	 defined	 as	 possible	 candidates	 to	 identify	 progenitor	 cells	 in	mice	
model	in	vivo	are	CD51/Alpha	V	(integrin	alpha	V),	PDGFRα,	CD105	and	CD90	(Arai	et	al.,	2002;	Kitaori	et	
al.,	2009;	Lundberg	et	al.,	2007;	Morikawa	et	al.,	2009;	Nakamura	et	al.,	2010).	In	previous	studies	from	
Kalajzic’s	 lab,	 Grcevic	 et	 al.	 (2012)	 have	 used	 alpha	 smooth	muscle	 actin(αSMA)–CreERT2	 transgenic	
mice	 to	demonstrate	 that	 the	majority	of	 the	callus	 cells,	 including	chondrocytes	and	osteoblasts,	are	
derived	 from	 αSMA-expressing	 cells	 (Grcevic	 et	 al.,	 2012).	 αSMA	 is	 a	 marker	 of	 pericytes	 and	
myofibroblastic	 cells	 that	 identifies	mesenchymal	 progenitor	 cells	with	 proliferative	 and	multi-lineage	
differentiation	 potential	 in	 bone	 marrow	 stromal	 cell	 cultures	 in	 vitro	 (Z.	 Kalajzic	 et	 al.,	 2008),	 and	
osteoblast	precursors	in	the	bone	marrow	and	periodontium	in	vivo	(Grcevic	et	al.,	2012;	Roguljic	et	al.,	
2013).	 Specifically,	 αSMA+	 cells	 isolated	 from	 periosteum	 exhibited	 skeletal	 progenitor	 cell	
characteristics,	including	the	expression	of	several	mesenchymal	progenitor	cell	markers	and	the	ability	
to	 differentiate	 along	 the	 osteogenic,	 chondrogenic	 and	 adipogenic	 lineage	 (Grcevic	 et	 al.,	 2012;	
Matthews	et	al.,	2014).	
	 In	this	study,	we	first	investigated	how	variations	in	extracellular	pH	can	affect	MSCs	behavior,	in	
light	of	their	great	importance	in	clinical	applications	of	regenerative	medicine.	We	therefore	evaluated	
the	effect	of	acidity	on	MSCs	proliferation,	osteogenic	potential,	activation	of	survival	mechanisms,	such	
as	 autophagy,	 and	 release	 of	 inflammatory	 molecules.	 We	 also	 aimed	 to	 identify	 progenitor	 cells	
activated	during	the	bone	healing	process	in	a	mouse	model	in	vivo.	We	looked	for	potential	markers	to	
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define	osteo-	and	chondro-progenitor	populations,	 focusing	our	attention	on	the	periosteum,	which	 is	
the	bone	compartment	that	gives	the	major	contribution	to	bone	healing	(Ferretti	&	Mattioli-Belmonte,	
2014).	
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Materials	and	methods		
Cell	cultures	
Human	 bone	marrow-derived	mesenchymal	 stem	 cells	 (BMMSCs)	 and	 human	 adipose	 tissue-
derived	 mesenchymal	 stem	 cells	 (ADMSCs)	 were	 purchased	 from	 Lonza	 (Euroclone)	 and	 from	 the	
American	 Type	 Cell	 Culture	 Collection	 (ATCC),	 respectively.	 Cells	were	 cultured	 in	Minimum	 Essential	
Medium	 Eagle	 Alpha	 Modified	 (aMEM)	 supplemented	 with	 10%	 fetal	 bovine	 serum	 (FBS)	 (Sigma-
Aldrich),	penicillin	 (100	U/ml),	and	streptomycin	 (100	mg/ml)	 (Thermo	Fisher	Scientific,	Waltham,	MA,	
USA)	at	37	°C	and	5	%	CO2.	BMMSCs	and	ADMSCs	were	always	used	before	the	5–6	passage	in	culture.	
Specific	pH	of	the	culture	medium	(acidic	pH	of	6.5	or	6.8,	and	physiological	pH	of	7.4)	was	maintained	
by	 using	 different	 concentrations	 of	 sodium	 bicarbonate,	 according	 to	 the	 Henderson-Hasselbach	
equation.	At	the	endpoint	of	each	experiment,	the	final	pH	of	the	supernatant	was	always	measured	to	
ascertain	the	maintenance	of	the	pH	value	along	the	incubation	time.		
 
Proliferation	assay	by	Ki67	staining	
BMMSCs	were	 seeded	on	 glass	 chamber	 slides	 (8x103	 cells/well),	 and	 synchronized	 in	 the	G0	
phase	of	 the	 cell	 cycle	by	 starvation	 treatment	 for	48	hr	 (Rosner	&	Hengstschläger,	 2011).	Cells	were	
then	cultured	with	aMEM	complete	medium	at	different	pHe	(6.5	or	7.4)	for	36	hr.	Subsequently,	cells	
were	 fixed	with	3.7	%	paraformaldehyde	 (Sigma-Aldrich)	 in	PBS	 for	20	min	at	 room	 temperature	 (RT)	
and	permeabilized	with	HEPES-triton	for	5	min.	Ki67	was	revealed	with	a	monoclonal	anti-Ki67	antibody	
(1:75,	DAKO,	 Santa	 Clara,	 CA,	USA).	 After	washing,	 cells	were	 incubated	with	 the	 secondary	 antibody	
Alexa	Fluor	488	nm	(1:1000,	Life	Technologies)	and	0.02	%	Evans	blue	for	1	hr.	Cells	were	analyzed	using	
a	fluorescence	microscope.	The	Ki67	index	was	determined	as	the	percentage	of	cells	with	Ki-67-positive	
nuclear	staining	in	respect	to	the	total	cell	population.		
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Osteogenic	differentiation	
To	 evaluate	 the	 effect	 of	 extracellular	 acidosis	 on	 osteogenic	 differentiation,	 BMMSCs	 were	
seeded	at	a	density	of	1×104	cells/cm2	in	aMEM	supplemented	with	10%	FBS,	50	mg/mL	L-ascorbic	acid	
2-phosphate,	10−8	M	dexamethasone	(Sigma-Aldrich),	at	different	pHe	(6.5	and	7.4).		
The	deposition	of	mineralized	matrix	was	evaluated	after	21	days	of	treatment	with	osteogenic	medium	
at	different	pHe.	Cells	were	fixed	in	3.7	%	paraformaldehyde	for	20	min	and	stained	with	2%	alizarin	red	
at	 pH	 4.2	 (Sigma-Aldrich)	 for	 1	 hr	 at	 RT.	 Then,	 the	 staining	 was	 eluted	 with	 a	 solution	 of	 10%	
cetylpyridinium	 chloride	 (CPC)	 (p/v)	 (Sigma-Aldrich)	 and	 the	 absorbance	 at	 570	nm	was	quantified	by	
using	a	microplate-reader	(Tecan	Infinite	F200pro,	Männedorf,	Switzerland).	The	results	were	expressed	
as	mean	optical	density	(OD).		
	
Western	blotting		
BMMSCs	were	cultured	at	both	physiological	 (7.4)	and	acidic	(6.8)	pH	for	different	time	points	
(1,	3	and	7	days),	to	analyze	protein	expression	of	typical	autophagic	markers	by	western	blotting.	The	
inhibitor	of	autophagy	bafilomycin	A1	(BafA1)	(Yamamoto	et	al.,	1998),	was	added	during	the	last	2	hr	of	
incubation	 to	 emphasize	 the	 autophagic	 process	 detection.	Whole-cell	 extracts	were	 lysed	with	 RIPA	
buffer	(150	mM	NaCl,	50	mM	Tris	pH	7.4,	1%	Nonidet	P-40	[Sigma,	I3021],	0.1%	SDS	and	0.5%	sodium	
deoxycholate)	 supplemented	 with	 protease	 and	 phosphatase	 inhibitors.	 Equal	 amount	 of	 lysate	 was	
analyzed	by	SDS–polyacrylamide	gel	electrophoresis	 (PAGE),	 followed	by	 immunoblotting	overnight	at	
4°C	with	 anti-human	 LC3B	 (Cell	 Signaling	 Technology,	 Danvers),	 anti-human	 p62	 (BD	 Biosciences,	 San	
Jose,	CA)	antibodies,	or	anti-human	ACTB	(Dallas,	TX)	antibody,	as	reference.	The	next	day	membranes	
were	 washed	 and	 incubated	 for	 1	 hr	 with	 HRP-conjugated	 secondary	 antibody	 and	 the	 binding	 was	
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detected	by	the	ECL	system.	Whole-cell	extracts	signals	 from	each	band	were	quantified	by	dedicated	
software	(Quantity	One,	Biorad	Laboratories	Headquarters,	Hercules,	CA).		
 
Electron	microscopy		
BMMSCs	were	 cultured	 at	 both	 physiological	 (7.4)	 and	 acidic	 (6.8)	 pH	 for	 3	 days,	 in	 order	 to	
explore	the	cells	content	with	a	transmission	electron	microscope.	After	the	3	days	incubation,	the	cells	
were	sedimented	and	immediately	fixed	with	2.5%	glutaraldehyde	0.1	M	cacodylate	buffer	pH	7.6	for	1	
hr	at	RT.	After	post-fixation	with	1%	osmium	tetroxide	in	cacodylate	buffer	for	1	hr	at	4°C,	pellets	were	
dehydrated	 in	 an	 ethanol	 series	 and	 embedded	 in	 Epon	 resin.	Ultrathin	 sections	 stained	with	 uranyl-
acetate	and	lead	citrate	were	observed	with	a	Jeol	Jem-1011	transmission	electron	microscope.	
 
Cytokines	secretion	analysis	
MSCs	from	different	sources	 (BMMSCs	and	ADMSCs)	were	seeded	at	3x104	cells/well	 into	24-
well	plates	for	protein	quantification	by	specific	ELISA	assay.	After	adhesion,	cells	were	incubated	with	
0.1%	FBS	aMEM	at	different	pH.	After	24	hr,	culture	supernatants	were	collected,	spun	and	tested	for	
the	release	of	inflammatory	cytokines.	IL-6	secretion	was	quantified	with	Human	IL-6	DuoSet,	IL-8	with	
Human	CXCL-8/IL-8	Quantikine	ELISA	kits	(R&D	Systems,	Minneapolis,	MN,	USA).	Data	were	normalized	
to	 the	 total	 protein	 content	 quantified	 by	 bicinchoninic	 acid	 (BCA)	 assay	 (Thermo	 Fisher	 Scientific,	
Waltham,	MA,	 USA).	 Colorimetric	 reactions	 for	 all	 the	 ELISA	 assays	were	 quantified	 by	 a	microplate-
reader	(Tecan	Infinite	F200pro,	Männedorf,	Switzerland).	
 
Real	time	PCR	
BMMSCs	and	ADMSCs	were	cultured	at	both	physiological	(7.4)	and	acidic	(6.8)	pH	for	different	
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time	points	(3,	6,	24,	168	hs),	to	analyze	inflammatory	cytokines	mRNA	by	Real	time	PCR.	Total	RNA	was	
extracted	from	cells	cultured	at	different	pH	by	using	RNeasy	Mini	Kit	(Qiagen	GmbH).	Total	mRNA	was	
reverse	 transcribed	by	 the	Advantage	RT-for-PCR	Kit	 (Roche).	 The	 expression	of	 the	 genes	 of	 interest	
was	evaluated	by	using	the	Light	Cycler	instrumentation	(Roche	Diagnostics)	by	amplifying	1	μg	of	cDNA	
and	the	Universal	Probe	Library	system	(Roche	Applied	Science).		Probes	and	primers	were	selected	by	
using	 a	web-based	 assay	 design	 software	 (ProbeFinder	 https://www.	 roche-applied-science.com):	 IL6-
fwd	 5’-GATGAGTACAAAAGTCCTGATCCA-3’;	 IL6-rev	 5’-CTGCAGCCACTGGTTCTGT-3’;	 IL8/CXCL8-FWD	 5’-
GAGCACTCCATAAGGCACAAA-3’;	IL8/CXCL8-5’-ATGGTTCCTTCCGGTGGT-3’).	The	protocol	of	amplification	
was:	95	°C	for	10	min;	95	°C	for	10s,	60	°C	for	30s,	and	72°C	for	1s	for	45	cycles;	40°C	for	30s.	The	results	
were	 expressed	 as	 ratio	 between	 the	 gene	 of	 interest	 and	 rRNA18s	 (rRNA18s-fwd	 5’-
GCAATTATTCCCCATGAACG-3’;	 rRNA18s-rev	5’-GGGACTTAATCAACGCAAGC-3’),	according	 to	 the	2-ΔΔCT	
method	(Livak	&	Schmittgen,	2001).	
 
Mouse	strains		
All	 animal	 procedures	were	 approved	by	 an	 institutional	 animal	 care	 and	use	 committee,	 and	
performed	 in	 an	AAALACi	 accredited	 facility.	Mice	were	 group	housed	 in	 individually	 ventilated	 cages	
(Thoren	Caging,	Hazleton,	PA)	with	a	photoperiod	of	12:12.	The	room	temperature	and	humidity	were	
maintained	at	22°C	and	30–70%	respectively.	Mice	were	fed	irradiated	Rodent	Diet	(Teklad	2918,	Invigo,	
Indianapolis,	IN),	made	available	in	pellets,	and	water	(reverse-osmosis)	ad	libitum.	Vendor	surveillance	
and	 colony	 sentinel	 monitoring	 results	 show	 that	 the	 colony	 is	 free	 from	 all	 pathogens	 tested.	 The	
aSMACreERT2	 (Grcevic	et	al,	2012)	 transgenic	mouse	has	been	previously	described.	The	SMACre/Ai9	
dual	transgenic	mice	were	generated	by	breeding	aSMACreERT2	mice	with	Ai9	reporter	mice	(B6;129S6-	
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J,	 stock	 #	 007905),	 obtained	 from	 Jackson	 Laboratory	 (Bar	
Harbor,	 ME,	 USA).	 SMACre/Ai9/Col2.3GFP	 transgenic	 mice	 were	 generating	 by	 breeding	
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SMACre/Col2.3GFP	 mice	 (I.	 Kalajzic	 et	 al.,	 2002),	 previously	 described,	 with	 Ai9	 mice.	 The	 Ai9	 mice	
harbor	a	 targeted	mutation	of	 the	Gt(ROSA)26Sor	 locus	with	a	 loxP-flanked	STOP	 cassette	preventing	
transcription	of	a	CAG	promoter-driven	red	fluorescent	protein	variant	(tdTomato).		
Immunodeficient	NSG	mice	(NOD.Cg-Prkdcscid	Il2rgtm1Wjl/SzJ,	stock	#	005557),	obtained	from	Jackson	
Laboratory	 (Bar	 Harbor,	 ME),	 carry	 two	 mutations	 on	 the	 NOD/ShiLtJ	 genetic	 background,	 severe	
combined	immune	deficiency	(scid)	and	a	complete	null	allele	of	the	IL2	receptor	common	gamma	chain	
(IL2rgnull).	The	scid	mutation	is	in	the	DNA	repair	complex	protein	Prkdcand	renders	the	mice	B	and	T	cell	
deficient.	 The	IL2rgnull	mutation	 prevents	 cytokine	 signaling	 through	 multiple	 receptors,	 leading	 to	 a	
deficiency	in	functional	NK	cells.	
Mice	 known	 as	 R26-M2rtTA/TetOP-H2B-GFP	 (B6;129S4-Gt(ROSA)26Sortm1(rtTA*M2)Jae	Col1a1tm7(tetO-
HIST1H2BJ/GFP)Jae/J,	stock	#	016836),	obtained	from	Jackson	Laboratory	(Bar	Harbor,	ME),	allow	doxycycline-
inducible,	fluorescent	labeling	of	cells.	In	the	first	targeted	mutation,	Human	HIST1H2BJ	(histone	cluster	
1,	 H2bj)	 produces	 a	 GFP	 fusion	 protein	 under	 the	 direction	 of	 the	 tetO	 minmal	 CMV	 promoter	
downstream	 of	 the	Col1a1	(collagen,	 type	 I,	 alpha	 1)	 gene;	 in	 the	 second	
mutation,	Gt(ROSA)26Sor	drives	expression	of	an	optimized	rtTA.		
In	 order	 to	 activate	 the	 tetO	 system,	 thus	 enhancing	 GFP	 expression,	 we	 fed	 donor	 mice	 for	
transplantation	 with	 doxycycline	 containing	 food	 starting	 3	 days	 prior	 to	 sacrifice.	 Doxycycline	 food	
contained	625	mg/kg	doxycycline	(Harlan	Laboratories,	Indianapolis,	IN),	resulting	in	an	estimated	daily	
doxycycline	dose	of	approximately	1.6-2.7	mg/day.	Recipient	mice	for	transplantation	(NSG)	were	also	
fed	with	 food	containing	 the	same	dose	of	doxycycline	mentioned	above,	 starting	a	 few	days	prior	 to	
surgery,	 which	 was	 switched	 with	 doxycycline	 water	 at	 a	 dose	 of	 2mg/ml	 in	 5%	 sucrose	 after	 the	
transplant.		
In	order	 to	 label	aSMA-expressing	 cells,	 tamoxifen	 (Sigma	Aldrich,	 St.	 Louis,	MO)	dissolved	 in	 corn	oil	
was	administered	by	intraperitoneal	injection	at	a	dose	of	75	μg/g	of	bodyweight.		
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Primary	cell	isolation	for	mice	studies	
Cells	 from	bone	marrow,	periosteum	and	endosteum	bone	 compartments	were	 isolated	 from	
mice	tibias	and	femurs.	Mice	bones	were	dissected,	muscle	and	tendon	tissue	were	removed,	and	bone	
marrow	flushed.	After	flushing,	bone	marrow	was	seeded	at	a	density	of	approximately	1x107	cells/100	
mm	 dish	 in	aMEM	 supplemented	 with	 20%	 FCS,	 and	 placed	 in	 a	 low	 oxygen	 incubator	 (5%	 O2)	 for	
traditional	BMMSC	adherent	culture;	media	was	changed	after	4	days	of	incubation,	and	the	cells	were	
confluent	after	7	days.			
BMMSC	were	 also	 used	 for	 flow	 cytometry	 analysis,	 and,	 in	 this	 case,	 cells	 were	 incubated	with	 red	
blood	cells	(RBC)	lysis	buffer	(155	mM	NH4Cl,	10	mM	KHCI3,	0.1	mM	EDTA	in	ddH2O).	RBC	was	added	to	
the	cells	for	5	min	incubation,	at	room	temperature;	lysed	cells	were	then	washed	with	staining	media	
(SM)	made	of	PBS	containing	2%	FBS	and	1	mM	EDTA,	and	filtered.	Periosteum	was	scraped	from	the	
diaphyseal	cortex,	then	digested	 in	PBS	containing	0.05%	collagenase	P	(Roche,	Mannheim,	Germany),	
and	 0.2%	 hyaluronadase	 (Sigma,	 St.	 Louis,	MO,	 USA)	 for	 1	 hr	 at	 37°C	with	 agitation;	 cells	 were	 then	
resuspended	 in	culture	media	containing	10%	FBS,	and	passed	through	a	strainer;	after	spinning,	cells	
were	washed	again	in	a	 large	volume	of	PBS	(~40	mL),	and	then	resuspended	in	SM.	Mice	bones	were	
then	washed	 repeatedly	 in	 PBS,	 and	 cut	 in	 smaller	 pieces,	 and	endosteum	cells	were	digested	 in	 PBS	
containing	0.05%	collagenase	A	(Roche,	Mannheim,	Germany)	for	1	hr	at	37°C	with	agitation;	the	bones	
were	crushed	after	 the	first	30	min	 incubation;	crushed	bones	were	then	washed	twice	with	PBS,	and	
filtered,	and	the	cells	were	eventually	resuspended	in	SM.	
 
Bone	injury	procedures	
Closed	 transverse	 diaphyseal	 fractures	 of	 the	 right	 tibias	were	 created	 in	 2-months-old	mice.	
Briefly,	before	 fracture,	a	0.38-mm-diameter	stainless	steel	pin	was	 inserted	 into	 the	medullary	canal.	
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Fractures	were	created	1	to	2	mm	proximal	to	the	distal	tibia-fibula	junction	using	a	drop-weight	blunt	
guillotine	device.	X-ray	(Faxitron	LX-60)	was	used	to	confirm	pin	and	fracture	placement.	
An	alternative	to	fracture	in	which	the	exclusive	contribution	of	periosteum	is	more	clear	is	the	scratch	
injury.	For	this	procedure,	mice	were	anesthetized	with	2-3%	isoflurane	in	oxygen,	and	then	scratched	
on	 all	 four	 limbs	 using	 a	 needle	 through	 the	 skin	 and	 the	muscle.	 In	 this	 way,	 there	 is	 a	 substantial	
thickening	of	the	periosteum,	and	the	activation	of	all	the	cells	involved	in	injury	repair	that	are	coming	
from	this	specific	bone	compartment.		
 
Histology		
Mice	bones	were	fixed	in	4%	paraformaldehyde	for	2-4	days	at	4°C,	the	intramedullary	pins	were	
removed	 from	 fractured	 samples,	 and	 bones	 were	 incubated	 overnight	 in	 30%	 sucrose/PBS,	 and	
embedded	in	Cryomatrix	(Thermo	Fisher	Scientific,	Waltham,	MA,	USA).	Sections	of	7	μm	were	obtained	
on	 a	 cryostat	 (Leica,	Wetzler,	 Germany)	 using	 a	 tape	 transfer	 system	 (Section-lab,	 Hiroshima,	 Japan).	
Sections	were	coverslipped	in	50%	glycerol	containing	DAPI.	 Imaging	was	performed	using	appropriate	
filter	 cubes	 on	 an	 Axioscan	 (Carl	 Zeiss,	 Thornwood,	 NY,	 USA).	 Consistent	 exposure	 times	 were	
maintained	to	allow	for	image	analysis.		
 
Immunostaining	
After	fluorescent	imaging,	coverslips	were	removed	and	immunostaining	was	performed	for	the	
chondrocyte	marker	Sox9	(1:100,	Santa	Cruz	Biotechnology,	Santa	Cruz,	CA,	USA),	for	the	tibias	samples.	
Sections	for	immunostaining	were	rehydrated	in	PBS,	permeabilized	in	0.1%	Triton	X-100	for	15	min,	and	
blocked	with	 2%	 BSA/PBS	 for	 1	 hr,	 in	 a	 humidified	 chamber	 at	 room	 temperature.	 Primary	 antibody	
diluted	 in	PBS	2%	BSA	was	applied	overnight	at	4°C.	After	washing,	 secondary	antibody	diluted	1:300	
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was	applied	for	1	hr	at	room	temperature	(goat	anti-rabbit	Alexa	Fluor	647,	Life	Technologies,	Carlsbad,	
CA,	USA).	Sections	were	then	coverslipped	again,	and	the	images	analyzed.		
 
Image	analysis	
aSMA+	cells	contribution	to	fracture	healing	was	quantified	in	histological	sections	using	ImageJ	
(NIH).	 Callus	 area	 was	 split	 in	 three	 parts,	 upper,	 lower	 and	 central,	 referring	 to	 a	 2-mm	 line	 drew	
starting	from	the	fracture	point.	Within	each	callus	region	of	interest	(ROI),	individual	cells	were	defined	
using	 the	 DAPI	 channel,	 and	 separated	 using	 the	 watershed	 algorithm.	 Appropriate	 standardized	
thresholds	 for	 the	 red	and	green	channels	were	determined,	 then	signal	 levels	 in	both	channels	were	
determined	for	each	nuclear	region,	and	used	to	count	the	number	of	red,	green,	and	dual-labeled	cells.	
The	proportion	of	labeled	osteoblasts	was	determined	by	calculating	the	proportion	of	green	cells	that	
were	 also	 red.	 Chondrocytes	 were	 quantified	 by	 drawing	 ROIs	 around	 areas	 of	 chondrocytes,	 as	
determined	by	SOX9	staining	and	confirmed	by	cells	morphology,	then	calculating	the	proportion	of	red	
nuclei	in	these	ROIs.	To	ensure	values	were	representative	of	all	the	samples,	3-4	sections	were	analyzed	
per	sample.		
 
Flow	cytometry	
Periosteum	was	used	 to	 sort	 cells	 for	 low	density	cultures	and	 to	perform	cell	 surface	marker	
analysis,	 together	 with	 bone	 marrow	 and	 endosteum.	 After	 processed	 as	 described	 above,	 cells	
resuspended	in	SM	were	stained	with	the	following	antibodies:	CD45	(clone	30-F11),	CD31	(clone	390),	
Ter119	 (clone	 TER-119),	 Sca1	 (clone	D7),	 CD105	 (clone	MJ7/18),	 PDGFRa	 (clone	APA5),	 all	 purchased	
from	eBioscience	 (San	Diego,	 CA,	USA),	 and	CD51	 (clone	RMV-7)	 and	CD90	 (clone	30-H12)	 purchased	
from	BioLegend	(San	Diego,	CA,	USA).	FACSAria	II	(BD	Biosciences,	San	Jose,	CA,	USA)	was	used	for	cell	
sorting,	while	LSR	II	(BD	Biosciences,	San	Jose,	CA,	USA)	was	used	for	cell	analysis.	Data	were	analyzed	
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with	FlowJo	(TreeStar,	Ashland,	OR,	USA)	and	FACS	Diva	(BD	Biosciences,	San	Jose,	CA,	USA)	software.	
Voltages	and	gates	were	set	based	on	unstained	samples	from	Cre-negative	and	Cre-positive	animals.	
 
Colony	Forming	Unit	(CFU)	assay	
Approximately	 0.5-1×103	 sorted	 cells	 per	 well	 were	 seeded	 on	 a	 6-well	 plate	 in	 aMEM	
supplemented	 with	 20%	 FCS,	 and	 placed	 in	 a	 low	 oxygen	 incubator	 (5%	 O2).	 Based	 on	 previous	
experience	 sorting	 on	 similar	 cell	 populations,	 we	 found	 a	 cell	 survival	 rate	 of	 about	 50%,	 so	 we	
considered	this	to	calculate	the	proper	density	to	seed.	Groups	of	cells	of	consistent	amount	were	also	
seeded	 at	 higher	 densities,	 generally	 the	negative	 population.	 Total	media	was	 changed	 after	 4	 days,	
and,	 after	 other	 3-4	 days,	 different	 tests	 were	 performed.	 PrestoBlue	 cell	 viability	 reagent	
(ThermoFisher	Scientific)	was	used	at	a	concentration	of	5%	in	aMEM	10%	FCS	to	test	cell	viability.	Our	
purpose	was	 to	 evaluate	 cell	 growth	 keeping	 the	 cells	 alive,	 in	order	 to	decide	when	 the	 culture	was	
ready	 to	be	 stopped.	PrestoBlue	 reagent	 is	 a	 resazurin-based	 solution	 that	 functions	as	a	 cell	 viability	
indicator	by	using	the	reducing	power	of	living	cells	to	quantitatively	measure	the	proliferation	of	cells.	
Cells	were	incubated	at	37°C	for	3	hs,	then	200	μL	of	each	well	supernatant	was	transferred	to	a	96-well	
plate,	and	the	fluorescence	was	measured	by	using	the	excitation	(570	nm)	and	emission	(583	nm)	peaks	
for	resorufin,	with	a	microplate	reader	(Tecan	Infinite	F200pro,	Männedorf,	Switzerland).	
Alkaline	phosphatase	(ALP)	assay	was	performed	to	detect	ALP	activity	of	the	cells	(CFU-ALP).	Cells	were	
fixed	 with	 10%	 formalin	 for	 ~5	 min,	 washed	 with	 water,	 then	 ALP	 reaction	 mix	 (Sigma-Aldrich)	 was	
added	to	the	wells.	After	20	min	in	the	darkness,	wells	were	gently	washed	with	water	and	left	to	dry.			
Crystal	violet	staining	 (250	mg	of	Crystal	violet	powder	 (Sigma-Aldrich)	dissolved	 in	500	μL	of	ethanol,	
and	500	mL	of	water)	was	performed	to	visualize	the	colony	formation	(CFU-F).	Cells	were	stained	for	~3	
min,	then	gently	washed	with	water	and	left	to	dry.		
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Plates	were	scanned,	and	colonies	were	counted	using	 ImageJ	 (NIH).	Adherent	cell	clusters	containing	
>50	cells	were	counted	as	a	colony.	
	
Calvarial	transplantation	
NSG	mice	were	anesthetized	with	ketamine	 (87	mg/kg)	and	xylazine	 (13	mg/kg),	and	 two	3.5-
mm	 diameter	 calvarial	 bone	 discs	 were	 extracted	 from	 both	 sides	 of	 the	 suture,	 carefully	 avoiding	
damaging	the	dura	mater.	Scaffold	discs	of	3.5	mm	of	diameter	and	0.5	mm	of	thickness	were	cut	from	a	
hydroxyapatite/collagen	matrix	(HEALOS,	DePuy	Spine,	Inc.,	Raynham,	MA,	USA),	to	be	placed	into	the	
defect	 area.	 Different	 numbers	 of	 sorted	 cells	 were	 loaded	 on	 each	 scaffold	 in	 5-7	 µL	 of	 media;	
tdTomato-negative	 loaded	 cells	were	 20000,	 tdTomato-positive	 loaded	 cells	were	 4-5000,	 CD51+	 and	
CD51+Sca1+	 loaded	 cells	 were	 13-20000,	 Sca1+	 loaded	 cells	 were	 2-4000.	 All	 the	 positive	 cells	 were	
loaded	 together	 with	 250000	 BMMSC	 as	 carrier.	 All	 the	 mice	 woke	 up	 and	 recovered	 well	 after	
transplantation,	and	were	maintained	for	5	weeks	after	surgery.	
 
Statistical	analysis	
Statistical	 analysis	 of	 human	 MSCs	 was	 performed	 by	 the	 StatViewTM	 5.0.1	 software	 for	
Windows	(SAS	Institute,	Cary,	NC,	USA).	To	evaluate	Ki67	index	for	cell	proliferation,	Wilcoxon	Rank	for	
paired	analysis	was	used.	To	evaluate	cytokines	secretion,	Mann–Whitney	U	test	was	used	as	unpaired	
comparison	 for	 two	 independent	 variables.	 Results	 were	 reported	 as	 mean	 ±	 standard	 error.	 Only	
p<0.05	were	considered	as	statistically	significant.	
Statistical	analysis	of	cells	isolated	from	mice	was	performed	by	the	GraphPad	Prism	statistical	software	
(Graph	Pad,	Inc,	San	Diego,	CA).	Data	are	reported	as	the	mean	value	±	standard	deviation.	Values	were	
analyzed	 by	 ANOVA	 with	 post-hoc	 analysis	 by	 the	 Tukey’s	 test	 method	 for	 multiple	 comparisons	
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between	 pairs	 or	 by	 Student’s	 t-test.	 Values	 were	 considered	 significant	 if	 p<0.05	 in	 comparison	 to	
negative	controls.	
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Results	
Acidic	microenvironment	impairs	BMMSCs	proliferation	and	osteogenic	differentiation.	
MSCs	 behavior	 is	 influenced	 by	 the	 niche	 microenvironment	 in	 vivo	 (Disthabanchong	 et	 al.,	
2007;	 Sacchetti	 et	 al.,	 2007).	On	 these	 basis,	 we	mimicked	 a	 peculiar	 microenvironment	 in	 vitro,	 by	
culturing	MSCs	in	acidic	medium,	and	then	analyzed	their	proliferation	and	differentiation	activity.	Even	
though	systemic	pH	of	7.0	or	below	is	generally	only	seen	clinically	in	multi-organ	failure	with	profound	
hypoperfusion,	local	tissue	pH	can	reach	even	lower	levels.	Hence,	in	bone	trauma,	it	is	conceivable	that	
intracellular	and	interstitial	 fluid	pHs	 in	the	 immediate	area	of	blood	supply	disruption	could	have	pHs	
down	to	6.4	–	6.5	(Bischoff,	Zhu,	Makhijani,	&	Yamaguchi,	2008).	
First,	 we	 verified	 if	 the	 culture	medium	 pH	 values,	 that	we	 chemically	 adjusted	 to	 simulate	 different	
extracellular	pHe,	were	maintained	over	the	incubation	period.	After	24	h,	the	culture	medium	that	was	
originally	buffered	at	the	physiological	value	of	pH	7.4	showed	a	slight	decrease	to	pHe	7.2	(Figure	1A),	
which	was	maintained	over	time.	For	the	medium	originally	buffered	at	acidic	pHe	6.5,	the	pH	value	was	
more	 stable	 and	 constant	 at	 all	 the	 examined	 time	 points	 (Figure	 1A).	 We	 then	 analyzed	 BMMSCs	
proliferation	in	low	pH	conditions,	and	observed	a	significant	reduction,	correlated	with	a	lower	number	
of	 cycling	 cells,	 as	 revealed	by	 the	Ki67	 index	 that	 significantly	 decreased	 in	 a	 pH-dependent	manner	
(Figure	1B).	
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Figure	1.	Extracellular	acidosis	inhibited	BMMSCs	cell	proliferation.	Cells	were	seeded	and	incubated	at	
the	specified	pH.	pH	maintenance	of	media	with	different	sodium	bicarbonate	concentrations	over	the	
culture	period	(A).	Representative	images	of	Ki67	staining	of	BMMSCs	at	different	pHe	(B).	Nuclear	Ki67	
(green)	 and	 cytoskeletal	 staining	 by	 Evans	 blue	 (red).	 Quantification	 of	 the	 Ki-67	 index.	 Results	 were	
obtained	with	two	different	donors	and	three	technical	replicates;	*	p	<	0.05.	
	
We	 also	 observed	 that	 extracellular	 acidosis	 impairs	 BMMSCs	 osteogenic	 differentiation	 (Figure	 2).	
Indeed,	the	formation	of	mineral	nodules,	an	 indirect	 index	of	osteogenic	differentiation,	was	strongly	
inhibited	at	pHe	6.5	compared	to	pHe	7.4	(Figure	2).	
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Figure	 2.	 Extracellular	 acidosis	 impaired	 osteogenic	 differentiation	 of	 BMMSCs.	 Representative	
pictures	of	alizarin	red	assay	after	21	days	of	 incubation	with	osteogenic	medium	at	different	pH,	and	
the	respective	quantification	(absorbance	at	570	nm).	Results	were	obtained	with	three	different	donors	
and	two	technical	replicates,	**	p	<	0.01.	
 
Autophagy	is	activated	by	BMMSCs	at	both	acidic	and	physiological	pH.	
It	has	been	shown	that	cells	activate	autophagy	as	a	survival	mechanism	in	microenvironmental	
stressful	conditions	(Kroemer	et	al.,	2010).	Autophagy	has	been	associated	with	the	regulation	of	MSC	
stem-like	 features	 (Sordella,	 Jiang,	 Chen,	 Curto,	 &	 Settleman,	 2003),	 and	 can	 be	 induced	 by	 acidic	
conditions.	The	autophagic	 flux	of	BMMSCs	was	evaluated	by	protein	expression	of	 typical	autophagic	
markers	 (LC3-II,	p62	and	Beclin1)	at	 lower	 (pH	6.8)	or	neutral	 (pH	7.4)	pH	 (Figure	3A,	3B).	Despite	we	
could	observe	a	detectable	autophagic	activity	of	BMMSCs	in	both	culture	conditions,	as	shown	by	LC3-I	
to	LC3-II	conversion,	no	significant	variations	between	pH	conditions	could	be	observed,	leading	to	the	
speculation	that	autophagy	is	not	the	main	mechanism	by	which	MSC	face	an	acidic	microenvironment.	
Ultrastructural	analysis	was	used	to	confirm	our	findings:	we	observed	the	typical	features	of	autophagy,	
such	 as	 formation	 of	 autophagic	 vacuoles	 containing	 cytoplasmic	 components	 and	 organelles	 (Figure	
3C),	but	no	qualitative	differences	among	different	pHe.	
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Figure	3.	Autophagic	 flux	 in	BMMSCs	was	detected	at	both	pH	7.4	and	pH	6.8.	Protein	expression	of	
typical	autophagic	markers	(LC3-II,	p62	and	Beclin1)	evaluated	by	Western	blot	(A),	and	autophagic	flux	
(AF)	quantification	(B).	Representative	transmission	electron	microscopy	image	of	a	double-membrane	
autophagosome	in	BMMSCs	cultured	at	acidic	pH	(C).	Scale	bar=1	μm.	
 
Acidic	microenvironment	triggers	BMMSCs	secretion	of	inflammatory	cytokines.	
Acidic	pH	values	of	6.8	are	commonly	associated	to	several	pathological	conditions	(Bischoff	et	
al.,	2008),	and	are	known	to	induce	the	activation	of	inflammatory	pathways	with	consequent	release	of	
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cytokines	(Lardner,	2001).	On	these	bases,	we	evaluated	the	paracrine	activity	of	the	MSCs	most	used	
sources	in	clinical	application	(BMMSCs	and	ADMSCs)	when	cultured	in	acidic	conditions,	at	both	protein	
and	 mRNA	 levels.	 An	 ELISA	 assay	 showed	 a	 significant	 increase	 in	 IL-6	 and	 IL-8	 secretion	 at	 pH	 6.8,	
compared	 to	 pH	 7.4	 (Figure	 4A).	 At	 the	 mRNA	 level,	 inflammatory	 cytokines	 presented	 a	 time-
dependent	regulation,	with	a	very	high	variability	due	to	the	intrinsic	differences	between	the	different	
MSCs	 sources	 used	 (Figure	 4B).	We	 thus	 observed	 an	 increased	 release	 of	 inflammatory	 cytokines	 at	
both	protein	and	mRNA	levels	(Figure	4A	and	4B).	
	
 
Figure	4.	Extracellular	acidosis	promotes	the	secretion	of	inflammatory	cytokines	IL-6	and	IL-8.	IL-6	and	
IL-8	protein	expression	after	24	hr	of	incubation	with	acidic	medium	by	using	specific	ELISA	(A).	IL-6	and	
IL-8	mRNA	analysis	of	BMMSCs	and	ADMSCs	at	different	time	points	of	incubation	with	acidic	medium.	
Results	were	obtained	with	three	different	donors	and	two	technical	replicates,	*	p	<	0.05.		
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Periosteum	is	significantly	enriched	in	progenitor	cell	markers,	including	αSMA,	compared	to	
endosteum	and	bone	marrow.	
MSCs	in	vivo	properties	are	mostly	studied	by	using	murine	models.	Some	of	the	MSCs	antigens	
are	not	universal	for	all	the	mouse	strains,	however	it	is	assessed	that	murine	mesenchymal	progenitor	
cells	are	confined	in	the	CD45-Ter119-CD31-	fraction	(Anjos-Afonso	&	Bonnet,	2011).	Most	studies	focus	
on	cells	isolated	from	the	bone	marrow,	or	total	bone	(Chan	et	al.,	2013;	Chan	et	al.,	2015;	Morikawa	et	
al.,	2009),	and	use	a	wide	number	of	cell	surface	marker	combinations,	although	there	are	differences	
between	 different	 groups.	 Sca1,	 PDGFRα,	 CD105,	 CD90,	 and	 CD51	 seem	 to	 be	 the	 most	 promising	
candidates	 as	markers	 to	 identify	 progenitor	 cell	 populations	 in	 bone	 (Chan	 et	 al.,	 2013;	 Chan	 et	 al.,	
2015;	 Lundberg	 et	 al.,	 2007;	 Morikawa	 et	 al.,	 2009;	 Nakamura	 et	 al.,	 2010;	 Steenhuis	 et	 al.,	 2008).	
Grcevic	 et	 al.	 (2012)	 previously	 demonstrated	 that	 the	 majority	 of	 the	 callus	 cells,	 including	
chondrocytes	 and	 osteoblasts,	 are	 derived	 from	 αSMA-expressing	 cells,	 thus	 qualifying	 αSMA	 as	 a	
marker	 of	 osteo-	 and	 chondro-progenitors.	 αSMA	 is	 known	 to	 be	 a	 marker	 of	 pericytes	 and	
myofibroblastic	 cells	 that	 identifies	 mesenchymal	 cells	 with	 proliferative	 and	 multi-lineage	
differentiation	potential	(Grcevic	et	al.,	2012;	Z.	Kalajzic	et	al.,	2008;	Roguljic	et	al.,	2013).	Specifically,	it	
has	 been	 observed	 that	 αSMA+	 cells	 isolated	 from	 periosteum	 exhibited	 skeletal	 progenitor	 cell	
characteristics,	including	the	expression	of	several	mesenchymal	progenitor	cell	markers	and	the	ability	
to	 differentiate	 along	 the	 osteogenic,	 chondrogenic	 and	 adipogenic	 lineage	 (Grcevic	 et	 al.,	 2012;	
Matthews	et	al.,	2014).	Periosteum	is	the	bone	compartment	from	which	most	of	the	cells	come	during	
the	 bone	 repair	 process,	 so	 it	 is	 of	 great	 interest	 in	 the	 study	 of	 identification	 of	 progenitor	 cell	
populations.	
The	mice	used	 in	 this	 study	 (SMACre/Ai9)	combine	a	 tamoxifen-inducible	Cre	 transgene	driven	by	 the	
αSMA	 promoter,	 and	 a	 Cre-activated	 fluorescent	 reporter	 tdTomato.	 This	 allows	 the	 tracking	 of	
developmental	progression	of	αSMA-expressing	cells	by	activating	the	expression	of	the	tdTomato	visual	
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reporter	through	Cre-mediated	recombination.	In	order	to	characterize	the	periosteum	cell	population,	
we	 performed	 flow	 cytometry	 analysis	 for	 stem	 cell	 surface	 markers	 expression.	 Mice	 were	 treated	
twice	 with	 tamoxifen	 before	 the	 sacrifice,	 and	 cells	 from	 the	 different	 bone	 compartments	 were	
collected.	We	excluded	from	the	analysis	the	cells	belonging	to	the	hematopoietic	and	the	endothelial	
lineages,	 gating	 for	 CD45/Ter119/CD31	markers.	We	 observed	 that	 all	 the	 stem	 cell	 surface	markers	
analyzed	are	expressed	 in	periosteum	cells.	 Specifically,	 the	 flow	analysis	 showed	a	 substantial	higher	
frequency	 of	markers,	 such	 as	 Sca1,	 PDGFRa,	 and	 CD90,	 in	 the	 periosteum	 compartment	 respect	 to	
endosteum	or	bone	marrow,	where	they	are	expressed	in	a	very	low	proportion	of	cells.	(Figure	5).		
	
 
Figure	5.	Stem	cell	surface	markers	are	expressed	in	a	high	number	of	cells	in	periosteum,	compared	
to	 endosteum	 and	 bone	 marrow.	 Cells	 from	 the	 different	 bone	 compartments	 were	 collected	 and	
analyzed	for	stem	cell	surface	markers	expression	by	flow	cytometry.	Cells	of	the	hematopoietic	and	the	
endothelial	 lineages	were	 excluded	 from	 the	 analysis.	 The	 graph	 shows	 an	 experiment	 in	which	 four	
groups	of	two	female-9-weeks-old	mice	each	have	been	used	(n=4).	We	repeated	the	same	experiment	
two	other	times,	and	we	obtained	the	same	trend	of	markers	frequency.	
	
aSMA	has	been	found	to	be	a	promising	marker	for	the	identification	of	progenitor	cells	(Grcevic	et	al.,	
2012;	Matthews	 et	 al.,	 2014),	 thus	we	 analyzed	 the	 frequency	 of	aSMA-labeled	 cells	 in	 the	 different	
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bone	compartments,	within	the	CD45-Ter119-CD31-	population.	We	observed	that	aSMA-labeled	cells	
are	more	abundant	in	periosteum	compared	to	endosteum,	and	that	they	are	almost	absent	in	the	bone	
marrow	(Figure	6).	 
 
Figure	 6.	 aSMA-labeled	 cells	 are	 more	 abundant	 in	 periosteum	 compared	 to	 the	 other	 bone	
compartments.	aSMA-labeled	cells	frequency	in	the	different	bone	compartments	was	analyzed	by	flow	
cytometry.	The	results	were	obtained	from	five	different	male	mice	of	7-8	weeks	of	age	(n=5).	
 
αSMA-labeled	cells	contribute	to	callus	osteoblasts	and	chondrocytes	formation	in	a	time-
dependent	way,	and	part	of	them	constitutes	a	local	population.	
Previous	 studies	 in	 Kalajzic’s	 lab	 have	 shown	 that	 αSMA-expressing	 cells	 contribute	 to	
chondrocytes	and	osteoblasts	formation	during	the	regenerative	process	(Grcevic	et	al.,	2012;	Matthews	
et	al.,	2014).	Our	interest	was	then	related	to	this	cells	activation	timing	and	their	origin.	On	these	bases,	
we	hypothesized	 the	existence	of	αSMA-expressing	 long-term	osteo-	 and	 chondro-	progenitors	 in	 the	
periosteum,	and	we	investigated	on	whether	these	αSMA-expressing	cells	were	tissue-resident.	For	this	
study,	 we	 used	 a	 tibial	 fracture	 mice	 model.	 To	 track	 the	 population	 of	 αSMA-expressing	 cells	 that	
contribute	 to	 generate	mature	 osteoblasts,	we	bred	 SMACre/Col2.3GFP	mice	 (Matthews	 et	 al.,	 2014)	
with	Ai9	mice,	obtaining	SMACre/Ai9/Col2.3GFP	mice.	Different	groups	of	mice	were	treated	twice	with	
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tamoxifen	 at	 different	 time	 points,	 which	 led	 us	 to	 permanently	 label	 αSMA-expressing	 cells,	 and	 to	
trace	their	progeny	during	the	fracture-healing	process	(Figure	7).		
 
Figure	 7.	 Experimental	 timeline.	Mice	were	 injected	 twice	with	 tamoxifen	 3	months,	 6	 and	 2	weeks	
prior	to	fracture,	at	the	fracture	time,	and	after	the	fracture.	All	the	groups	of	mice	were	sacrificed	7	and	
14	days	after	fracture.	
	
After	 the	 formation	 of	 the	 fracture	 callus,	 we	 collected	 and	 processed	 the	 tibias	 to	 quantify	 the	
fluorescent	 signals:	 red-tdTomato	 signal	 for	 αSMA-expressing	 cells,	 and	 green-Col2.3GFP	 signal	 for	
mature	osteoblasts.	The	colocalization	of	the	two	fluorescent	signals	is	represented	by	the	yellow	color	
(Figure	8A).	We	observed	that,	in	the	groups	of	mice	sacrificed	7	days	after	fracture	(Figure	8B),	about	
80%	of	osteoblasts	in	the	callus	are	also	αSMA-expressing	cells	when	the	label	occurs	soon	(day	0,	day	
+1)	after	fracture,	and	about	60%	when	it	occurs	on	the	day	of	fracture	(day	-1,	day	0).	In	the	groups	of	
mice	 sacrificed	 14	 days	 after	 fracture	 (Figure	 8C),	 we	 found	 about	 60%	 of	 αSMA+	 osteoblasts	 in	 the	
callus	 when	 the	 label	 occurred	 on	 the	 day	 of	 fracture	 (day	 -1,	 day	 0).	 These	 findings	 led	 us	 to	
hypothesize	that	αSMA	identifies	the	majority	of	osteoprogenitors	that	differentiate	into	osteoblasts	in	
the	fracture	callus.	This	percentage	decreases	as	the	labeling	is	induced	at	farther	time	points	from	the	
day	 of	 fracture.	 Based	 on	 these	 observations,	 we	 hypothesized	 that	 αSMA+	 periosteal	 cells	may	 not	
have	 significant	 self-renewing	 capabilities.	 After	 labeling	 the	 αSMA-expressing	 cells,	 3	months	 or	 2-6	
weeks	 later,	 some	 of	 those	 cells	 had	 either	 died	 or	 differentiated	 into	 a	 type	 of	 cell	 that	 does	 not	
proliferate	and	aid	in	the	fracture	healing.	There	are	most	likely	other	αSMA-negative	populations	in	the	
periosteum	that	also	contribute	to	osteoblasts	and	chondrocytes	in	the	callus.	
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Interestingly,	we	still	observe	a	subset	of	αSMA-expressing	cells	that	contribute	to	osteoblast	formation	
in	the	callus	at	 least	three	months	after	 labeling,	representing	a	 long	term	osteoprogenitor	population	
(Figure	8).	However,	this	result	is	not	statistically	significant	due	to	the	low	number	of	replicates,	thus	it	
will	be	interesting	to	repeat	this	experiment	to	consolidate	our	hypothesis.	
The	group	of	mice	that	did	not	get	tamoxifen	injections	showed	only	a	very	small	percentage	of	labeled	
cells,	 due	 to	 some	 spontaneous	 activation	 of	 the	 Cre	 recombinase.	 This	 negative	 control	 group	 is	
important	to	validate	the	reliability	of	the	mouse	model	system	we	used	for	the	study.			
	
 
Figure	 8.	αSMA	 identify	 the	majority	 of	 osteoprogenitors	 that	 contribute	 to	 the	 early	 stages	 of	 the	
healing	process.	Representative	images	of	a	tibia	fracture	callus,	with	ROIs	drawn	(right	image)	to	show	
how	 the	 image	 analysis	 was	 performed	 (A).	 αSMA-labeled	 cells	 are	 detected	 in	 the	 red	 fluorescence	
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channel,	Col2.3GFP-labeled	osteoblasts	 in	 the	green	one.	The	overlay	between	 the	 red	and	 the	green	
channels	is	represented	by	the	yellow	color.	Different	percentages	of	dual	labeled	cells	have	been	found	
in	 the	 fracture	callus	at	different	 time	points	of	 tamoxifen	 injection,	 in	groups	of	mice	sacrificed	7	 (B)	
and	14	(C)	days	after	fracture.	The	results	were	obtained	from	groups	of	5-7	female	mice	of	8	weeks	of	
age	at	time	of	tamoxifen	injection.	Tukey’s	multiple	comparison	test	(ANOVA)	was	applied.	Each	group	
of	mice	that	got	injected	with	tamoxifen	was	compared	to	the	negative	control	group.	*	p	<	0.05	
	
We	also	 investigated	αSMA-labeled	cells	 that	contribute	to	cartilage	 formation.	According	to	 the	well-
known	fracture-healing	process,	a	soft	callus	 is	 formed	within	5-10	days	after	 injury,	and	 it	 is	made	of	
fibrous	tissue	and	cartilage.	On	these	bases,	we	performed	Sox9	staining	on	day	7	fracture	sections	to	
detect	 the	 presence	 of	 chondrocytes.	 We	 detected	 non-specific	 staining	 in	 some	 sections,	 so	 we	
analyzed	the	 images	drawing	ROIs	that	had	both	Sox9	fluorescent	signal	and	chondrocyte	morphology	
(Figure	9).	We	observed	 that	 about	 40%	of	 chondrocytes	 in	 the	 callus	 are	 also	αSMA-expressing	 cells	
when	 the	 label	 is	 induced	 one	 day	 after	 fracture,	 and	 about	 30%	 when	 it	 is	 induced	 on	 the	 day	 of	
fracture,	and	that	this	value	decreases	depending	on	the	time	of	 labeling.	As	for	osteoblast	formation,	
we	 can	 conclude	 that	 αSMA-expressing	 cells	 contribute	 to	 chondrocytes	 generation	 after	 fracture,	
although	a	 lower	proportion	of	cells	 is	 labeled,	thus	suggesting	that	there	may	be	some	differences	 in	
the	cells	that	contribute	to	osteoblasts	respect	to	those	that	contribute	to	chondrocytes.		
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Figure	9.	αSMA-expressing	cells	contribute	to	chondrocytes	generation	after	fracture.	Representative	
images	of	a	tibia	fracture	callus	(A).	Sox9-positive	chondrocytes	are	detected	in	the	green	fluorescence	
channel,	 αSMA-labeled	 cells,	 in	 the	 red	 one.	 The	 overlay	 between	 the	 green	 and	 the	 red	 channels	 is	
represented	by	the	yellow	color.	Chondrocytes	can	be	distinguished	by	their	morphology,	too.	Different	
percentages	of	dual	 labeled	cells	have	been	found	 in	the	fracture	callus	 (B)	at	different	time	points	of	
tamoxifen	injection.	The	results	were	obtained	from	groups	of	5-7	female	mice	of	8	weeks	of	age	at	time	
of	tamoxifen	injections.	Tukey’s	multiple	comparison	test	(ANOVA)	was	applied.	Each	group	of	mice	that	
got	injected	with	tamoxifen	was	compared	to	the	negative	control	group.	*	p	<	0.05	
	
We	were	 also	 interested	 in	 investigating	 if	 αSMA-expressing	 cells	 contributed	 equally	 to	 the	 types	 of	
cells	throughout	the	callus.	Based	on	this	question,	we	compared	the	different	(middle	and	distal)	callus	
areas	 in	 terms	 of	 percentage	 of	 αSMA-labeled	 cells,	 7	 (Figure	 10A)	 and	 14	 (Figure	 10B)	 days	 after	
fracture.	We	observed	that	 the	proportion	of	αSMA-labeled	cells	 is	 related	to	the	timing	of	 tamoxifen	
administration,	 and	 that	 these	 cells	 show	 similar	 prevalence	 in	 both	 central	 and	 distal	 areas	 of	 the	
fracture	callus	(Figure	10).		
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Figure	10.	Similar	percentages	of	αSMA-labeled	cells	have	been	found	in	the	different	callus	area,	at	
all	the	different	time	points	of	tamoxifen	injection.	A	similar	trend	is	shown	7	(A)	and	14	(B)	days	after	
fracture.	 The	 results	 were	 obtained	 from	 groups	 of	 5-7	 female	 mice	 of	 8	 weeks	 of	 age	 at	 time	 of	
tamoxifen	injection.	
	
In	 order	 to	 confirm	 that	 the	 Col2.3GFP-labeled	 cells	 reflected	 what	 we	 already	 knew	 about	 the	
osteoblasts	 behavior	 in	 the	 fracture	 healing	 process,	 we	 compared	 the	 percentages	 of	 Col2.3GFP-
labeled	cells	(osteoblasts)	in	the	different	callus	area	(Figure	11).	We	observed,	as	expected,	that	7	days	
after	fracture	(Figure	11A)	osteoblasts	are	more	prevalent	in	the	distal	area	with	respect	to	the	middle	
one,	 while	 14	 days	 after	 fracture	 (Figure	 11B),	 the	 difference	 of	 osteoblasts	 prevalence	 through	 the	
callus	is	decreased,	due	to	callus	progression.		
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Figure	11.	The	difference	in	the	percentage	of	osteoblasts	distribution	in	the	callus	decreases	with	its	
progression.	A	higher	prevalence	of	osteoblasts	is	observed	in	the	distal	callus	area	7	days	after	fracture	
(A).	This	difference	decreases	14	days	after	 fracture	due	 to	callus	mineralization	 (B).	The	 results	were	
obtained	from	groups	of	5-7	female	mice	of	8	weeks	of	age	at	time	of	tamoxifen	injection.	
 
αSMA-labeled	cells	are	capable	of	density-independent	growth	in	vitro,	and	expand	but	do	not	
show	evidence	of	osteogenic	differentiation,	in	vivo.	
In	order	to	test	periosteum	αSMA-expressing	cells	ability	to	form	bone	when	isolated,	we	used	
SMACre/Ai9/Col2.3GFP	mice,	 injected	with	 tamoxifen,	 with	 or	 without	 bone	 injury.	 In	 this	 study,	 we	
injured	the	mice	with	a	scratch	injury,	an	alternative	to	the	fracture	in	which	the	exclusive	contribution	
of	periosteum	 is	more	clear	 (Figure	12).	 For	 this	procedure,	anesthetized	mice	were	 scratched	on	 the	
limbs	using	a	needle	through	the	skin	and	the	muscle.		
 
Figure	12.	Scratch	injury	representative	image.	Periosteal	activation	after	scratch	injury	is	shown	on	the	
left	 image,	 as	 highlighted	 by	 the	 Col2.3+	 cells	 (osteoblasts,	 green).	 Intact	 periosteum	 is	 shown	 in	 the	
right	image,	in	which	it	is	detectable	as	a	thin	layer.	bm=bone	marrow;	c=cortical	bone;	pe=periosteum.	
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We	 sorted	 by	 flow	 cytometry	 tdTomato-positive	 cells	 and	 tdTomato-negative	 cells	 within	 the	 CD45-
Ter119-CD31-	population.	Part	of	 these	cell	populations	were	used	to	establish	 low	densities	cultures,	
and	part	to	perform	in	vivo	transplantation	into	NSG	mice	with	calvarial	defect	(Figure	13).	
	
 
Figure	13.	Schematic	representation	of	experimental	procedure.	αSMA-expressing	cells	were	tested	for	
their	progenitor	properties,	by	in	vitro	low	density	culture	and	in	vivo	transplantation.			
	
Sorted	 cells	 were	 plated	 at	 low	 density	 to	 investigate	 their	 ability	 to	 grow	 in	 colonies,	 in	 a	 density-
independent	way	 in	 vitro,	which	 is	 a	 typical	 feature	 of	 progenitor	 cells	 (Figure	 14).	We	 visualized	 the	
colonies	 formation	 by	 performing	 Crystal	 Violet	 staining	 (Figure	 14A).	 We	 also	 tested	 the	 Alkaline	
Phosphatase	 (ALP)	 enzyme	 activity	 of	 the	 cells	 (Figure	 14B),	 as	 it	 represents	 a	 bone-related	 feature.	
tdTomato-positive	cells	enriched	for	colonies,	especially	 in	 injured	mice,	while	tdTomato-negative	cells	
almost	didn’t	enrich	for	colonies	at	all.	ALP	activity	was	detected	only	in	tdTomato-positive	cells	isolated	
from	injured	mice.	
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Figure	 14.	Quantification	 of	 tdTomato	 positive	 and	 negative	 colonies,	 in	 intact	versus	 injured	mice.	
Crystal	violet	stain	(A)	was	detectable	almost	only	in	tdTomato-positive	cells,	with	a	higher	prevalence	in	
injured	mice	respect	to	intact	mice.	ALP	activity	(B)	was	detectable	only	in	tdTomato-positive	cells	from	
injured	mice.	The	number	of	colonies	per	1000	seeded	cells	 is	shown	 in	the	graphs.	 	The	results	were	
obtained	from	2-3	groups	of	2-4	male	mice	each,	of	3-9	weeks	of	age,	and	two	technical	replicates.	
	
Sorted	tdTomato-positive	cells	from	SMACre/Ai9/Col2.3GFP	mice	were	also	used	to	evaluate	their	ability	
to	form	bone	in	vivo.	For	this	purpose,	we	chose	a	mouse	model	with	calvarial	defect,	which	reproduces	
a	condition	of	critical	size	defect	that	can	take	place	in	vivo.	Together	with	bone	marrow	stromal	cells	as	
carrier,	4-5000	tdTomato-positive	cells	were	 loaded	on	healos	and	placed	 into	 immunodepressed	NSG	
mice	with	 calvarial	 defect.	 After	 5	weeks,	mice	 calvaria	were	 collected	 and	 processed	 for	 fluorescent	
image	 analysis.	 tdTomato-positive	 transplanted	 cells	 showed	 a	 good	 engraftment	 into	 the	 defect,	
however	there	was	no	bone	formation,	as	highlighted	by	the	absence	of	Col2.3GFP-positive	cells	(Figure	
15).	 Interestingly,	 we	 observed	 some	 Col2.3GFP-positive	 cells	 in	 the	 transplanted	 tdTomato-negative	
	 79	
mice	 (data	 not	 shown),	 most	 likely	 due	 to	 osteogenic	 differentiation	 of	 other	 progenitor	 cells.	 This	
experiment	was	performed	one	time	only,	so	it	needs	to	be	repeated.	
	
 
 
Figure	15.	 tdTomato-positive	 transplanted	cells	 showed	a	good	engraftment	 into	 the	defect,	but	no	
bone	formation.	Mouse	x-ray	shows	the	calvarial	defect	of	the	skull	filled	with	the	scaffold	as	it	appears	
5	weeks	after	 the	surgery.	Calvarial	 section	 image	 is	here	magnified	 to	enable	 the	visualization	of	 the	
engraftment	 of	 αSMA-expressing	 cells	 (red	 color).	 Osteoblasts	 Col2.3GFP	 green	 signal	 was	 not	
detectable.	This	 is	 a	 representative	 image	 from	one	mouse.	The	experiment	has	been	performed	one	
time.	
 
Periosteum	CD105+	and	CD90+	cells	are	capable	of	density-independent	growth	in	vitro		
 Surface	 markers	 such	 as	 CD105	 and	 CD90	 have	 been	 defined	 as	 useful	 indicators	 for	
multipotency	 of	 cultured	 murine	 progenitor	 cells	 (I.	 Kalajzic	 et	 al.,	 2002).	 We,	 therefore,	 tested	
periosteum	 cells	 for	 the	 presence	 of	 these	 surface	markers.	 Cells	 isolated	 from	 periosteum	 of	 intact	
mice	were	sorted	by	flow	cytometry	by	using	antibodies	for	CD105	and	CD90	markers	(Figure	16).	Cells	
belonging	 to	 the	 hematopoietic	 and	 the	 endothelial	 lineages	 were	 excluded	 from	 the	 sorted	
populations,	 gating	 for	 CD45/Ter119/CD31	 markers.	 Sorted	 CD105+,	 CD105-,	 CD90+,	 and	 CD90-	 cell	
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populations	were	plated	at	low	density	to	investigate	their	ability	to	grow	in	colonies	in	vitro	(Figure	17).	
Within	7-8	days	from	seeding,	PrestoBlue	assay	was	performed	(Figure	17A),	and	we	observed	that	both	
CD105+	and	CD90+	cell	populations	were	able	 to	grow,	as	 confirmed	by	 the	 significant	enrichment	of	
colonies	respect	to	the	CD45-	control	population	detected	with	Crystal	violet	stain.	ALP	assay	showed	a	
significant	enzyme	activity	in	the	CD90+	cell	population,	while	it	appeared	almost	absent	in	the	CD105+	
cell	population	(Figure	17B).	Both	Crystal	violet	stain	and	ALP	stain	resulted	almost	undetectable	in	the	
negative	populations.		
 
 
Figure	 16.	 Flow	 cytometry	 sorting	 for	 CD105	 and	 CD90	 cell	 surface	markers.	 Periosteum	 cells	 from	
intact	mice	were	 sorted	by	 flow	cytometry	 to	 select	 the	CD105	and	CD90	 surface	markers	expressing	
populations.	The	hematopoietic	and	the	endothelial	cells	were	excluded	from	the	sort.	
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Figure	 17.	Periosteum	CD105+	 and	 CD90+	 cells	 are	 capable	 of	 density-independent	 growth	 in	 vitro.	
PrestoBlue	assay	on	sorted	cells	(A).	Quantification	of	Crystal	violet	stain	and	ALP	activity	on	sorted	cells	
(B).	 CD105+	 and	 CD90+	 populations	 significantly	 enrich	 for	 CFU-Fs	 compared	 to	 the	 CD45-	 control	
population,	while	CD105-	 is	 significantly	 lower	 compared	 to	 the	CD45-	 control.	 CD90+	 cell	 population	
significantly	enriches	for	CFU-ALPs	compared	to	the	CD45-	control	population,	while	CD105-	ALP	activity	
is	 significantly	 lower	compared	to	 the	CD45-	control.	The	number	of	colonies	per	1000	seeded	cells	 is	
shown	in	the	graphs.	The	results	were	obtained	from	2-3	groups	of	2-4	male	mice	each,	of	5-8	weeks	of	
age,	and	two	technical	replicates.	*	p	<	0.05	(paired	t	test	applied).	
 
Periosteum	Sca1+,	CD51+,	and	double-positive	Sca1+CD51+	cell	populations	are	capable	of	
density-independent	growth	in	vitro,	and	show	promising	results	of	osteogenic	differentiation	in	
vivo.	
 Sca1	 and	 CD51,	 as	 well	 as	 their	 combination,	 are	 potential	 marker	 for	 the	 identification	 of	
murine	mesenchymal	progenitor	cells	(Morikawa	et	al.,	2009).	On	these	bases,	we	tested	Sca1+,	CD51+,	
and	 double-positive	 Sca1+CD51+	 periosteum	 cell	 populations	 for	 their	 ability	 to	 form	 colonies	 in	 a	
density-independent	 way	 in	 vitro,	 and	 to	 differentiate	 into	 osteoblasts	 in	 vivo.	 Cells	 isolated	 from	
periosteum	of	 intact	and	 injured	SMACre/Ai9/Col2.3GFP	mice	were	sorted	by	flow	cytometry	by	using	
antibodies	 for	 Sca1	 and	 CD51	 markers	 (Figure	 18).	 Cells	 belonging	 to	 the	 hematopoietic	 and	 the	
endothelial	lineages	were	excluded	from	the	sorted	populations,	gating	for	CD45/Ter119/CD31	markers.	
Sorted	 Sca1+,	 CD51+,	 double-positive	 Sca1+CD51+,	 and	 double-negative	 Sca1-CD51-	 cell	 populations	
were	plated	at	low	density.	The	double	negative	population	was	plated	at	high	density,	too.		
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Figure	 18.	 Schematic	 representation	 of	 experimental	 procedure.	 Sca1+,	 CD51+,	 double-positive	
Sca1+CD51+,	 and	 double-negative	 Sca1-CD51-	 cell	 populations	 were	 tested	 for	 their	 progenitor	
properties	by	in	vitro	low	density	culture.			
	
Within	7-8	days	from	seeding,	PrestoBlue	assay	was	performed	for	both	intact	and	injured	mice	(Figure	
19,	A	 and	B).	 All	 the	 positive	 populations	 grew,	while	 the	 double	 negative	 one	was	 not	 able	 to	 form	
colonies.	Crystal	violet	stain	showed	that	Sca1+	and	double-positive	Sca1+CD51+	populations	grew	in	a	
significantly	higher	number	of	colonies	 respect	 to	 their	CD45-	control	 in	 the	 intact	mice	group	 (Figure	
20A),	 while	 only	 the	 Sca1+	 population	 significantly	 enriched	 for	 colonies	 in	 the	 injured	 mice	 group	
(Figure	20B).	ALP	assay	showed	a	slight	enzyme	activity	 in	 the	Sca1+	and	double-positive	Sca1+CD51+	
populations,	only	in	the	intact	mice	group	(Figure	20A).	Both	Crystal	violet	stain	and	ALP	stain	resulted	
undetectable	in	the	negative	populations.	
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Figure	19.	Periosteum	Sca1+,	CD51+,	and	double-positive	Sca1+CD51+	cell	populations	are	capable	of	
density-independent	 growth	 in	 vitro.	 PrestoBlue	 assay	 on	 sorted	 Sca1+,	 CD51+,	 double-positive	
Sca1+CD51+,	and	double-negative	Sca1-CD51-	cell	populations,	 in	the	 intact	mice	group	(A)	and	 in	the	
injured	ones	(B).	The	double	negative	population	was	not	able	to	grow.	The	number	of	colonies	per	1000	
seeded	cells	is	shown	in	the	graphs.	The	results	were	obtained	from	1-2	groups	of	2-3	male	mice	each,	of	
3-8	weeks	of	age,	and	two	(injured)-three	(intact)	technical	replicates.	
 
 
Figure	 20.	Periosteum	 Sca1+,	 CD51+,	 and	 double-positive	 Sca1+CD51+	 show	 stem	 cell	 properties	 in	
vitro.	 Quantification	 of	 Crystal	 violet	 stain	 and	 ALP	 activity	 on	 sorted	 cells	 from	 intact	mice	 (A),	 and	
injured	 mice	 (B).	 Sca1+	 and	 double-positive	 Sca1+CD51+	 populations	 significantly	 enrich	 for	 CFU-Fs	
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compared	to	the	CD45-	control	population,	 in	the	 intact	mice	only;	Sca1+	alone	enriches	for	CFU-Fs	 in	
the	injured	mice	only.	The	number	of	colonies	per	1000	seeded	cells	is	shown	in	the	graphs.	The	results	
were	 obtained	 from	 1-2	 groups	 of	 2-3	male	mice	 each,	 of	 3-8	weeks	 of	 age,	 and	 two	 (injured)-three	
(intact)	technical	replicates.	*	p	<	0.05	(paired	t	test	applied).	
	
Interestingly,	 we	 also	 sorted	 endosteum-derived	 cells	 from	 some	 of	 groups	 of	 animals	 used	 in	 the	
experiments	 above	 by	 flow	 cytometry	 using	 antibodies	 for	 the	 above-mentioned	 progenitor	 cell	
markers.	 We	 observed	 that	 sorted	 cells	 were	 able	 to	 grow.	 Specifically,	 the	 CD45-	 cell	 population	
showed	a	mean	CFU-F	value	of	0.75	colonies	per	1000	seeded	cells	 for	the	 intact	mice	group	versus	a	
mean	 of	 5.77	 observed	 in	 periosteum,	 and	 0.54	 colonies	 per	 1000	 seeded	 cells	 for	 the	 injured	mice	
group	versus	a	mean	of	2.48	observed	 in	periosteum.	These	 results	 confirmed	 that	periosteum	 is	 the	
most	progenitor-enriched	bone	compartment.		
	
In	 order	 to	 test	 Sca1+,	 CD51+,	 and	 double-positive	 Sca1+CD51+	 cells	 ability	 to	 differentiate	 into	
osteoblasts	 in	 vivo,	 sorted	 cells	 from	 the	 periosteum	 of	 R26-M2rtTA/TetOP-H2B-GFP	 mice	 were	
transplanted	into	immunodepressed	NSG	mice	with	calvarial	defect	(Figure	21).	In	order	to	activate	the	
tetO	 system,	 thus	 enhancing	 nuclear	 GFP	 expression	 in	 cells	 undergoing	 mitosis,	 we	 fed	 donor	 and	
recipient	mice	with	doxycycline	containing	food	starting	a	few	days	prior	to	surgery.	The	recipient	mice	
kept	receiving	the	doxycycline	diet	after	the	transplantation,	switching	from	food	to	water	the	last	week	
before	 the	 sacrifice.	 Sca1+,	 CD51+,	 and	 double-positive	 Sca1+CD51+	 loaded	 cells,	 which	 were	
respectively	2-4000	and	13-20000,	were	loaded	on	scaffolds	together	with	BMMSC	as	carriers.	
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Figure	 21.	 Schematic	 representation	 of	 experimental	 procedure.	 Sca1+,	 CD51+,	 and	 double-positive	
Sca1+CD51+	 periosteum	 cell	 populations	 were	 tested	 for	 their	 progenitor	 properties	 by	 in	 vivo	
transplantation.			
	
Five	weeks	after	 the	 transplant,	 calvaria	were	 collected	and	processed	 for	 fluorescent	 image	analysis.	
CD51+	 transplanted	 cells	 didn’t	 engraft	 in	 the	 defect,	 while	 interesting	 results	 were	 shown	 by	 Sca1+	
(Figure	22A)	 and	double-positive	 Sca1+CD51+	 (Figure	22B)	 transplanted	 cells,	which	 engrafted	well	 in	
the	defect,	and	seemed	to	give	rise	to	osteoblasts,	as	shown	by	the	colocalization	of	some	of	the	green	
donor	cells	with	the	ALP	stain	(red	color).	Cell	morphology	and	ALP	stain	can	help	in	identifying	potential	
osteoblasts,	 however	 we	 are	 looking	 for	 a	 better	 way	 to	 detect	 osteoblasts.	 Furthermore,	 this	
experiment	was	performed	one	time	(n=2	sorts),	so	it	would	be	interesting	to	repeat	it.	
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Figure	22.	Periosteum	Sca1+,	CD51+,	and	double-positive	Sca1+CD51+	cell	populations	show	promising	
results	 of	 osteogenic	 differentiation	 in	 vivo.	 Calvarial	 section	 images	 of	 transplanted	 Sca1+	 (A)	 and	
double-positive	 Sca1+CD51+	 (B)	 cells	 in	 NSG	mice.	 The	 images	 are	 here	magnified	 to	 appreciate	 the	
engraftment	 of	 the	 donor	 cells	 (green	 color)	 and	 the	 colocalization	 of	 some	 of	 them	 (possibly	
osteoblasts)	 with	 the	 ALP	 stain	 (red	 color).	 This	 is	 a	 representative	 image	 from	 one	mouse	 for	 each	
transplanted	marker.	The	experiment	has	been	performed	one	time.	
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Discussion	
Interstitial	acidic	pH	characterizes	various	pathological	conditions	(L.	Dong	et	al.,	2013;	Hardy	&	
Cooper,	2009;	Kraut	&	Madias,	2010;	Martin	&	Jain,	1994)	and	tissues	with	impaired	vascularization,	as	
well	as	fractures	(T.	R.	Arnett,	2010;	Newman,	Stone,	&	Mukherjee,	1987).	
These	conditions	are	characterized	by	pH	values	of	 interstitial	 fluids	 ranging	 from	pH	6.0	 to	pH	7.0	 (L.	
Dong	et	al.,	2013).	It	has	been	shown	that	extracellular	acidosis	is	able	to	modulate	MSCs	proliferation,	
differentiation,	 paracrine	 activity	 (Disthabanchong	 et	 al.,	 2007),	 stemness	 and	 regenerative	 potential	
(Mohyeldin	et	al.,	2010).	Similarly,	the	cell	process	autophagy	has	been	associated	with	the	regulation	of	
MSC	stem-like	features,	as	well	as	with	senescence	and	cell	death/survival	(Eom	et	al.,	2014),	and	can	be	
induced	by	acidic	conditions.		
The	activation	of	inflammatory	pathways	by	local	acidosis	(Lardner,	2001)	is	a	condition	typically	found	
in	 several	 chronic	 inflammatory	 diseases,	 associated	 with	 bone	 loss,	 secondary	 osteoporosis,	 thus	
increased	fracture	risk	with	impaired	bone	healing	(Claes	et	al.,	2012;	Hardy	&	Cooper,	2009).	Fracture	
healing	 is	 a	 regenerative	 process	 that	 involves	 coordinated	 responses	 of	 many	 cell	 types,	 but	 the	
characterization	of	these	specific	cell	populations	has	been	limited.	In	the	bone	repair	process,	MSCs	are	
essential	 elements	 that	 can	 contribute	 to	 bone	 healing	 directly,	 since	 they	 can	 differentiate	 into	
osteoblasts,	 and	 indirectly,	 with	 the	 secretion	 of	 cytokines	 and	 growth	 factors	 involved	 in	 the	
modulation	of	vascularization	and	 inflammatory	response	 (Granero-Moltó	et	al.,	2009).	Therefore,	 the	
infusion	 of	 MSCs	 represents	 a	 therapeutic	 approach	 to	 fracture	 healing	 (Rosset,	 Deschaseaux,	 &	
Layrolle,	 2014).	 However,	 the	 success	 of	 regenerative	 strategies	 may	 be	 impaired	 by	 a	 hostile	
extracellular	microenvironment	(Dimmeler,	Ding,	Rando,	&	Trounson,	2014;	Sui	et	al.,	2017).	
In	this	study,	we	focused	our	attention	on	how	acidic	extracellular	pH	can	affect	MSCs	behavior	in	terms	
of	proliferation,	osteogenic	potential,	activation	of	autophagy,	and	release	of	 inflammatory	molecules,	
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and	 looked	 for	potential	osteo-	and	chondro-progenitor	 cell	 populations	activated	during	 the	 fracture	
healing	process	in	the	periosteum	of	a	mouse	model	in	vivo.	
We	 cultured	 human	 BMMSCs,	 representing	 the	 most	 commonly	 used	 source	 of	 MSCs	 in	 clinical	
applications,	in	acidic	medium	of	pH	6.5	or	6.8,	to	reproduce	the	typical	microenvironment	of	the	above-
mentioned	 pathological	 conditions,	 and	 in	 physiological	 medium	 of	 pH	 7.4,	 as	 a	 standard-culture	
control.	We	observed	a	significant	decrease	in	BMMSCs	proliferation	at	low	pH	conditions,	as	revealed	
by	 the	 index	 quantification	 of	 the	 nuclear	 protein	 associated	 to	 cell	 proliferation	 Ki67	 (Scholzen	 &	
Gerdes,	2000).	Not	only	BMMSCs	proliferation,	but	also	their	mineralization	was	found	to	be	 impaired	
by	extracellular	acidosis,	as	shown	by	the	inhibition	of	mineral	nodules	formation	observed	at	pHe	6.5,	
compared	to	pHe	7.4.	The	significantly	reduced	ability	of	BMMSCs	to	deposit	mineralized	matrix	 in	an	
acidic	microenvironment	 had	 been	 previously	 described	 (T.	 R.	 Arnett,	 2008;	 Frick	&	 Bushinsky,	 1998;	
Kohn,	 Sarmadi,	 Helman,	 &	 Krebsbach,	 2002).	 Arnett	 (2008)	 has	 connected	 it	 to	 a	 decreased	 alkaline	
phosphatase	activity	and	an	 increased	solubility	of	hydroxyapatite	at	 low	pH,	which	 is	 in	 line	with	our	
observations.	 Interestingly,	 recent	 studies	 have	 demonstrated	 that	 a	 short-term	 exposure	 to	 pH	 6.5	
inhibits	glycolysis	in	MSCs	(Chano	et	al.,	2016),	and	cell	metabolism	variations	have	been	shown	to	exert	
an	 indirect	 control	 of	 cell	 differentiation	 (Agathocleous	 &	 Harris,	 2013),	 leading	 us	 to	 speculate	 that	
MSCs	metabolism	 is	modulated	by	extracellular	acidosis.	Overall,	our	observations	and	considerations	
show	 a	 close	 correlation	 between	 inhibition	 of	MSCs	 osteogenic	 mineralization	 and	 acidic	 pH	 of	 the	
extracellular	microenvironment.		
The	 survival	mechanism	 of	 autophagy	 is	 known	 to	 be	 activated	 by	 cells	 under	 acidic	 conditions,	 and	
previous	 literature	associated	 it	with	 the	 regulation	of	MSCs	 stem-like	 features	 (Kroemer	et	al.,	 2010;	
Sordella	et	al.,	2003).	Therefore,	we	evaluated	BMMSCs	autophagic	flux	by	protein	expression	of	typical	
autophagic	 markers	 (LC3-II,	 p62	 and	 Beclin1)	 at	 low	 and	 physiological	 pHs.	 We	 confirmed	 previous	
studies	showing	that	the	autophagic	flux	is	constitutively	activated	in	human	MSCs	(Oliver,	Hue,	Priault,	
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&	Vallette,	2012;	Salemi,	Yousefi,	Constantinescu,	Fey,	&	Simon,	2012),	as	evidenced	by	LC3-I	to	LC3-	II	
conversion	detected	 in	BMMSCs	cultured	at	physiological	pH.	However,	we	did	not	observe	significant	
differences	between	the	two	culture	conditions,	leading	us	to	conclude	that	autophagy	is	not	the	main	
mechanism	by	which	BMMSCs	adapt	to	an	acidic	microenvironment.		
Tissue	acidification	is	commonly	associated	with	inflammation	(Punnia-Moorthy,	1987),	and	consequent	
release	of	cytokines	(Lardner,	2001).	Indeed,	we	detected,	at	the	protein	level,	a	significant	increase	in	
IL-6	 and	 IL-8	 secretion	 at	 the	 acidic	 pH,	 compared	 to	 the	 physiological	 one.	 This	 effect	 caused	 by	
extracellular	pH	was	observed	24	hs	after	induction,	by	analyzing	the	cultures	supernatant	with	an	ELISA	
assay.	At	the	mRNA	level,	we	observed	an	increased	release	of	IL-6	and	IL-8	in	acidic	conditions,	as	well.	
The	high	variability	detected	 in	this	analysis	may	be	due	to	the	use	of	both	bone	marrow-derived	and	
adipose	 tissue-derived	MSCs.	 It	 is	well-known	 that	MSCs	 isolated	 from	different	 sources	 share	 similar	
biological	 features	 but	 display	 differences	 in	 immunophenotype,	 transcriptome,	 proteome,	
differentiation	 potential,	 and	 immunomodulatory	 activity	 (Jin	 et	 al.,	 2013;	 Strioga,	 Viswanathan,	
Darinskas,	 Slaby,	 &	 Michalek,	 2012).	 According	 to	 these	 considerations	 and	 our	 results,	 it	 would	 be	
interesting	to	further	characterize	MSCs	secretion	of	 inflammatory	molecules,	specifically	 investigating	
the	differences	between	different	sources.	These	observations	have	allowed	to	deepen	the	knowledge	
of	MSCs	biology	in	a	non-physiological	context,	which	can	be	observed	in	patients	with	an	altered	acid-
base	balance.	Restoring	physiological	pH	is	necessary	to	obtain	new	bone	deposition,	indeed	variations	
in	extracellular	pH	have	been	taken	into	consideration	for	the	development	of	novel	treatments	of	bone	
diseases	and	tissue	engineering	strategies.	
Inflammation	is	an	important	factor	during	bone	healing,	with	molecular	factors	and	immune	cells	acting	
locally	at	 the	 fracture	 site	 in	a	 finely	 tuned	sequence	of	events.	 Since	 the	periosteum	 is	an	 important	
source	of	 cells	 during	 fracture	healing,	we	 focused	on	 cells	 belonging	 to	 this	bone	 compartment.	 The	
periosteum	 is	 a	 tissue	 that	 responds	 rapidly	 to	 injury,	 makes	 a	 major	 cellular	 contribution	 to	 both	
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cartilage	and	bone,	and	promotes	angiogenesis	during	the	healing	process,	such	that	healing	is	impaired	
when	 the	 periosteum	 is	 absent	 (Colnot,	 2009;	 Ozaki	 et	 al.,	 2000;	 X.	 Zhang	 et	 al.,	 2005).	 Periosteal	
replacement	can	heal	critical-sized	bone	defects	in	animal	models	(Chang	&	Knothe	Tate,	2012;	Knothe	
Tate	 et	 al.,	 2007).	 Cells	 isolated	 from	 the	 periosteum	 may	 also	 be	 suitable	 for	 tissue	 engineering	
applications	(Agata	et	al.,	2007;	Ribeiro	et	al.,	2010).	However,	the	identity	of	mesenchymal	progenitor	
cells	within	the	periosteum	is	not	well	defined.	Previous	studies	in	Kalajzic’s	lab	have	identified	αSMA	as	
a	 marker	 of	 a	 population	 of	 mesenchymal	 progenitor	 cells	 in	 the	 periosteum	 that	 contributes	 to	
osteochondral	 elements	 during	 fracture	 healing	 (Grcevic	 et	 al.,	 2012;	 Matthews	 et	 al.,	 2014).	
Furthermore,	a	number	of	studies	have	shown	that	periosteal	cells	express	markers	such	as	CD105	and	
CD90	 in	 culture,	 but	 there	 have	 been	 very	 few	 studies	 that	 have	 characterized	 freshly	 isolated	 cells	
(Sakaguchi,	Sekiya,	Yagishita,	&	Muneta,	2005;	van	Gastel	et	al.,	2012).	
We	analyzed	cell	surface	markers	frequency	in	freshly	isolated	cells	of	the	periosteum	of	a	mouse	model	
in	 vivo,	 and	observed	 that	periosteum	 is	highly	enriched	 for	progenitor	 cell	markers	 compared	 to	 the	
other	bone	compartments.	This	is	a	notable	result,	since	it	represents	the	evidence	that	periosteum	is	of	
great	interest	in	the	identification	of	progenitor	cell	populations.	The	current	literature	investigating	the	
presence	of	 cells	 expressing	 stem	 cell	markers	 focuses	mostly	 on	 cells	 isolated	 from	bone	marrow	or	
total	bone	(Chan	et	al.,	2013;	Chan	et	al.,	2015;	Morikawa	et	al.,	2009),	while	our	result	pave	the	way	to	
further	 studies	 towards	 the	 analysis	 of	 the	 periosteum	 bone	 compartment	 as	 the	 main	 source	 of	
progenitors.	
Periosteum	 has	 also	 been	 found	 to	 be	 enriched	 in	 αSMA+	 cells	 compared	 to	 the	 other	 bone	
compartments.	 There	 are	 some	 studies	 in	 literature	 showing	 that	 αSMA-expressing	 cells	 give	 a	
substantial	 contribution	 to	 osteoblasts	 and	 chondrocytes	 generation	 after	 bone	 injury.	 Kinner	 et	 al.	
(2002)	detected	αSMA+	cells	in	a	mouse	tibia	fracture	model	3-7-14-21-28	days	after	fracture;	this	group	
observed	the	presence	of	αSMA+	cells	throughout	all	the	phases	of	the	heling	process,	specifically	in	the	
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periosteum	prominent	to	the	fracture	site,	and	their	co-expression	with	newly	formed	osteoblasts	and	
chondrocytes	 (Kinner	et	 al.,	 2002).	Mori	et	al.	 (2016)	has	 recently	demonstrated	 the	 co-expression	of	
αSMA+	 cells	 with	 Dkk3+	 cells	 after	 fracture;	 Dkk3	 is	 a	 secreted	 protein	 of	 the	 Dickkopf	 (Dkk)	 family	
(Krupnik	et	al.,	1999),	whose	physiological	role	and	biological	function	of	Dkk3	remain	largely	elusive;	in	
the	mentioned	study,	Dkk3+	cells	have	been	found	to	co-localize	with	αSMA+	cells,	and	increase	a	few	
days	 after	 fracture,	 then	 originating	 fibrocartilage	 elements	 (Mori	 et	 al.,	 2016).	 Previous	 studies	 in	
Kalajzic’s	lab	used	a	SMACre	mouse	tibia	fracture	model	to	analyze	αSMA-expressing	cells	2	and	17	days	
after	 fracture;	 the	presence	of	αSMA+	cells	was	detected	 in	newly	 formed	chondrogenic	 areas	of	 the	
fracture	 callus	 and	 areas	 of	 the	 new	 bone	 formation	 (Grcevic	 et	 al.,	 2012).	 Matthews	 et	 al.	 (2014)	
confirmed	αSMA+	cells	osteochondral	contribution	specifically	to	the	earliest	stages	of	fracture	healing	
(2	and	6	days	post	fracture),	and	demonstrated	αSMA+	cells	expression	of	progenitor	cell	markers	after	
fracture	(Matthews	et	al.,	2014).		
Our	 study	 aimed	 at	 investigating	 if	 this	 αSMA-expressing	 population	 involved	 in	 fracture	 healing	
identifies	a	long-term	resident	progenitor	cell	population.	Although	we	confirmed	the	previously	shown	
contribution	of	αSMA+	periosteal	cells	in	osteoblasts	and	chondrocytes	generation	in	the	fracture	callus	
(Grcevic	 et	 al.,	 2012;	 Kinner	 et	 al.,	 2002;	Matthews	et	 al.,	 2014;	Mori	 et	 al.,	 2016),	we	observed	 that	
some	of	these	cells	may	not	have	significant	self-renewing	capabilities.	Three	months	or	six/two	weeks	
before	 the	 injury	 event,	 some	 of	 the	 αSMA+	 periosteal	 cells	 that	 we	 labeled	 had	 either	 died	 or	
differentiated	 into	 types	 of	 cell	 that	 do	 not	 participate	 in	 the	 fracture	 healing,	 while	 perhaps	 other	
αSMA-negative	populations	in	the	periosteum	contribute	to	osteoblasts	and	chondrocytes	generation	in	
the	 callus.	 However,	 a	 subset	 of	 αSMA-expressing	 cells	 has	 been	 still	 found	 active	 as	 a	 long	 term	
osteoprogenitor	population	in	the	fracture	callus.	Furthermore,	we	showed	that	αSMA+	periosteal	cells	
labeled	 the	 day	 before	 and	 the	 same	 day	 of	 the	 injury	 have	 the	 ability	 to	 grow	 in	 vitro	 in	 a	 density-
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independent	 way,	 thus	 confirming	 their	 feature	 of	 progenitor	 cell	 population.	 Specifically,	 αSMA+	
enriched	for	about	20	colonies	per	1000	seeded	cells	in	the	intact	mice	group,	and	about	60	colonies	in	
the	injured	one.	CFU-ALPs	were	observed	only	in	the	αSMA+	cells	from	the	injured	mice	group,	and	the	
transplantation	 of	 αSMA+	 cells	 in	 a	 mouse	 model	 with	 calvarial	 defect	 showed	 good	 engraftment	
without	bone	formation.	According	to	our	observations	showing	that	injury	stimulates	αSMA+	periosteal	
cells	participation	in	osteoblasts	generation	during	the	bone	healing	process,	it	would	be	interesting	to	
transplant	periosteal	αSMA+	cells	freshly	isolated	from	injured	mice,	and	investigate	if	they	are	able	to	
form	bone.		
Several	studies	mainly	conducted	on	bone	marrow	or	total	bone	(Chan	et	al.,	2013;	Chan	et	al.,	2015;	
Morikawa	 et	 al.,	 2009)	 identify	 markers	 such	 as	 Sca1,	 CD51/Alpha	 V,	 PDGFRα,	 CD105	 and	 CD90	 as	
potential	 positive	markers	 for	 the	 identification	 of	murine	mesenchymal	 progenitor	 cells	 (Arai	 et	 al.,	
2002;	Kitaori	et	al.,	2009;	Lundberg	et	al.,	2007;	Morikawa	et	al.,	2009;	Nakamura	et	al.,	2010;	Steenhuis	
et	 al.,	 2008).	 In	 the	 present	 study,	 we	 observed	 that	 all	 the	 periosteal	 cells	 expressing	 the	 above-
mentioned	surface	markers	display	the	typical	stem	cells	ability	to	grow	in	a	density-independent	way	in	
vitro.	 Specifically,	 CD90+	 sorted	 cells	 enriched	 the	 most	 for	 both	 CFU-Fs,	 by	 forming	 more	 than	 40	
colonies	 per	 1000	 seeded	 cells,	 and	 CFU-ALPs,	 with	 almost	 30	 colonies	 grew	 per	 1000	 seeded	 cells.	
Unexpectedly,	injury	did	not	seem	to	stimulate	the	progenitor	phenotype	of	Sca1+,	CD51+,	and	double-
positive	Sca1+CD51+	cell	populations	 in	vitro,	as	shown	by	the	reduced	ability	to	grow	as	colonies	 in	a	
density-independent	way	observed	in	the	injured	mice	group,	compared	to	the	intact	one.		
Interestingly,	promising	results	are	shown	by	Sca1+,	and	double-positive	Sca1+CD51+	cells	after	 in	vivo	
transplantation	in	mice	with	calvarial	defect.	While	CD51+	transplanted	cells	alone	did	not	engraft	in	the	
defect,	 Sca1+	and	double-positive	 Sca1+CD51+	 transplanted	 cells	 appeared	 to	generate	osteoblasts	 in	
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this	model.	However,	 the	use	of	 transplantation	 in	mouse	with	calvarial	defect	as	a	system	to	analyze	
progenitor	 cells	 contribution	 to	 bone	 formation	 in	 vivo	 might	 not	 be	 the	most	 appropriate	 one.	 The	
mouse	 calvarial	 defect	 model	 has	 been	 shown	 to	 permit	 evaluation	 of	 drugs,	 growth	 factor,	 or	 cell	
transplantation	 efficacy,	 together	 with	 offering	 the	 benefit	 of	 utilizing	 genetic	 models	 to	 study	
intramembranous	bone	formation	within	defect	sites	(Samsonraj	et	al.,	2017;	Wu,	Wang,	Deng,	&	Watts,	
2014).	However,	recent	studies	underline	the	importance	of	ectopic	bone	formation	models	in	vivo,	such	
as	the	kidney	capsule	transplantation.	The	kidney	capsule	model	is	a	method	of	ectopic	bone	formation,	
in	which	material	 is	 placed	 between	 the	 thin,	 fibrous	 capsule	 of	 the	 kidney	 and	 the	 underlying	 renal	
parenchyma.	 Significant	 features	 of	 the	 renal	 capsule	 model	 include	 increased	 blood	 flow	 to	 the	
implant,	 which	 helps	 engrafted	 cells	 to	 survive	 and	 proliferate	 once	 in	 place,	 theoretical	 lack	 of	
endogenous	bone-forming	stem	cells,	 thus	 it	 is	almost	certain	 that	 the	engrafted	cells	are	 responsible	
for	any	observed	bone	formation,	and	size	limitations	of	the	implant,	a	very	determinant	feature	when	
the	model	used	is	a	mouse	(Chun	et	al.,	2011;	S.	H.	Park	et	al.,	2006;	Slater,	Lenton,	James,	&	Longaker,	
2009;	 Yu	 et	 al.,	 2007;	W.	 Zhang,	 Liu,	Wang,	 &	 Li,	 2011).	 In	 general,	 ectopic	 bone	 formation	 models	
reduce	 the	 number	 of	 variables	 involved	 in	 bone	 formation,	 thus	 it	 would	 be	 interesting	 to	 further	
investigate	this	kind	of	model	for	our	progenitor	cells	studies	in	vivo.		
	
Summarizing,	 in	 this	 study,	 we	 showed	 the	 close	 correlation	 between	 MSCs	 behavior	 and	 the	
surrounding	extracellular	microenvironment.		
Specifically,	MSCs	 proliferation	 and	mineralization	 potential	 decrease	 at	 low	 pH	 conditions,	while	 the	
release	 of	 cytokines	 such	 as	 IL-6	 and	 IL-8	 increases.	 Notably,	 we	 observed	 a	 high	 variability	 within	
cytokines	 mRNA	 analysis,	 which	 we	 attributed	 to	 the	 use	 of	 MSCs	 derived	 from	 different	 sources,	
BMMSCs	and	ADMSCs.	This	 result	 led	us	to	consider	 further	studies	aimed	to	clarify	 the	discrepancies	
existing	 among	 the	 different	 MSCs	 sources	 of	 isolation,	 in	 the	 light	 of	 their	 importance	 in	 clinical	
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applications	of	regenerative	medicine.	Recent	studies	show	that	extracellular	acidosis	can	be	overcome	
by	 using	 specific	 drugs,	 and	 this	may	 improve	 the	 process	 of	 bone	 regeneration,	 usually	 impaired	 in	
patients	with	chronic	sub-acidosis	(Amer	et	al.,	2011;	W.	Chen	&	Abramowitz,	2014).		
Autophagy	 was	 found	 to	 be	 activated	 by	 MSCs	 at	 the	 same	 level	 in	 both	 acidic	 and	 physiological	
conditions.	We,	thus,	concluded	that	autophagy	is	not	the	main	mechanism	that	BMMSCs	activate	in	an	
acidic	microenvironment,	most	likely	there	are	other	processes	involved,	so	further	studies	are	needed.	
An	altered	extracellular	microenvironment	characterizes	the	early	stages	of	the	fracture	healing	process,	
and	 the	 identification	 of	 the	 cells	 participating	 in	 bone	 repair	 is	 necessary	 to	 eventually	 improve	
therapeutic	approaches	of	regenerative	medicine.	The	periosteum	is	the	major	contributor	of	progenitor	
cells	during	bone	healing.	Although	we	observed	that	αSMA+	periosteal	cells	may	not	have	significant	
self-renewing	capabilities,	we	demonstrated	that	markers	previously	characterized	in	bone	marrow	are	
suitable	for	identification	of	stem/progenitor	cell	populations	in	periosteum.	Further	studies	are	needed,	
especially	 aimed	 to	 better	 investigate	 different	 surface	markers	 combination,	 and	 the	 ability	 of	 these	
progenitor	 cells	 to	 form	 bone	 in	 vivo,	 by	 increasing	 the	 number	 of	 replicates,	 and	 overcoming	 the	
technical	issues	we	experienced.		
	
In	conclusion,	we	highlighted	the	 importance	of	the	extracellular	microenvironment	 in	the	modulation	
of	MSCs	behavior,	and	contributed	to	the	 identification	of	osteo-	and	chondro-progenitors	 involved	 in	
bone	repair,	aiming	to	improve	approaches	of	regenerative	medicine,	especially	in	patients	in	which	the	
healing	process	is	impaired	by	pathological	conditions.		
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